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Summary
Adipose tissue plays a central role in the regulation of metabolic homeostasis. In
obesity adipocytes are challenged by many insults: surplus energy, inflammation,
insulin resistance and considerable endoplasmic reticulum (ER) stress. ER stress has
been casually linked to increased inflammation and insulin resistance. Also, obesity
linked type 2 diabetes is associated with hyperglycaemia, lipotoxicity and
endotoxemia. Therefore, the aims of this thesis briefly were to 1) characterise human
pre-adipocytes during differentiation, as a suitable primary cellular model to examine
intracellular pathways, 2) investigate the role of glucose and fatty acids on ER stress
pathway; as these primary insults are considered to have clear impact on
inflammation, insulin resistance (IR) status and diabetes pathogenesis 3) to examine
the role of lipopolysaccharide (LPS), a gut derived bacterial fragment, on ER stress;
as LPS is now considered a systemic circulating factor raised in conditions of IR, 4)
the role of salicylate, known to have anti-inflammatory properties which may negate
or at least attenuate the effects of ER stress.
Components of the ER stress pathways were studied in human abdominal
subcutaneous (AbSc) adipose tissue (AT) from obese and lean subjects. Following
characterisation, culture and differentiation of primary human pre-adipocytes, these
adipocytes were treated with lipopolysaccharide (LPS), high glucose (HG),
tunicamycin (Tun) and saturated fatty acids (SFA) either alone or in combination with
sodium salicylate (Sal). Quantitative RT-PCR, western blotting, adipokine analysis
were used to assess expression levels.
XXII
Markers of ER stress were significantly increased in AbSc AT from subjects with
obesity (P<0.001). Differentiated primary human adipocytes treated with LPS, Tun,
HG and SFA showed significant activation of p-eIF2α and ATF6 and their down-
stream targets (P<0.05). This effect was alleviated in the presence of Sal. There was
also significant activation of AktSer473 during ER stress (P<0.05).
This thesis presents important evidence that firstly, there is increased ER stress in
human adipose tissue of obese individuals, secondly, LPS, hyperglycaemia and
saturated fatty acids induce significant ER stress in primary human adipocytes and
finally that induction is alleviated by salicylate. Taken together these studies
highlights that ER stress occurs in human differentiated pre-adipocytes is exacerbated
in conditions of high glucose, high saturated fatty acids and LPS, as well as
determining that such primary insults can be reduced by salicylates providing initial
evidence that therapeutic agents have the potential capacity to alleviate ER stress in
human adipose tissue.
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Chapter 1
Introduction
21.1 Definition and Epidemiology of Obesity
Obesity is defined as an excessive accumulation of fat that may impair health (WHO). According
to the World Health Organisation there were 400 million obese adults in 2005 and it is estimated
that there will be more than 700 million obese adults by 2015. Due to the widespread of obesity
across the world, obesity is now considered to have reached pandemic proportions (pandemic
being the widespread of obesity across geographical locations (WHO, 2006)).
Within the UK population, obese individuals account for 23% of total population in 2003
(NHS, 2010). By 2007, the UK Department Office for Science published a report, FORESIGHT
REPORT, addressing the prevalence of obesity in the UK. In this report the scientific panel
estimated that 40% of Britons will be obese by 2025 which will make Britain an obese society by
2050 (Butland et al, 2007). However such obesity is not limited to the UK, the world’s largest
economy, United States of America, has shown an alarming increase in obese population since
the 1960’s (NHLBI, 2000). With a population around 240 millions the latest published reports
estimate obese population to be over one third of Americans, 33.8 %, as such this currently
suggests just under 73 million people are managing with obesity daily (Flegal et al, 2010).
Indeed, obesity is such a worldwide problem that it is not just affecting the western world but
emerging economies such as China, India as well as the developing countries in the Middle East.
In 2002, data showed that obese individuals comprised about 2.6 % of the Chinese population
(Wu, 2006). Although, the percentage may appear small, its translation into 26 million of
individuals which will have future significance in the biggest populated nation on earth.
Currently, WHO estimates obesity levels in China lie just under 5%. This is an alarming increase
in obesity levels coming from a nation once considered to have the leanest population. India is
3also following suite and obesity is acknowledged as a rising health risk indicator (Agrawal,
2002). As per 2006 reports, obesity rates range between 12.1 % and 14.8 % for men and women
respectively (IIPS, 2006). Surprisingly, countries in the Middle East are claiming their territory
on the obesity map as well. A study published in 2005 suggested that an overall obesity
prevalence of 35.5 % in the Kingdom of Saudi Arabia (Al-Nozha et al, 2005) whilst the United
Arab Emirates, although small in size and population also reported high prevalence of obesity
(Malik & Bakir, 2007) The epidemic of obesity is so global that it has proven that no region of
the world is spared. Even those considered poor African countries that are classified as under-
nuritioned nations are being hit by the obesity epidemic. It has become apparent that obesity now
co-exists alongside under-nutrition in the African continent (Kruger et al, 2005).
1.2 Consequences of Obesity
As is the case with any ailment, obesity is a health condition that bears medical, psychological
and economic consequences. The following sections will look at these aspects in more detail
1.2.1 Medical
The scientific evidence is mounting rapidly of the medical consequences associated with obesity.
It has been shown that obesity is linked to cardiovascular diseases such as heart conditions and
strokes (Poirier et al, 2006; Lavie et al, 2009; Arsenault et al, 2010). Obesity predisposes to
diabetes (Mokdad et al, 2003; Lazar, 2005; Dandona et al, 2005; Freemantle et al, 2008) and is
associated with musculoskeletal disorders such as osteoarthritis (Wearing et al, 2006; Krul et al,
42009; Anandacoomarasamy et al, 2008). Some medical research has also linked obesity to the
development of some cancers such as endometrial, colon and breast cancers (Rapp et al, 2005;
van Kruijsdijk et al, 2009; Fleming et al, 2009; Sinicrope & Dannenberg, 2011; Roberts et al,
2010).
1.2.2 Psychological
Obese individuals are often stigmatised and it has been often socially acceptable to become the
centre of ridicule. Even the modern media and film-industry play a part in promoting this social
attitude towards obesity. These social pressures manifest themselves in the form of psychological
disorders suffered by the obese individuals. These disorders range from low-self esteem and
social isolation from the rest of the community to clinical depression. Psychologically, self-
isolation and clinical depression often prelude to increased food intake as a compensatory
measure for loneliness which creates a vicious cycle that revolves around obesity (Friedman et
al, 2002; Pratt et al, 2007; Gariepy et al, 2010).
1.2.3 Economic
The world has started to realize the economic and financial implications of obesity. The world
health organization and governments of the industrialized world are feeling the burden of the
increasing requirement to deal with obesity associated diseases; all of which presents a
developing substantial burden in order to either treat current conditions or long-term look into
prevention programmes. In England, the economic cost of treating obesity and its associated
5ailments was estimated to be over four billion pounds in 2007 (Butland et al, 2007; Swanton,
2008) whereas the estimates in the United States of America were over 75 billion dollars in 2000
(CDC, 2009) and both estimates are rising annually (Sassi et al, 2010).
1.2.4 Global Intervention
In response to the realisation of
a) the medical, social and economic implications of obesity and
b) its epidemic proportions
Many countries have created different organizations, societies and research centres to address the
wide spread of obesity and find practical solutions to its associated problems. Indeed, obesity has
become a major and urgent issue for the International obesity task force (IOTF). This
organisation was established to provide guidelines and propose policies to combat obesity
(IASO, 2011). Such guidelines examined adult populations and their needs as well as looking
long term to examine the needs and potential prevention requirements for children to reduce the
developing obesity epidemic in this group. Childhood obesity has been increasingly reported in
many countries, whether industrialised or developing, and these countries highlight the rise and
the concern for the next generation as childhood obesity develops widely (Malik & Bakir, 2007;
Ji, 2008; Jafar et al, 2008; Gill et al, 2009; Sullivan, 2010; Stamatakis et al, 2010).
61.3 Measurement of Obesity
Epidemiological studies which were carried out just after World War II concluded that the best
practical formulae to reflect the range of body weight indices was dividing the weight in
kilograms by the square of height in meters [Weight (kg) / height (m2)]. This ratio was called the
Quetelet Index after Adolphe Quetelet (1796 – 1874), he was a Belgian social scientist and
statistician who pioneered this kind of epidemiological studies. However, Quetelet Index was
changed into Body Mass Index (BMI) by Ancel Keys in 1972 (Eknoyan, 2008) which has
become familiar to most people as a way of categorising body weight.
Classification BMI(kg/m
2)
Principal cut-off points
Underweight <18.50
 Severe thinness <16.00
 Moderate thinness 16.00 - 16.99
 Mild thinness 17.00 - 18.49
Normal range 18.50 - 24.99
Overweight ≥25.00
 Pre-obese 25.00 - 29.99
Obese ≥30.00
 Obese class I 30.00 - 34.99
 Obese class II 35.00 - 39.99
 Obese class III ≥40.00 
Table 1.3.1 Categorising humans based on body mass index into different groups,
underweight, normal range, overweight or obese classes. (www.who.int/bmi)
7Due to the broad range of body weights, the world health organization has divided body mass
index into categories as shown in the table 1.3.1.
It is important to note that body mass index, waist circumference and waist-hip ratio can give a
relatively clear index of potential risk by using such simple measurements. Primary care
physicians find such measurements easy to determine from patients and monitor; noting caution
that this is not to determine muscle mass to fat mass ratio. However such assessment of adipose
tissue only gives an approximate idea concerning general total body fat; more accurate
measurement of adipose tissue mass and distribution can be obtained by performing
sophisticated analytical procedures such as Computed Tomography (CT), Dual Energy X-ray
Absorption (DEXA) and Magnetic Resonance Imaging (MRI) (Bosello & Zamboni, 2000;
Bozzetto et al, 2010; Kuk et al, 2005; Gallagher et al, 2009).
1.4 Diabetes
Obesity predisposes to many conditions including type 2 diabetes Mellitus (T2DM). According
to the world health organisation, T2DM is defined as “a chronic disease that occurs either when
the pancreas does not produce enough insulin or when the body cannot effectively use the insulin
it produces” (WHO, 2011). Insulin aids target tissues such as liver, fat (adipose tissue) and
muscle, to uptake glucose from the blood stream for metabolism. Depending on the cause,
diabetes is classified into three different types as follows:-
8I. Type 1 diabetes where the pancreas does not produce sufficient insulin for
blood glucose metabolism. This type of diabetes can only be controlled by
life-long and daily administration of insulin.
II. T2DM where there is sufficient amount of circulating insulin in the blood but
the target body tissues are not responsive enough to the circulating insulin.
Controlled management of this type of diabetes ranges from physical
activities and diet to insulin sensitizers and agonists.
III. Gestational diabetes is defined as a state of increased blood glucose during
pregnancy. This type of diabetes is pregnancy-related and can be cured if
managed properly during pregnancy.
There are also conditions which prelude to diabetes such as impaired glucose tolerance (IGT)
and impaired fasting glycaemia (IFG); these two states form intermediaries, where blood glucose
levels are bordering the cut-off points, between normality and diabetes. People with impaired
glucose tolerance and impaired fasting glycaemia are at higher risk than normal people in
becoming diabetic in later life.
1.4.1 Prevalence of Diabetes
T2DM is the most common form of diabetes comprising about 90% of diabetics. According to
the current estimates, there are more than 220 million diabetics worldwide and the number is
rising annually (WHO, 2011). In England, the prevalence of diabetes is about 5.4% in 2009
(NHS, 2010) whereas its prevalence in the United States of America is estimated at about 7.8%
in 2007 (NIDDKD, 2011). Globally, the prevalence of diabetes show surprising results being
9most prevalent in developing countries. The ten top countries of diabetes prevalence lie in the
Middle and Far East regions of the world (IDF, 2006).
1.4.2 Complications of Diabetes
As T2DM progresses, it starts affecting different body tissues. Therefore, its range of
complications is wide and varied. Complications of T2DM have been well established (Reenders
et al, 1993; Fowler, 2008; Mazzone et al, 2008; Moore et al, 2009). Patients with Diabetes have
much higher risk of developing cardiovascular diseases (Kannel & McGee, 1979; Fox et al,
2007; Kelly et al, 2009), late stages of diabetes can lead to neuropathy (Caputo et al, 1994;
Resnick et al, 2002; Mert et al, 2010), retinopathy (Kahn & Bradley, 1975; Bodansky et al,
1982; Moloney & Drury, 1982; Fong et al, 2004) and nephropathy (Borchjohnsen et al, 1992;
Parving et al, 2001; Schena & Gesualdo, 2005).
In neuropathy, the patient with T2DM starts losing sensation and feeling in limbs, most
commonly feet, which may end up in amputation of the limb; in diabetic retinopathy, the
patient’s eye sight begins to deteriorate until blindness; and in nephropathy, progressive diabetes
affects the functionality of the kidney resulting in kidney failure eventually. It is evident that late
stages of T2DM can be fatal. However, fatal consequences of T2DM can be triggered at any
stage of diabetes if it is uncontrolled such as in the case of developing ketoacidosis. Subjects
with T2DM are also higher vulnerability to infections. It is also worth noting that patients with
T2DM are prone to psychological depression as well (Lin et al, 2010).
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1.4.3 Global Impact
Due to the increasing prevalence of T2DM and the wide range of complications associated with
it, world economies expenditure on treatment and prevention is totalling billions of dollars
(Zimmet et al, 2001; Yach et al, 2006). Worldwide there are many organisations and societies
formed in response to the urgent need for advisory and research bodies to promote diabetes
prevention and improve its treatment (IDF, 2006).
1.4.4 Obesity-Induced Diabetes or Diabesity
The link between obesity and diabetes is evident as research progression indicates (Astrup &
Finer, 2000; Freemantle et al, 2008). This close link prompted some researchers to coin a new
term elucidating this link, diabesity (Astrup & Finer, 2000; Farag & Gaballa, 2011). Although,
obesity is a risk factor for developing T2DM, it should be noted that not all obese subjects are
diabetic nor will develop diabetes at later stage. As mentioned earlier that obesity is a risk factor
for CVD as well, as such morbid obesity coexists with heart attacks, strokes, hypertension and
T2DM. These associated factors led to the existence of a cluster of pathologies collectively
termed metabolic syndrome or syndrome X (James et al, 2004; Weiss et al, 2004; Bruce et al,
2011; Han & Lean, 2011). World health organisation set five defining criteria for diagnosing
metabolic syndrome. Those criteria were slightly simplified by the international diabetes
federation so that they become more practical and could be accommodated for use in the clinics
by physicians (Table 1.4.4.1).
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Criteria for diagnosis of metabolic syndrome:
1. Central obesity (waist circumference of ≥ 94 cm for European men and ≥ 80 cm for 
European women, with ethnicity specific values for other groups)
In addition to any TWO of the following four factors:
2. Raised triglyceride level:  (≥150 mg/dL or 1.7 mmol/L) 
Or specific treatment for this lipid abnormality
3. Reduced high density lipoprotein, HDL: (<40 mg/dL or 1.03 mmol/L in males)
and (<50 mg/dL or 1.29 mmol/L in females)
Or specific treatment for this lipid abnormality
4. Raised blood pressure: (systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg 
Or treatment of previously diagnosed hypertension
5. Raised fasting plasma glucose, FPG: (≥100 mg/dL or 5.6 mmol/L 
Or previously diagnosed type 2 diabetes
Table 1.4.4.1 The new International Diabetes Federation (IDF) definition, 2011
The recommendation from the IDF was that three out of the five criteria should be present in a
patient for the condition to be diagnosed as metabolic syndrome. However, one single criterion is
central to the diagnosis of metabolic syndrome, namely increased body waist circumference;
meaning this criterion must always be one of the three factors (James et al, 2004). This emphasis
on abdominal obesity proves the instrumental role played by obesity compared with other
morbidities; one of which is T2DM. An increase in waist girth has been shown to be a valid
indicator of morbid obesity and a risk factor associated with other diseases such as CVD and
T2DM, hence the current emphasis on the measurement of the increase in body waist
circumference. Another important aspect of measuring the waist circumference is its practicality
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and ease of its use in the clinic (Grundy, 2004; Despres & Lemieux, 2006; Yoshimura et al,
2011). Obesity-induced diabetes has been the theme of research for the last decade to elucidate
the mechanisms by which it can develop. The current answer to the question of how obesity
causes T2DM directs us to the core of obesity, the role of adipose tissue. The widely accepted
explanation is that chemical messengers secreted by adipose tissue interfere with the action of
insulin in the target tissues leading to a phenomenon called insulin resistance (Bosello &
Zamboni, 2000; Weiss et al, 2004; Despres & Lemieux, 2006; Han & Lean, 2011).
In this condition, target tissues such as liver, muscle and adipose tissue itself all become
insensitive to the normal level of circulating insulin in the bloodstream. This results in increased
level of glucose in the blood and glucose starvation in the target tissue which responds by
synthesising glucose, gluconeogenesis as is the case in of liver and muscle. In addition, liver
cells secrete glucose into the blood stream which increases the glucose level even further, thus
creating a vicious cycle. Adipose tissue in itself is a target tissue for insulin and insulin resistance
in adipose tissue which may induce even more detrimental consequences on health such as
hypertriglyceridemia and ectopic adiposity. Hypertriglycerdemia adds a compounding effect to
insulin resistance by interfering with insulin action at the cellular level. Ectopic adiposity is the
deposition of fat outside the adipose tissue such as liver, muscle, heart and kidneys. Ectopic
adiposity occurs when the adipose tissue is overloaded and excess fat is transferred to other sites
for deposition. Ectopic adiposity exacerbates the pathologic effects of adipose tissue as it
compromises the functionality of the other tissues as TG are not supposed to be stores in these
organs (Bosello & Zamboni, 2000; Yoshimura et al, 2011). For these reasons adipose tissue is
the focus of ongoing research.
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1.5 Adipose Tissue
For many years, adipose had been regarded as the storage site of excess energy in the form of
triglycerides. During prolonged postprandial fasting those triglycerides are broken down into free
fatty acids and metabolised to produce energy units, Adenosine Tri Phosphate (ATP). The free
fatty acids are secreted into the bloodstream to be metabolised by the liver as well. Another
function of adipose tissue is to act as a physical cushion from external physical bodily insults and
a thermal insulator from cold. Adipose tissue plays a more active role in the body
thermoregulation where it produces heat in a process called thermogenesis. The main component
of adipose tissue is adipocytes (Figure 1.5.1). Nonetheless, it contains other cell types which are
collectively referred to as the Stromal Vascular Fraction (SVF). Stromal vascular fraction
consists of cells such as pre-adipocytes, mature adipocytes, vascular cells, nerves, macrophages
and fibroblasts (Gesta et al, 2007).
A B
Figure 1.5.1 This shows human (panel A) pre-adipocyte cells during proliferation
and (panel B) mature lipid filled adipocytes. (Magnification x20)
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There are two types of adipose tissue: white adipose tissue (WAT) and brown adipose
tissue (BAT). These two types are distinctive both in terms of histology and function. The
reference to brown fat occurs due to colour distinction based on the morphological appearance of
adipocytes (Figure 1.5.2). Brown adipocytes contain much more mitochondrial organelles, thus
appearing brown when viewed under the microscope (Gesta et al, 2007). WAT is unilobular and
considered to acts as a storage facility for free fatty acids (although also has a multitude of other
important endocrine functions regulating appetite and insulin sensitivity through release of
adiopkines discovered over recent years). In contrast, the main function of BAT is to generate
heat for the organism through non-shivering effects of uncoupled oxidative metabolism, utilizing
Uncoupling Protein 1 (UCP-1). Histologically, BAT appears multilobular and contains an
abundance of mitochondria, providing its brown coloration.
A B
Figure 1.5.2 Histological comparison of human (A) brown adipose tissue showing dense
intracellular matter observed with red staining and (B) white adipose tissue showing mature
(lipid filled) adipocyte cells without dense intracellular matter (denoted by a honeycomb appearance).
(A, B: x 20 magnification).
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Due to its function as heat-generating tissue, BAT also has a rich blood supply to
improve the efficiency of heat transport around the organism (Enerback, 2010a; Enerback,
2010b). Due to their relatively large surface area to volume ratios, BAT developed evolutionarily
in small mammals as a means to avoid reductions in body temperatures resulting from relatively
large losses of heat from the skin. Human neonates also contain a relatively large amount of
inter-scapular BAT which is presumably an adaptive response to a proportionately large amount
of heat dissipation from the skin of human neonates (compared with human adults).
There has been a resurgence of interest in BAT in recent years following the discovery
that human adults (in addition to human neonates) also have some BAT. There is also evidence
that the activity of BAT (shown on Positron Emission Tomography Computerized Tomography
Fluoro-Deoxy-Glucose [PET/CT FDG] uptake scans) in human adults correlates with age, BMI
and sex with more BAT occurring in young and lean women (Pfannenberg et al, 2010; Lee et al,
2010). There is even evidence that BAT activity (shown on PET/CT FDG uptake) varies in the
same individual over time, and that this variance in BAT activity also correlates with
longitudinal changes in BMI in the same individual (Lee et al, 2010). Potential seasonal changes
in BAT activity, independent of changes in BMI, could be of further interest. From a research
perspective, the presence of BAT in adult humans is interesting as BAT activity, through the
generation of heat, expends energy in the process and therefore holds the potential to affect
metabolic rate and promote weight loss. In addition to appetite and exercise, a further novel
approach to managing obesity might be through manipulation of BAT and therein lies an
important goal for the future. Despite its clear relevance for human metabolism, and its potential
for therapeutic manipulation, a major obstacle to the study of human BAT to date has been the
lack of a safe, reliable, accurate, sensitive and reproducible means of quantifying the amount of
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BAT present through techniques such as imaging and other biochemical biomarkers. Without
such techniques, it is difficult to derive meaningful conclusions about the role of BAT in humans
Research into the genetic profile of adipose tissue found some difference in gene
expression between BAT and WAT. Site specific variations in genetic gene expression have also
been shown within white adipose tissue itself; that is subcutaneous verses visceral (Gesta et al,
2006; Vohl et al, 2004) highlighting adipose tissues depots at times as unique sites.
1.5.1 Abdominal Subcutaneous & Omental Adipose Tissue
In human adults, white adipose tissue can be found in several anatomical sites and
depending on the site, white adipose tissue is termed either as subcutaneous (Sc) adipose tissue
or Visceral (V) adipose tissue. As the terms imply, subcutaneous adipose tissue is located under
the skin layer mostly in thighs, buttocks, arms, face, neck and back region whereas visceral
adipose tissue lies deep within the viscera such as omentum, intestines and perirenal areas (Gesta
et al, 2007; Bozzetto et al, 2010; Kuk et al, 2005). Abdominal subcutaneous adipose tissue can
comprise as much as 80% of total adipose tissue mass, with Visceral adiposity only comprising
6-20% of the total adipose tissue mass (Montague et al, 1997). Therefore changes in adipose
tissue distribution, as well as alteration in circulating factors related to risk profile, can have
critical influences on adipose tissue metabolism. From our anatomical understanding, omental
adipose tissue drains directly into the portal vein and further studies have suggested (Klöting et
al, 2007) that this exposure of the liver to high concentrations of metabolites and adipokines
released from visceral adipocytes may increase the cardio-metabolic risk (Hayashi et al, 2004;
Onat et al, 2007; Despres et al, 2001; Empana et al, 2004; Elisha et al, 2010).
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It should also be documented that similar studies have also addressed the risk of accumulating
abdominal subcutaneous adipose tissue, (Blackburn & Waltman, 2005; Sardinha et al, 2000;
Goodpaster et al, 1997; Misra et al, 1997) whilst all conclude that central obesity remains a
reliable predictor of these cardiovascular disease profiles (Lee et al, 2007; Valsamakis et al,
2004; Smith et al, 2006; Nordstrand et al, 2011; Murakami et al, 2007).
1.5.2 Gender Differences in Adipose Tissue Distribution
Differential anatomic accumulation of adipose tissue is fundamental to the metabolic risk profile
of T2DM. It is apparent that different patterns of obesity occur; central obesity is noted as an
increase in intra-abdominal fat, particularly abdominal subcutaneous and visceral adipose tissue.
Lower body obesity however is characterised by fat stored predominantly in subcutaneous
regions of hips, thighs and lower trunk. These different fat distributions are readily identified
between women and men, as we note men to be more apple shaped and women to be noted as
more pear shaped in their adipose tissue distribution, this upper body obesity (i.e. central or
abdominal) is also referred to as either 'android' or 'male type obesity' and is compared with
'gynoid' or 'female type obesity' (lower body or gluteo-femoral) identified in women. It should be
stressed that age and BMI matched women have a lower incidence of T2DM than men, however
changes in fat distribution during the menopause have been shown to correlate with a higher
incidence of glucose intolerance and high fasting plasma triglycerides compared with women
with predominantly lower body or ‘gynoid fat’ distribution (Kissebah et al, 1982); which offers
an important marker for potential metabolic complications.
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In addition to the increased hyperlipolytic activity in omental (visceral) versus abdominal
subcutaneous adipose tissue which has been implied to mediate profound differences in receptor
expression and adipokine secretion between subcutaneous and visceral adipocytes.
Figure 1.5.2.1 The Gender differences in fat distribution, male pattern android ‘apple’ and women
‘pear shaped’, that alters with age (menopause) and weight gain to more android shape in women.
Adapted from book entitled ‘Medical Review: E. Gregory Thompson, MD - Internal Medicine’
Studies have shown that adipokines such as leptin (Van Harmelen et al, 1998) are secreted more
abundantly in subcutaneous adipose depots, whereas adiponectin, IL1β, IL8 and PAI-1 are more 
abundant in visceral adipose tissue (Motoshima et al, 2002). Adipokines have an important and
influential effect on metabolism.
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1.5.3 Adipokines
As mentioned earlier, adipose tissue had been regarded as a storage depot but this belief
has changed in 1994 with the discovery of leptin. Since then our understanding of adipose tissue
has changed and a new uncharted territory of research has been unravelled (Wozniak et al,
2009). Leptin is a chemical mediator of hormone-like properties synthesised and secreted into
the bloodstream by adipose tissue. Leptin and all the subsequently discovered chemical
mediators were termed adipokines. This discovery of adipokines called for a new definition of
adipose tissue. Adipose tissue has been redefined as an endocrine organ and is considered to be
the largest endocrine organ in the human body because of its vast capacity to increase its mass
and spread within the human body. Some adipokines are secreted by white tissue adipocytes
such as leptin, adiponectin and Retinol Binding Protein-4 (RBP-4); while some adipokines are
secreted by other cells within the adipose tissue from the stromal vascular fraction cells. Tumour
Necrosis factor α (TNF-α), interluekin-6 (IL-6) and resistin are just examples of adipokines 
secreted by stromal vascular cells. However, some adipokines are secreted by both cell types.
Currently, the number of discovered adipokines exceeds over one hundred. Research thus
far has shown that adipokines influence and play roles in energy homeostasis, metabolism and
inflammation (Gnaci ska et al, 2009). Adipokines provide an explanation for morbidities caused
and associated with obesity and are the link by which adipose tissue influence and interact with
other body organs. Due to the wide range of secreted adipokines and their broad array of
physiological effects, adipokines have been classified and labelled according to their
physiological effects.
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Figure 1.5.3.1 The multiple roles of Adipokines (Adapted from Lago et al, 1007).
Most notably, adipokines have been classified according to their hormonal effects on
metabolism or their inflammatory effects (Figure 1.5.3.1) (Gnaci ska et al, 2009; Wozniak et al,
2009; Balistreri et al, 2010). It should be noted that those two effects are not mutually exclusive
of each, thus creating a grey area of interaction between them. Adipokines exert an autocrine
and paracrine effects as well as systemic. The sheer number of adipokines and their various
physiological effects coupled with the fact that secretion of some adipokines is tissue site-
specific mirror the complexity of adipose tissue (Figure 1.5.3.2) (Wozniak et al, 2009).
Nonetheless, the jigsaw is yet far from being assembled. Examples of secreted adipokines are
shown in the following figure and are categorised according to their physiological effects. Some
adipokines will be explored in
thesis.
Figure 1.5.3.2 This figure illustrates site
including their local and system
more detail as these are examined within the main
-specific adipokines expression in
physiological effects. Adapted from (Wozniak
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body of the
white adipose tissue
et al, 2009).
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1.5.4 Metabolic Stress
Obesity has been characterised as a morbidity of epidemic proportions which predisposes
as well as coexists with other diseases such as T2DM, CVD and inflammation. So the question
that follows is how does obesity prelude to those pathologies?
At this point it is worth pausing to sum up what goes on during obesity. What follows are the
main event that categorise the state of obesity.
1. Excess of nutrients or positive energy balance
2. Adipocytes become hypertrophied
3. Which leads to hypoxia within hypertrophied “obese” adipose tissue and production of
ROS
4. Secretion of pro-inflammatory adipokines from adipose tissue increases
5. Existence of hypertriglyceridemia and ectopic adiposity
6. Both of points number 4 and 5 result in tissue insulin insensitivity and ultimately insulin
resistance and T2DM.
Secretion of pro-inflammatory adipokines and ectopic adiposity show an increase in adipose
tissue activity which has negative implications (Figure 1.5.4.1). Although adipocytes have a high
threshold for accumulating fat; it is that excess fat accumulation which triggers adipocytes to
produce pro-inflammatory adipokines.
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Figure 1.5.4.1 This figure highlights the key events leading to secretion of inflammatory
adipokines due to obesity and ER stress
Metabolic Stress (Excess Nutrients)
ER Stress
Activation of UPR
Activation of Inflammatory Pathways (JNK, NFkB, IKK
CREBH) and production of Reactive Oxygen Species
Secretion of pro-inflammatory adipokines (such as TNF-α, IL-6, Resistin,      
RBP-4, MCP-1) and lipolysis
Ectopic adiposity and insulin resistance in muscle, liver
and adipose tissue
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Figure 1.5.4.2 This figure shows interaction between adipose tissue and other tissues. Adapted
from (Iyer & Brown, 2011)
In the state of obesity, adipose tissue elicits an inflammatory response by producing high
levels of pro-inflammatory adipokines such as TNF-α, IL-6, MCP-1 and others. Those pro-
inflammatory adipokines act as a chemo attractant to circulatory immune cells such as
macrophages (Sell & Eckel, 2010; Suganami & Ogawa, 2010). Therefore in obese subjects,
adipose tissue becomes infiltrated with an additional number of microphages and adipose tissue
becomes inflamed (Figure 1.5.4.2). Thus from pathological point of view, obesity is classified as
a chronic state of inflammation. Hyperlipidemia and ectopic adiposity contribute to the spread of
hypertrophied adipose tissue depots within the viscera which ultimately exacerbate the
inflammatory effects of obesity. Obesity can exist in a person for many years and as such a slow
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low level mediator of inflammation can arise for many years leading to stress of cellular
mechanisms (Wellen & Hotamisligil, 2005; Day, 2006; Nishimura et al, 2009); the mechanisms
by which stress is initiated within the ER will comprise considerable focus of this current thesis.
Adipose tissue can accommodate large quantities of triglycerides in form of fat droplets.
The common route to accumulate fat is by hyperplasia (increases in adipocytes number).
However, if there is high consumption of nutrients then the positive balance of energy stored as
fat and this creates an overload on adipocytes. In order to cope with increasing demand for fat
storage, adipocytes become hypertrophied and the rate of hypertrophy exceeds that of
hyperplasia (de Ferranti & Mozaffarian, 2008). Hypertrophied adipocytes become stressed if the
energy balance is not restored. Cellular stress caused by excess nutrients is referred to as
metabolic stress which adversely affects sub cellular organelles of metabolic functions such as
endoplasmic reticulum (ER) and mitochondria as illustrated in figure 1.5.4.3 (de Ferranti &
Mozaffarian, 2008; Gregor & Hotamisligil, 2007; Hotamisligil, 2010). Endoplasmic reticulum is
involved in protein synthesis and folding, lipid synthesis and regulation of calcium storage;
whereas mitochondria are involved in cellular respiration and production of energy.
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Figure 1.5.4.3 The figures shows hypertrophied adipocytes. Adapted from (de Ferranti &
Mozaffarian, 2008)
1.6 Endoplasmic Reticulum (ER)
ER is a membranous structure in the form of completely enclosed convoluted tubular sac.
It surrounds the nucleus whose membrane is continuous with that of the ER. The endoplasmic
reticulum exists in two forms, rough and smooth. The rough ER has ribosomes attached to it
during protein synthesis, whereas the smooth ER is free from ribosomes.
Figure 1.6.1 Schematic diagram of Endopalsmic Reticulum and Golgi Appartus
from www.vcharkarn.com
The endoplasmic reticulum has the following functions:
1. Synthesis of plasma membrane and secreted proteins
2. Proper folding of those proteins
3. Synthesis of lipids and sterols
4. Storage of free calcium
It is self evident that the proper functionality of ER is vital for any cell to sustain life and all
of the ER functions are pivotal in this respect. Nonetheless, ER can malfunction if it is exposed
to either physiological or pathological insults. ER
-
malfunction is commonly called ER stress;
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. Reproduced
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whereby physiological stress occurs when there is an increased demand for protein production
and pathological stress occurs as a result of accumulation of misfolded proteins or viral infection.
ER stress can be due to genetic mutation or hereditary genotype (Lin et al, 2008; Yoshida, 2007).
Figure 1.6.2 This diagram shows stressors of ER and resultant pathologies. Adapted from
(Wellen & Hotamisligil, 2005)
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Due to the highly critical and important functions carried by the ER, its malfunction is
associated with a wide range of diseases as shown in following table.
Table 1.6.1 List of ER stress-related diseases. Adapted from (Kim et al, 2008)
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Table 1.6.1 illustrates that stressed ER in different tissues lead to different diseases. Thus the
importance of ER cannot be over emphasised. To understand the mechanisms of dysregulation in
the ER during stress, it is worth while reviewing the normal function of ER. Steps of protein
synthesis and folding are outlined below:-
1. Protein synthesis is initiated when mRNA strand attaches to the ribosome for translation
2. This attachment translocates the ribosome to the ER membrane surface to begin protein
translation in a process called cotranslation.
3. Translocation and attachment of the ribosome-mRNA unit to surface causes ER
membrane to open at the point of attachment (called translocon) and translation begins
4. The synthesised chain of amino acids enters the ER lumen as it is synthesised.
5. Once translation process is complete, translocon closes and the ribosome-mRNA unit
dissociates from the ER membrane surface
6. The newly synthesised amino acid chain is processed and folded into its correct
conformation. Processing and folding of the amino acid chain is handled by special ER
proteins called chaperone proteins. Processing of the newly synthesised amino acid chain
entails addition of a carbohydrate entity (as is the case of glycosylated proteins), proper
positioning of a sulphide bond (carried out by PDI) or imposing a specific allosteric
conformation (either cis or trans) which is performed by peptidyl proline isomerase (PPI).
7. If correct folding of the newly synthesised protein cannot be attained due to genetic
mutation for example, this misfolded or unfolded protein is retrotranslocated to the
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cytosol for degradation by the proteasomes. This process is referred to as ER Assisted
Degredation (ERAD).
8. Upon completion of ER-assisted folding, the newly synthesised protein is exported to the
Golgi apparatus for further modification, if required, and finally the fully mature protein
is exported from Golgi to either become an integral part of the plasma membrane or be
secreted by the cell.
As mentioned in step 6 of the outline, protein processing and folding are handled by the ER
luminal proteins called chaperones. As such any malfunction of those proteins leads to improper
processing and eventually misfolded final protein product. ER has the ability to sense any
improper processing or misfolding within the ER lumen, so that any processing error may be
rectified. In a state of obesity, adipocytes are bombarded with a continuous high level of lipids
which leads to hypertrophy. Hypertrophy exerts an extra pressure on the metabolic machinery of
adipocytes in order to keep up with the increasing demand, which in turn is translated into ER
stress and oxidative stress in the mitochondria. ER stress can accommodate an increase in
metabolic demand up to the chaperones capacity to handle newly synthesised proteins. If this
capacity is exceeded, then misfolded proteins start to accumulate within the lumen of the ER.
This accumulation calls on the activation of a rescue response termed Unfolded Protein
Response (UPR) (Gregor & Hotamisligil, 2007; Boden et al, 2008; Karalis et al, 2009;
Hotamisligil, 2010; Hummasti & Hotamisligil, 2010).
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1.6.1 Unfolded Protein Response (UPR)
The unfolded protein response (UPR) team consists of a group of ER protein who work
closely together. Those proteins act as molecular sensors and regulators of the UPR. The UPR
main aim is to relieve ER from its overload or stress. Notwithstanding if the relief efforts fail
then UPR triggers apoptic pathway (Kim et al, 2008; Xu et al, 2005). The UPR exerts its action
by recruitment of the proteins which in turn activate the three different pathways. The ultimate
result of those pathways is to increase production of chaperone proteins in order to cope with the
increasing demand for protein synthesis, however if the demand still exceeds ER capacity to
recover, then cell death is the other resort. As illustrated in the figure 1.6.1.1, the three main
proteins of UPR are inositol-requiring protein-1(IRE-α), activating transcription factor-6 (ATF-
6) and protein kinase-like ER kinase (PERK). Those proteins span the ER membrane with their
N-terminus in the lumen of the ER and their C-terminus in the cytosol. Normally, those proteins
are inactivated by the association of a sensory protein known as Binding immunoglobulin
Protein (BiP). ER stress results in BiP dissociation from IRE-α, ATF-6 and PERK which in turn 
activates the UPR proteins. The three active forms of UPR proteins initiate a cascade of events
leading to
1. Attenuation of global mRNA translation so the influx of proteins into the ER is halted
temporary
2. An increase in the transcription of chaperone proteins to facilitate the existing increasing
demand for protein folding
3. An increase in the induction of the ERAD proteins
4. Finally if all fails, pro-apoptotic pathways are activated
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Many studies propose that ER stress is one potential route which links obesity to insulin
resistance and T2DM. This study has ER stress as a focal point of investigation with the UPR as
a whole and its constituent components are used as an explorative tool to examine the ER stress
in obesity linkage to insulin resistance and T2DM. As stated earlier, UPR exerts its adaptive
effects via three arms of action as shown in the figure 1.6.1.1.
Figure 1.6.1.1 Pathways of Unfolded Protein Response (Adapted from Lin et al, 2008)
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1.6.1.1 IRE-1α Pathway 
The IRE-1α UPR protein is a transmembrane protein weighs approximately 100 kDa and has 
two domains; serine/threonine kinase domain and an endoribonuclease domain. The dissociation
of the ER sensory protein BiP causes IRE-1α to oligomerise. This oligomerisation activates IRE-
1α mRNAase domain which is located in the cytosolic side of the ER membrane. IRE-1α 
mRNAase splice the mRNA of XBP-1 protein (Kim et al, 2008; Hummasti & Hotamisligil,
2010; Ron & Walter, 2007; Yoshida, 2007; Marciniak & Ron, 2006). This spliced mRNA is
translated and the resulting protein translocates to the nucleus to induce an increased rate of
expression of
i) ER chaperone proteins
ii) ERAD proteins
iii) Lipid synthesis proteins and
iv) ER biogenesis proteins
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1.6.1.2 ATF-6 Pathway
The second arm of the UPR is the ATF-6 protein. In response to ER stress, ATF-6 is released
from BiP and is translocated to the Golgi apparatus for cleavage by resident proteins S1P (Site 1
Protease) and S2P (Site 2 Protease). The cleaved ATF-6, also called ATF-6f (“f” for fragment) is
released into the cytosol to enter the nucleus and regulate gene expression. ATF-6 pathway
activation results in the upregulation of the ER chaperone proteins (Marciniak & Ron, 2006;
Yoshida, 2007; Ron & Walter, 2007; Fong et al, 2004; Kim et al, 2008).
1.6.1.3 PERK Pathway
PERK mechanism of activation is similar to that of IRE-1α as both possess a 
serine/threonine kinase domain protruding into the cytoplasm. Once BiP dissociates, PERK is
activated by oligomerisation and autophosphorylation. This active form of PERK causes the
phosphorylation of the α-subunit of eukaryotic translational Initiation Factor 2 (eIF2α) protein in 
the cytoplasm. This phosphorylation inactivates eIF2α which results in attenuation of global 
proteins translation. Thus decreasing the protein folding load on the ER chaperon proteins (Kim
et al, 2008; Bastard et al, 2006; Ron & Walter, 2007; Hummasti & Hotamisligil, 2010;
Marciniak & Ron, 2006; Yoshida, 2007).
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1.6.1.4 Pro-apoptotic pathway
The aim of the UPR is to relief the ER from its overload and stress firstly by increasing
the expression of the ER chaperone and biogenesis proteins in addition to attenuating the
translation of global proteins. If the ER functional integrity cannot be restored through those
adaptive processes, then apoptosis is induced as a last resort option. Basically, each of the three
UPR pathways plays a role in initiating the apoptotic process albeit some are more prominent
than others. The most prominent and direct route is triggered through PERK pathway. Although
the activation of PERK has an inhibitory effect on eIF2α which subsequently attenuates global 
protein translation, interestingly, inactivated eIF2α results in increased translation of ATF-4 
(Activating Transcription Factor-4), whose target gene is C/EBP homology protein (CHOP).
CHOP is a protein involved in inducing apoptosis and its gene promoter has binding sites for
ATF-6f as well as XBP-1s. So that ATF-6 and IRE-1α can trigger apoptosis via this route. 
However, IRE-1α has a distinct apoptosis-inducing pathway. Through its protein kinase activity, 
the cytoplasmic portion of IRE-1α binds to TRAF2 (Tumour necrosis factor Receptor-Associated 
Factor 2), an adaptor protein forming a unit which then binds to and forms a complex with ASK1
(Apoptosis Signal-regulating Kinase 1). This complex, IRE-1α – TRAF2 – ASK1, 
phosphorylates JNK (Jun Kinase) protein has a pro-apoptotic effect (Yoshida, 2007; Marciniak
& Ron, 2006; Hummasti & Hotamisligil, 2010; Kim et al, 2008; Ron & Walter, 2007).
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1.7 ER Stress and Insulin Resistance
Some studies have noted that ER stress is associated with insulin insensitivity and
ultimately to insulin resistance (Ozcan et al, 2006; Hummasti & Hotamisligil, 2010;
Hotamisligil, 2010; Karalis et al, 2009; Gregor & Hotamisligil, 2007; Boden et al, 2008;
Nakatani et al, 2005). One route could be the activation of JNK/IKK which causes inhibition of
IRS-1 and IRS-2. Activation of JNK/IKK leads to phosphorylation of IRS-1 and IRS-2 at the
serine residue, thus rendering the plasma insulin receptor non-responsive to circulating insulin.
Figure 1.7.1 Cross talk between ER, inflammatory cytokines and Insulin Receptor. Adapted
from (Hotamisligil, 2010)
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1.8 ER Stress and Inflammation
Similarly, ER stress pathways intersect with inflammatory pathway at JNK/IKK (Figure
1.8.1). It is well documented that JNK/IKK is one of the main pathways of inflammation (Jiao et
al, 2010; Hotamisligil, 2008; Karalis et al, 2009; Hotamisligil, 2010; Hummasti & Hotamisligil,
2010). The trigger of this pathway leads to production of pro-inflammatory adipokines. This may
create an additional burden on ER internally and externally. Internally, ER has to cope with a
further increasing demand for pro-inflammatory adipokines synthesis. Externally, if those pro-
inflammatory adipokines were to be successfully synthesised and secreted, they would exert their
pro-inflammatory effects on an autocrine and paracrine level, thus creating an even worse
vicious cycle as depicted in figure 1.8.2.
Figure 1.8.1 ER stress and Inflammation. Adapted from (Hotamisligil, 2010)
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Figure 1.8.2 This figure shows the cascade of events leading to secretion of inflammatory
adipokines thus creating a vicious cycle of ER stress.
Excess nutrients
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TRL-2,
TRL-4
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Activation of NFkB / IKB
Protein synthesis capacity exceeded
ER Stress
Expression of Pro-inflammatory adipokines
such as TNF-α, IL-6 and others 
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1.9 Anti-inflammatory Chemicals
Due to the close link between ER stress and inflammation represented by JNK/IKK
activation, chemicals of anti-inflammatory properties have been used experimentally to relief ER
stress. The most common and widely used anti inflammatory drug is salicylate which is
commercially known as ASPIRIN. Salicylate exerts its anti-inflammatory action by blocking the
activation of NFkB, thus interrupting the inflammatory pathway and the production of pro-
inflammatory adipocytokines (Yuan et al, 2001; Amann & Peskar, 2002; Yin et al, 1998; Kopp
& Ghosh, 1994).
Figure 1.9.1 This figure shows salicylates mode of action. Adapted from (Davies et al, 2007)
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1.10 Aims of Study
The study was designed to explore specific points related to ER stress in human adipose tissue.
Cultured differentiated human pre-adipocytes were used as a model to mimic certain pathologies
that result from or co-exist with obesity. The aims of the study can be summarised in the
following points:-
1. To characterize cultured differentiated human pre-adipocytes as a valid model for human
adipose tissue.
2. To examine the ER stress marker proteins in the adipose tissue of lean and obese
subjects.
3. To investigate the origins of ER stress in primary human adipocytes in metabolic stress
states of hyperglycemia, hyperlipidemia and endotoxicity.
4. To examine the effect of salicylate as an anti inflammatory agent on ER stress.
Taken together this thesis sought to explore the potential mediators of sub-clinical
inflammation and the effect such stimulants have on ER stress and whether an anti-
inflammatory agent could abate such ER stress and what pathways are affected.
Chapter 2
General Methods & Materials
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The following chart summarizes the main laboratory procedures discussed in this
chapter.
Figure 2.1 A chart of laboratory procedures followed during the course of this study
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This chapter details the methods and materials most frequently used throughout the
thesis. Precise information outlining specific methods for each study will be covered
within each appropriate chapter. Information on recipes of all in-house made reagents
is mentioned in the Appendices as well as a list of manufacturers and companies used
to purchase reagents.
The starting cellular materials were human adipose tissue, preadipocytes extracted
from the human adipose tissue.
Abdominal Subcutaneous (AbSc) adipose tissue was collected from subjects
undergoing elective cosmetic surgery (liposuction) in accordance with local ethics
committee guidelines. All subjects with a history of malignancies or under treatment
or suffering from any endocrine abnormalities were excluded from the study. The
fresh primary adipose tissue was utilised in the following ways; either frozen and
stored or processed to isolate preadipocyte cells.
2.1 Freezing Adipose Tissue
Approximately 40 ml of adipose tissue obtained from liposuction was aliquoted into
sterile 50 ml centrifuge tubes then flash frozen in liquid nitrogen. To ensure minimal
protein damage or degradation, frozen AbSc adipose tissue samples were placed
directly from liquid nitrogen into a -80C freezer for storage until further use.
2.2 Isolation of Preadipocyte Cells: Collagenase Digestion
Adipose tissue (25 ml) obtained from liposuction was poured directly into sterile 50
ml centrifuge tubes. In order to aid the mechanical break-up of adipose tissue into its
different celluar components, the enzyme collagenase was used. Adipose tissue was
suspended in 20 ml of warm collagenase solution then incubated at 37oC in a
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continuous shaking (100 cycles/min) water bath for 30-45 min, with additional
shaking at 10 min intervals until the consistency of the adipose tissue was a smooth
homogeneous liquid. Following collagenase digestion, adipose tissue was filtered
through a sterile fine cotton mesh into another sterile 50 ml centrifuge tube.
Centrifugation at 360 x g for 5 min separated the collagenase digested adipose tissue
into three independent layers: the lower stromal-vascular fraction containing a pellet
of pre-adipocyte cells, the central adipocyte layer and the upper supernatent fraction
containing lysed adipocyte cells. The supernatant fraction and the adipocyte layer
were discarded whereas the pellet was resuspended in lysis buffer and left at room
temperature for 20 minutes. The suspension was centrifuged at 2000 rpm for 5
minutes. The resulting supernatant was discarded and the pellet was resuspended in a
mixture of DMSO and foetal calf serum. The suspension was aliquoted in cryogenic
vials and stored at -80 C overnight then in liquid nitrogen until further use.
2.3 Extraction of Protein from Whole AbSc Adipose Tissue using RIPA
Protein samples from whole AbSc adipose tissue to be analysed by Western blotting
were extracted using RIPA buffer. Whole adipose tissue was collected from -80C
storage, then, without allowing the sample to defrost, ~100 mg of adipose tissue was
cleaved off using a sterile scalpel and forceps then transferred into a 5 ml bijou tube.
RIPA buffer (600 µl) was added to the tissue. The sample mixture was then
homogenised using a rotor-stator homogeniser at 1100-4200 x g for 3-5 s. The
homogenised mixture was then transferred to 1.5 ml microcentrifuge tubes and flash
frozen in liquid nitrogen. Once thawed, the samples were centrifuged at 60,060 x g for
30 min at 4oC. Using a fine bore needle and syringe, liquid from below the solid layer
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was extracted and aliquoted into fresh 0.5 ml microcentrifuge tubes and stored at -80
oC until further use.
2.4. Propagation and Differentiation of Extracted Primary Preadipocytes
Cryovials containing extracted primary preadipocytes were removed from liquid
nitrogen and placed in a 37º C water bath for about 10 minutes. The thawed cells were
plated in cell culture flasks containing growth culture medium. Growth culture
medium consists of DMEM/F12 Ham phenol-free medium supplemented with
glutamine (1%), foetal bovine serum (10%), transferrin (1%), penicillin (100 units/ml)
and streptomycin (100 µg/ml). The growth medium was refreshed every 3 days until
the cells reached about 80% confluence. At this stage, the cells were trypsinised, and
plated in cell culture 6-well plates. Trypsinisation process involved aspirating the
existing culture medium and washing the cells with phosphate buffered saline (PBS).
PBS was then aspirated and trypsin was added to the cells to incubate for 5 minutes,
after which, growth medium was added to inactivate trypsin. The mixture was mixed
properly to ensure the detachment of all cells and uniformity of cellular distribution
within the suspension. A small suspension (20 µl) was used to count the number of
cells using a haemocytometer. This was to ensure that all wells had an approximately
similar number of cells. Depending on the calculation result, equal volumes of cells-
containing suspension was aliquoted in 6-well plates. Growth medium was refreshed
every 3 days until the cells reached 100% confluence. Once confluent, preadipocytes
differentiation was induced using differentiation medium (PromoCell, Germany). The
cells were differentiated over 4 days with differentiation medium refreshed on day 3.
On the fifth day, the medium was refreshed with nutrition medium (PromoCell,
Germany) supplemented with penicillin and streptomycin. Nutrition medium was
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refreshed every 3 days until lipid droplets formation; which was noted as an indication
of differentiation. The process of lipid droplets formation within the cells was
complete by 10 – 14 days.
At this stage, the cells were ready for the treatment experiments.
2.5 Experimental Treatment of Differentiated Primary Preadipocytes
In order to prepare the cells for the planned treatments, the cells underwent a wash-out
period of all growth and biochemical factors. This procedure is referred to as
Detoxification and is necessary to minimize any biochemical interference with any
proposed treatments. Detoxification was carried out for 24 hours and involved
changing the nutrition medium with detoxification medium, which consists of
DMEM/F12 Ham and 3% foetal bovine serum only (Invitrogen, UK).
The detoxification medium was refreshed after 24 hours and the proposed treatments
were added to each well as explained in the relevant results chapters. Cells cultured
under different treatment regimes were extracted following the treatment period for
protein and RNA analysis.
2.6 Protein and RNA Cellular Extraction
At the end of the specific experimental period, conditioned media were collected and
aliquoted in eppendorfs and stored at -80º C to be analyzed by ELISA at a later stage.
Cell culture wells containing differentiated preadipocytes were then washed twice
with ice-cold PBS and gently tapped on the back of the plate against a tissue paper to
remove any PBS excess. Plates were then placed on ice tray and 250 µl of Qiazol
(Qiagen, Germany) was added to cells designated for RNA collection and 250 µl of
ice-cold protein lysis buffer were added to cells designated for protein extraction.
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Whilst waiting for the protein lysis buffer to incubate for at least 5 minutes, RNA
collection was begun. The process of RNA collection comprised removing of cells
manually with a scrapper, aspirating the Qiazol-scrapped suspensions and pipetting it
into eppendorfs tubes then flash freezing the tubes in liquid nitrogen. The tubes were
then stored at -80º C.
Protein lysis buffer-containing cell culture wells were also manually scrapped and the
suspensions were placed in eppendorf tubes and centrifuged in a pre-cooled centrifuge
at a temperature of 4º C for 5 minutes at 16000 g. Once spun, a pellet and a
supernatant were formed. The protein-containing supernatant is pipetted into new
eppendorf tubes and stored at -80º C whilst the pellets were discarded.
2.7 Determination of Protein Concentration
Protein concentrations of samples from adipose tissue and differentiated primary
adipocytes were measured according to the following procedures. To determine the
protein concentration, Bio-Rad Protein Assay kit was used. Frozen aliquots of the
extracted protein sample were thawed and vortexed to ensure a homogenous sample
distribution. The Bio-Rad Protein assay kit constitutes a 5 fold concentrated dye
reagent and a bovine serum albumin (BSA) protein standard in a lyophilized form.
The dye reagent was diluted with deionised water to yield 1X concentration. BSA was
reconstituted with distilled water to yield a concentration of 1.4 mg/ml. Using the
BSA reconstitute, seven protein standards were prepared of different concentrations
(0, 1, 2.5, 5, 10, 15, 20 µg/ µl) where 0 µg/ µl was made from the dye reagent without
the addition of any BSA and is regarded as a blank. Four micro litres of each extracted
protein sample were added to 1 ml dye reagent and mixed in cuvettes. The sample
mixtures were incubated for 30 minutes at room temperature. The absorbance of all
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samples was measured against the blank at optical density of 595 nm using a
spectrophotometer (6505 UV/VIS, Jenway, UK). The absorbance values of the seven
BSA standards were used to plot the standard curve against which sample protein
concentrations were read using their respective absorbance values.
2.8 Western Blot Analysis of Differentiated Preadipocytes
& Whole adiposeTissue
Western blotting is an immunoassay-based technique that allows the sizing,
identification and quantification of specific proteins. In brief, proteins of interest
undergo electrophoresis through a gel. Proteins are separated according to their
molecular weight (Mr). Following electrophoresis, proteins are electrophoretically
transferred onto a polyvinylidene-fluoride (PVDF) or nitrocellulose membrane.
Proteins of interest are then detected by probing with antibodies raised against them.
Proteins are then visualised using a chemiluminescent detection system. This method
is detailed below in full.
2.8.1 Preparation of Protein Samples for Electrophoresis
Quantified protein samples were thawed and vortexed. Equal volumes of protein
were then transferred into 1.5 ml eppendorfs containing loading buffer, at a minimum
ratio of 1:2 (sample: loading buffer) (Table 2.8.1.1). Varying quantities dH2O were
added to the sample mixture to standardise final volumes. Seven micro litres of a
rainbow molecular weight marker (14,300-220,000 Da) was loaded alongside each set
of samples (i.e. minimum 1 lane per gel), providing a visual protein size record with
which protein samples could be compared. The sample mixtures were then heated at
95oC for 5 min to denaturise and linearise the proteins.
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REAGENT QUANTITY
FINAL
CONCENTRATION
Tris HCl (pH 6.8) 625 µl 125 mM
SDS (10%) 500 µl 4%
Glycerol 1000 µl 20% (w/v)
DTT 200 µl 6.5x10-3 mM (w/v)
Bromophenol Blue 125 µl 2.5x10-3 mM (w/v)
dH2O 250 µl N/A
Table 2.8.1.1 Quantities of reagents in loading buffer for
Western blot analysis.
2.8.2 Electrophoretic Protein Separation
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate proteins
according to their size (4% stacking gel, pH 6.8; 8-15% resolving gel, pH 8.8
(percentage of resolving gel was chosen according to the size of the protein of
interest). The reagents and their quantities for each gel used throughout the thesis are
shown in Tables 2.8.2.1 and 2.8.2.2.
RESOLVING GEL QUANTITY FOR
8% GEL
QUANTITY FOR
12% GEL
QUANTITY
FOR
15% GELREAGENT
Protogel* 5.3 ml 8 ml 9.9 ml
Protogel Resolving Buffer* 5.2 ml 5.2 ml 5.2 ml
dH2O 9.3 ml 6.6 ml 4.5 ml
Ammonium Persulphate† 200 µl 200 µl 200 µl
TEMED¶ 20 µl 20 µl 20 µl
Table 2.8.2.1 Components of resolving gel (8%, 12% and 15%)
used for Western blot analysis. † 0.1% (w/v)
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STACKING GEL
QUANTITY FOR 4% GEL
REAGENT
Protogel 1.3 ml
Protogel Stacking Buffer 2.5 ml
dH2O 6.1 ml
Ammonium Persulphate† 50 µl
TEMED¶ 10 µl
Table 2.8.2.2 Components of stacking gel (4%) used for Western blot analysis.
† 0.1% (w/v)
The gel casting unit was constructed according to the manufacturers’ instructions.
Glass plates were slotted into the clamp assembly and water-tightness tested to ensure
no leaks. The resolving gel was prepared as detailed above, vortexed and poured to
~15 mm of the total height of the glass plates. To enhance polymerisation and reduce
meniscus formation, ~3 mm of 70% isopropanol was carefully layered over the
resolving gel. The gel was then left to set for ~30 min at RT. Once set, the surface of
the resolving gel was gently washed with dH2O and the stacking gel prepared. This
gel solution was poured onto the surface of the resolving gel and wells created by
inserting a comb (1.5 mm thickness, 10 teeth of 5 mm wide each) at an angle to
minimise introducing air bubbles into the gel. Any loss of gel was immediately
replaced. Once the stacking gel was set, the comb was removed vertically and wells
were flushed vigorously with a syringe containing electrode buffer. Gels encased
within the glass plates were transferred to a tank containing 1L of 1X electrode buffer
and secured into place creating two separate reservoirs, allowing ionic movement only
through the gels. Wells were flooded and any leakages between the two reservoirs
were stopped. Samples were loaded using specific loading tips (Fisher, UK) and air
bubbles expelled. Samples were resolved by electrophoresis.
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2.8.3 Electrophoretic Transfer (Blotting)
Immobilon-PTM PVDF membranes (0.45 µm) were briefly immersed in 100%
methanol, washed in dH2O for 1 min then soaked in transfer buffer until use. For
smaller sized proteins, Westran PVDF membranes (0.2 µm) were briefly immersed in
100% methanol and soaked in Transfer Buffer for 5 min. After ~1 hr, gels containing
the resolved proteins were removed from the glass plate housing. Stacking gels were
discarded and the resolving gels were soaked in transfer buffer for 10 min. Fibre pads
and filter paper sets (2 sets per gel) were soaked in transfer buffer for 10 min. Two
pieces of filter paper were laid over a saturated fibre pad and gel layered on to the
filter paper (orientated to be identical to loading sequence) expelling all air bubbles.
One piece of permeabilised Immobilon-PTM membrane was then layered over the gel,
ensuring that no bubbles interrupted the contact between the gel and membrane. This
was sandwiched between further layers of saturated filter paper and fibre pads. These
stacks were transferred to transfer casings and placed into a tank containing 1L of
transfer buffer. Proteins were transferred electrophoretically at a constant voltage of
100V for 1hr.
2.8.4 Primary Antibody Application
Following the transfer of proteins, membranes were removed from between the filter
paper and fibre pads layers and trimmed to mark orientation and membrane number.
Membranes were incubated with 10% non-fat milk solution diluted in 0.5% PBS
(Tween 20 (0.1% (v/v),) and placed on an orbital shaker for either 1 hr at RT or
overnight for ~14 hr at 4oC (conditions vary depending on the protein of interest).
This procedure prevents the primary antibody binding directly to the PVDF
membrane and further blocks non-specific binding of proteins to the membrane.
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Following blocking, membranes were rinsed 3 times in PBS and once in 0.1% PBS-T.
Primary antibody was then prepared in sufficient quantity to cover the surface of the
membrane at a concentration of 0.1% PBS and 0.1% PBS-T and incubated in a 50 ml
centrifuge tube for 1 hr at RT or 4oC overnight on an orbital shaker. After ~14 hr at
4oC, membranes were washed 3 times with PBS and once in PBS-T. Membranes were
returned to the shaker for three 10 min washes in excess 0.1 % PBS-T.
2.8.5 Secondary Antibody Application
Secondary antibody was made up in 0.1% PBS/PBS-T. Membranes were incubated at
RT for 1 hr on an orbital shaker (80-100 cycles/min). Following incubation with
secondary antibody, membranes were then rinsed three times in 0.1% PBS/PBS-T
with three further 10 min washes in excess 0.1% PBS-T.
2.8.6 Immunodetection of Antibody Labelled Proteins
The secondary antibody allows the detection of specific proteins by serving as a
catalyst for luminol, a substrate that luminesses, which part of an ECL plus Western
blotting detection system. The reaction is based on the oxidation of the cyclic
diacylhydrazide luminol. Secondary antibody conjugated with horseradish-peroxidase
(HRP) binds to the specific primary antibody that is attached to the protein of interest.
Combined HRP and peroxide catalyses the oxidation of the lumigen PS-3 acridan
substrate generating thousands of acridinium ester intermediates per minute (Figure
2.8.6.1). These intermediates react with peroxide under slightly alkaline conditions to
produce a sustained, high intensity chemiluminescence.
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The light exuding from the reaction can be visualised by application of photographic
X-ray film or real-time digital photography. Following secondary antibody incubation
and subsequent washes in PBS (120 mM, pH 7.6), membranes were ready for the
immunodetection of proteins. Membranes were firstly placed protein side-up on saran
wrap. ECL plus Solution A (Tris Buffer) was mixed with Solution B (Acridin
Solution in Dioxane and Ethanol) at a 1/40 ratio to a volume required to cover each
membrane (4 ml/membrane). This mixture was incubated on the membrane for 5 min
at RT. Following incubation, ECL plus was discarded and the corner of the membrane
blotted on tissue paper to remove excess ECL mixture. Membranes were then
sandwiched between two sheets of clear plastic and excess ECL was removed with
tissue paper and then placed into a film cassette. The filters were then exposed to
photographic X-ray film (Kodak, UK) for varying times depending on the antibody
used (1-60 min).
Figure 2.8.6.1 Chemiluminescent reaction of Lumigen PS-3 with horseradish-
peroxidase (HRP) (Modified from Isacsson and Watermark 1974).
55
2.8.7 Quantification of Western Blot Protein Bands
Autoradiographs were quantified by gel blot analysis using UVP Gel Blot Analysis
System and appropriate statistical analysis as detailed in individual results chapters
2.9 Extraction & Quantification of RNA.
2.9.1 RNA Isolation & Purification from Adipose Tissue for Quantitative PCR
RNA samples from adipose tissue and differentiated primary adipocytes were
purified, quantified and processed according to the following procedures.
A column-based method (RNeasy Lipid Tissue Mini Kit for total mammalian mRNA
isolation) was implemented to extract mRNA from the adipose tissue in accordance
with manufacturer’s instructions. This process included a deoxyribonuclease (DNase)
digestion step with 5µl DNase enzyme diluted in 5 µl reaction buffer to remove any
contaminating genomic DNA. The tubes containing these reactants were incubated at
standard RT for 15 min before the reaction was quenched through the addition of 5 µl
of stop solution and immediate incubation at 70oC for 10 min. RNA was quantified
with a spectrophotometer using a ratio of readings at a wavelength of 260 and 280
nm. Once quantified the isolated RNA samples were stored at -70C.
2.9.2 Reverse Transcription of Isolated mRNA from Adipose Tissue
An aliquot containing 1 µg of mRNA from each sample was pipetted into a sterile
microcentrifuge tube along with 0.5 µl of random hexamers mixed in equal quantities.
To standardise, nuclease free water was then added to each aliquot to make up a final
volume of 10 µl. Each reactant mixture was then incubated at 70oC for 10 min.
Reverse transcriptase (RTn) master mix was then prepared (Table 2.9.2.1) in
sufficient quantities to allow for the required number of RTn reactions. After a
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thorough vortex, 10 µl of master mix were added to each incubated sample of mRNA.
Each sample was then vortexed, centrifuged briefly and heated at 37oC. After 1 hr, the
reaction was quenched by a consecutive incubation at 95C for 5 min to denature the
enzymes. The resultant cDNA product was stored at -20C for further use.
Table 2.9.2.1 The contents of the reverse transcription master mix. The final volume
of cDNA sample is 20 µl where 1 µl equals 50 ng of single stranded cDNA.
2.9.3 Quantitative Real-Time PCR
The real-time PCR reaction was performed in 25 µl volumes on 96 well plates, in a
reaction buffer (Taqman universal PCR master mix), containing 3 mM Mn(Oac)2,
200 pM dNTPs, 1.25 units ampliTaq gold polymerase, 1.25 units ampErase UNG,
100-200 nmol Taqman probe, 900 nmol primers and 25-125 ng cDNA. All reactions
were multiplexed with the housekeeping gene for the 18S ribosomal subunit, provided
as a pre-optimised control probe enabling data to be expressed in relation to an
internal reference to allow for differences in RT-PCR efficiency. Data were obtained
as the cycle number at which logarithmic PCR plots cross a calculated threshold line
or the Ct value. In accordance of the manufacturer’s guidelines ∆Ct values were 
determined (∆Ct=Ct of the target gene minus Ct of the housekeeping gene). 
Contents of Reverse
Transcription Master Mix
Concentration in Final 20 L
Volume Quantity Added (L)
Reverse Transcription
10X Reaction Buffer
(Mg2++ free)
1x (v/v) 2.0
Mg2++ (25 mM) 5 mM 4.0
dNTPS (10 mM) 1 mM 2.0
AMV (20 U/µl) 0.5 u/µl (v/v) 0.5
RNasin (40 U/µl) 1 u/µl (v/v) 0.5
Nuclease free H2O 5% 1.0
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Measurements were carried out in triplicate and the target gene probes were labelled
with the fluorescent label FAM, and the housekeeping gene with the fluorescent label
VIC. Reactions are as described in Table 2.9.3.1.
Thermal
Cycler
Times and Temperatures
First Steps
1 of 44 cycles
Melt Anneal/Extend
ABI Prism
7700
Sequence
Detector
Hold Hold Cycle
2 min
50C
10 min
95C
15 s
95C
1 min
62C
Table 2.9.3.1 RT-PCR reaction conditions as pre-set on the ABI 7700.
2.9.4 Data Handling & Statistical Analysis
For RNA analysis to exclude potential bias due to averaging data, which had been
transformed through the equation 2-Ct, all statistics were performed at the Ct stage.
For both mRNA and protein findings, statistical analysis was undertaken using an
unpaired Student’s t-test. The threshold for significance was p<0.05. Data in the text
and figures are presented as mean±SD as noted in the relevant results chapters.
2.10 Enzyme Linked Immunosorbent Assay (ELISA)
The sandwich enzyme-linked immunosorbent assays (ELISAs) used was based on the
reaction between an antigen and an antibody. In essence ELISAs involve the
attachment of a capture antibody to a solid phase support. Samples containing known
or unknown antigens are then added in a matrix or buffer that will minimize
attachment to the solid phase. An enzyme-labelled antibody is then added for
detection as illustrated in Figure 2.10.1.
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All ELISA based assays applied in this thesis were performed using ready prepared
commercially available kits. The sources of these kits are outlined in the relevant
chapters. In all cases, both ELISA analyses were carried out in accordance of the
manufacturers’ instructions of the individual kits. All the corresponding CV, intra-
and interassay values are given for each individual assay in the relevant chapters.
Appropriate statistical analysis for ELISA was carried out using a statistical software
package (SPSS for Windows, Version 14.0, Woking, UK).
Figure 2.10.1 Schematic diagram depicting steps of ELISA protocol
Adopted from http://www.millipore.com/catalogue/module/c77254
Chapter 3
Characterisation of Differentiating Primary Human
Abdominal Subcutaneous Preadipocytes
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3.1 Introduction
Within AT, in addition to mature adipocytes, there are a variety of other cell types required
for normal tissue function, including pre-adipocytes, leukocytes, macrophages and
endothelial vascular cells. The main cell type within AT are adipocytes, uniocular cells which
can range in diameter from 20-200 microns (µm) and have the capacity to increase their
diameter of up to 20-fold, allowing them to increase in volume of up to several 1000-fold, in
order to maximise energy storage (Fruhbeck et al., 2001). Pre-adipocytes are undifferentiated
precursor cells for adipocytes, and act as an adipocyte store in cases where hyperplastic
growth is required, causing pre-adipocyte cells to fully differentiate into mature adipocytes.
Endothelial cells form the tissue vasculature supplying blood to AT, and transporting proteins
to and from the periphery. Leukocytes, particularly macrophages, reside within AT and are
recruited to a site of inflammation to eliminate infected cells. The predominant immune cell
within AT is the macrophage, constituting 5-10% of cells in lean subjects, and expanding to
up to 40% of the AT cell population in individuals with a diet induced increase in adiposity
(Weisberg et al., 2003).
The maintenance of energy homeostasis requires a balance to be maintained between
energy consumption and energy expenditure. When this balance can no longer be maintained
e.g. via excessive energy intake in relation to energy expenditure, a ‘positive energy balance’
is created; this can result from insufficient physical exercise and excessive calorie intake.
This excess energy is stored within white AT (Frayn et al. 1995; Gregoire and Smas, 1998),
and can negatively impact upon the AT architecture. Adipocytes can rapidly grow in size
(hypertrophy due to lipid uptake) and number (hyperplasia due to cell differentiation and
proliferation). Both processes are regulated genetically and hormonally, and key genes are
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involved in TG formation (lipogenesis), and TG breakdown (lipolysis) (Gregoire et al.,
1998).
Hyperplasia and hypertrophy are the processes by which AT is acquired shortly after
birth (Gregoire et al., 1998). The increase in AT mass through hyperplasia and hypertrophy is
termed ‘adipogenesis’, a process which continues throughout adulthood. Hyperplastic
adipocyte growth, or ‘proliferation’ occurs through ‘clonal expansion’ of preadipocytes and
leads to formation of new precursor cell populations (Prins et al., 1997). Hyperplastic growth
and its control involve preadipocyte proliferation and differentiation from pluripotent stem
cells (Rodriguez et al., 2005). Such cells are capable of undergoing cellular ‘differentiation’
or ‘maturation’ and developing into a range of different cell types, including adipocytes,
chondrocytes, osteocytes or myocytes (MacDougald and Mandrup; MacDougald and
Mandrup, 2002).
The propensity of preadipocytes to proliferate and differentiate into different cell types is
under tight regulation from adipogenic stimulatory factors, such as ‘insulin-like growth
factor-1 receptors’ which act through insulin receptor substrate (IRS) molecules (Miki et al.,
2001), peroxisome proliferator activated receptor (PPAR)-γ (MacDougald and Mandrup) and 
free fatty acids (FFAs); adipogenic inhibitory factors, that inhibit hyperplastic growth, such
as inflammatory cytokines, that include tumour necrosis factor-α (TNF-α), interleukin-6 (IL-
6) (Skurker et al, 2005; Maury and Brichard, 2010) interferon-γ,  growth factors 
(MacDougald and Mandrup, 2002), and certain androgens (Dieudonne et al., 2000).
The aim of this current chapter was to document that the abdominal subcutaneous pre-
adipocytes, gained through elective surgery, undergo appropriate differentiation to be used
for subsequent treatment regimens 15 days post-differentiation. These current studies
examined lipid turnover, through glycerol release, and lipid accumulation, through oil red O
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staining, to observe differentiation; photographic evidence was also taken to support the oil-
red O data captured. Gene expression levels were assessed in the differentiating adipose cells
and included adiponectin, PPAR, CCAAT enhancer-binding protein alpha (CEBP) and
perilipin. Final analysis examined protein secretion of adiponectin and leptin into the media
from differentiating adipocytes, in order to substantiate that the abdominal subcutaneous pre-
adipocytes were fully differentiated post 12 days.
The ultimate aim of this chapter was to characterise the differentiation of the human
preadipocyte cells to show that the cells could be differentiated and their properties were
consistent across all the differentiated cells. Fifteen days post-differentiation, these cells
would be cultured in different treatment regimens for subsequent studies.
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3.2 Materials & Methods
3.2.1 Adipose Tissue Isolation
AbSc AT from seven subjects was digested with collagenase (Worthington Biochemical,
Reading, USA) as previously described in the methods chapter. In brief the isolated stromal
fractions of human AbdSc AT were routinely cultured into tissue culture flasks until
confluent and then trypsinised to obtain cells to carry out the study. The pre-adipocytes from
the same passage were grown in 6-well plates to confluence (100% cell plate cover) in
DMEM/Ham’s F-12 phenol-free medium (Invitrogen, Paisley, UK) containing 10% foetal-
calf serum (FCS), penicillin (100 U/ml), streptomycin (100 µg/ml), and transferrin (5 µg/ml).
At confluence, preadipocytes were differentiated in preadipocyte differentiation media
(Promocell, Germany) containing biotin (8 μg/ml), insulin (500 ng/ml), dexamethasone (400 
ng/ml), IBMX (44 μg/ml), L-Thyroxin (9ng/ml) and a thiazolidinedione, Ciglitazone 
(3μg/ml) for 72 hrs. After this period, the differentiating cells were grown in nutrition media 
containing DMEM/Ham’s F-12, 3% FCS, d-biotin (8 μg/ml), insulin (500 ng/ml) and 
Dexamethasone (400 ng/ml) until fully differentiated (15 days) up until day 21.
3.2.2 Lipolysis Studies in Differentiated Pre-adipocytes
In brief, conditioned media collected during the course of differentiation of the preadipocytes
was assessed for glycerol production as a measure of lipolysis (µM/mL) using a
commercially available colorimetric kit (Randox Laboratories, Co. Antrim, UK). Cell culture
medium samples were analysed for free glycerol content using the commercial glycerol free
assay reagent and glycerol standards according to manufacturer’s protocol. Briefly, to 25ul of
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conditioned media in each well, 200ul of free glycerol reagent was added per well, incubated
for 15mins at RT and absorbance read at 540nm. Glycerol release in the samples was
calculated from the reference curve generated from known concentrations of glycerol.
3.2.2.1 Lipid Staining of Differentiated Preadipocytes
Oil red O is a fat soluble dye, and can be used as an effective reagent in the assessment of the
extent of preadipocyte differentiation, as it targets and stains TG and lipids within the cell.
Subsequent release of oil red O, following staining, can enable assessment of lipid
accumulation within the culture. Lipid staining was performed using a modified method by
Mcvean et al, (McVean et al., 1965). Briefly, during defined intervals, differentiated
preadipocytes were washed with Hanks’ Balanced Salt Solution (HBSS), fixed for 1hr in
10% formalin, washed with water and stained with 0.3% Oil Red O (Gurr Ltd., London, UK)
for 15 min at room temperature. After thorough washings with water, microscopic images
were taken to visualize pink to red oil droplets staining differentiated cells. Then, after
evaporation of excess water, oil red was extracted in isopropyl alcohol (Fisher Scientific
Ltd., Loughborough, UK) and the absorbance was monitored at 520 nm using microplate
reader for semi-quantitative determination of lipid accumulation.
3.2.2.2 Leptin & Adiponectin Secretion in Differentiating Human Preadipocytes
Conditioned media samples were collected during the course of differentiation and assayed
for leptin and adiponectin secretion, as markers of differentiation, using respective enzyme-
linked immunosorbant assay (ELISA) kits (leptin, Millipore; adiponectin Millipore,
Hertfordshire, UK). Conditioned media were analysed using a solid phase ELISA, the leptin
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ELISA had a sensitivity limit of 0.5 ng/ml, CV intra-assay 2.6-4.6% and inter-assay
variability was 1.4-4.9%; adiponectin’s assay limit was 0.78ng/ml, CV intra-assay 7.4% and
inter-assay variability was 2.4-8.4%. Methodology for a standard ELISA is given in the
materials and methods.
3.2.2.3 Extraction of differentiating Preadipocytes for RNA Extraction and Quantitative
RT-PCR
RNA was extracted from treated isolated adipocytes using the GenElute total mammalian
RNA kit (Sigma-Aldrich Corp.), which included a deoxyribonuclease digestion step to
remove any contaminating genomic DNA. RNA (1µg) from each sample was reverse
transcribed using Superscript (Invitrogen, Paisley, UK) and random hexamers in 20µl
reaction volumes, according to the manufacturer’s instructions. The mRNA levels were
determined using an ABI 7500 real-time PCR Sequence Detection system (PE Applied
Biosystems, Warrington, UK), as previously described (McTernan et al., 2002). The
reactions were performed in 25µl volumes on 96-well plates in reaction buffer containing
TaqMan Universal PCR Master Mix (PE Applied Biosystems) and commercially available
specific gene expression assays (PE Applied Biosystems).
3.2.2.4 Quantitative Primer and Probe Sequences for Adiponectin, PPAR, Perilipin
and CEBP, Genes were analyzed using Commercially Available Gene Expression
Assays
All reactions were multiplexed with the housekeeping gene 18S, provided as a preoptimized
control probe (PE Applied Biosystems, Warrington, UK), enabling data to be expressed in
relation to an internal reference to allow for differences in RT efficiency. Data were obtained
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as Ct values according to the manufacturer’s guidelines (the cycle number at which
logarithmic PCR plots cross a calculated threshold line) and were used to determine ΔCt
values (ΔCt = Ct of the target gene minus Ct of the housekeeping gene). Measurements were
carried out on at least three occasions for each sample. To exclude potential bias due to
averaging data that had been transformed through the equation 2-∆∆Ct, all statistics were
performed at the ΔCt stage.
3.2.3.1 Statistical analysis
For analysis of conditioned media and gene expression data, statistical analysis was
undertaken using unpaired t tests unless otherwise stated, where data were analysed using
nonparametric tests. The threshold for significance was P < 0.05. The data in the text and
figures are presented as the mean ± SEM unless otherwise stated.
3.3 Results
3.3.1. Influence of Differentiation on Lipolysis
To assess the effect of differentiation over time in preadipocytes, studies examined glycerol
release as a marker of lipolysis in cultured AbSc adipocytes. Glycerol release was examined
at day 0, 4, 9, 14, 18 and 21 post differentiation. Glycerol release increased over time as lipid
content within the differentiating cells increased from baseline allowing a significant turnover
of glycerol (Day 0: 4.23 ± (SD) 1.3 µg/ml; Day 4: 4.06±0.1 µg/ml; Day 9: 9.89±4.2 µg/ml*;
Day 14: 10.99±2.4 µg/ml; Day 18: 14.63± 3.5 µg/ml**; Day 21: 15.28±4.5 µg/ml**; p-
values: *p<0.05, **p<0.01, n=4; Figure 3.3.1.1).
67
Figure 3.3.1.1 Measurement of glycerol release from differentiation of AbSc preadipocytes.
This figure highlights the increase in glycerol release over time, with significant
changes noted when comparing day 0 with days 9, 14, 18 and 21(p-values: *p<0.05, **p<0.01).
3.3.2 Lipid Staining of Differentiated Preadipocytes
Oil red O release from lipid stained differentiated adipocytes was measured on the same days
as the glycerol release studies and changes noted using a spectrophotometer, with absorbance
defined as optical density units ODU at wavelength 520nM. There was a significant increase
in lipid accumulation over time compared with baseline (Day 0: 0.075 ± (SD) 0.01 ODU;
Day 4: 0.080±0.016 ODU; Day 9: 0.099±0.02 ODU; Day 14: 0.182±0.06 ODU**; Day 18:
0.159±0.01 ODU**; Day 21:0.169±0.002 ODU**; p-values: **p<0.01, n=4; Figure 3.3.2.1).
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In addition to the spectrophotometric analysis of differentiation by oil-red O photographs
were taken on selected days of differentiation as a visual sign of morphological changes in
the preadipocytes as they accumulated lipids (Figure 3.3.2.2A-D).
Figure 3.3.2.1 Measurement of oil-red O from Abd Sc differentiation of preadipocytes.
This figure highlights the increase in lipid accumulation as measured by oil-red O staining (520nM)
of lipid over time, with significant changes noted when comparing day 0 with days 14, 18 and 21
(p-values: **p<0.01).
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Figure 3.3.2.2 Photographic representation of lipid acc
preadipocytes.The photographs show the oil red O stained adipocytes from day 6
( magnification x40).
3.3.3 Leptin & Adiponectin Secretion in Differentiating H
Leptin was measured in conditioned media derived from differentiating AbdSc
cultured in differentiation media,
From analysis of the data comparing baseline Day 0 leptin secretion, leptin levels increased
over the period of differentiation to a maximal level as denoted at Day 18 and Day 21 (Day 0:
0.35±0.039 ng/ml; Day 4: 0.14
Day 14: 6.46±0.25ng/ml**; Day
values: **p<0.01, p-values:, n=7;
umulation in differentiating Ab
uman Preadipocytes
as defined in the methods and materials of this chapter.
±0.045 ng/ml; Day 9:
18: 10.73±2.29ng/ml**; Day 21: 10.56
Figure 3.3.3.1).
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Adiponectin was also measured in conditioned media as a marker of differentiation. From
analysis of the data comparing baseline Day 0 adiponectin secretion, adiponectin levels
increased over the period of differentiation to a maximal level as denoted at Day 9 with
subsequent days reducing levels of adiponectin secretion, although still above day 0 secreted
levels (Day 0: 0.199 ± (SD) 0.03 ng/ml; Day 4: 0.22 ± 0.065 ng/ml; Day 9: 0.47 ± 0.069
ng/ml∗∗; Day 14: 0.36 ± 0.01 ng/ml**; Day 18: 0.335 ± 0.097 ± ng/ml*; Day 21: 0.36 ±
0.086 ng/ml*; p-values: *p<0.05, **p<0.01, p-values:, n=7; Figure 3.3.3.2).
Figure 3.3.3.1 Secretion of leptin from differentiation of AbSc preadipocytes over time.
This figure highlights the increase in leptin secretion over time, with significant changes noted
comparing day 0 with days 9, 14, 18 and 21 (p-value: **p<0.01).
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Figure 3.3.3.2. Secretion of adiponectin from AbSc differentiation of preadipocytes over time.
This figure highlights the increase in adiponectin secretion over time, with significant changes noted
comparing day 0 with days 9, 14, 18 and 21 (p-value: *p<0.05, **p<0.01).
3.3.4 Gene Expression of Markers of Differentiation
Four gene expression markers of differentiation, adiponectin, PPARγ, perilipin and CEBPα, 
were utilised to examine the changes in their mRNA levels during differentiation, in order to
affirm the differentiation of the AbSc preadipocytes, in accordance with previous studies.
Table 3.3.4.1 shows the ΔCt changes during differentiation (n=7); whilst Figure 3.3.4.2. A-D 
shows the relative fold expression with day zero given an arbitrary value of 1.
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3.4 Discussion
To date, there has been more than 60 papers examining the role of human preadipocyte
differentiation and factors that can affect lipolysis, lipogenesis, as well as mRNA and protein
expression and secretion of adipokines (Deng et al., 2006; Dicker et al., 2007; Kappes and
Loffler, 2000; Marshak and Greenwalt, 2007; Payne et al., 2007; Tian et al., 2010). These
papers have specifically concentrated on what mechanisms are affected by the perturbation of
the differentiating system and how genes alter.
Early papers examining differentiation investigated whether lipolytic action was a
function of differentiation or whether the rate of lipolysis can predict the state of preadipocyte
differentiation. Such studies induced lipolysis using noradrenaline which was noted to
increase significantly until day 12 of differentiation. However changes in mRNA expression
of lipolysis related genes (such as hormone sensitive lipase (HSL), adipocyte triglyceride
lipase, the alpha2-and beta1-adrenoceptors, perilipin and fatty acid binding protein) all
appeared to reach maximal effect much earlier during differentiation, specifically by day 8
(Dicker et al., 2007). The studies presented here, examining perilipin and PPAR mRNA
expression, identified a similar pattern with a significant increase in mRNA expression from
baseline up until day 6 and then a subsequent and substantial drop that appeared to increase
slightly after day 9 but never reached the marked increase in mRNA expression observed on
day 6. Additionally, as the cells were given a TZD to drive differentiation, it was clearly
noted that PPAR responded to this stimulus – thus substantiating previous findings that
PPAR plays an important role in lipid metabolism, as well as insulin sensitivity, during
differentiation of preadipocytes (Deng et al., 2006). Previous studies have highlighted that
expression of the HSL gene is up-regulated by PPAR and PPAR agonists (rosiglitazone and
pioglitazone) in cultured hepatic cells and differentiating preadipocytes (Deng et al., 2006).
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Taken together, these mRNA data affirm previous findings on differentiation. In subtle
contrast, functional analysis of glycerol release and oil-red O staining highlighted that lipid
accumulation continued despite a reduction in lipid related genes, as demonstrated previously
by Dicker and co-workers (Dicker et al., 2007).
These current studies also examined mRNA expression of CAAT/enhancer-binding
protein alpha (C/EBP alpha) which, along with C/EBP beta, has previously been shown to
regulate Diacylglycerol acyltransferase 2 (DGAT2) expression during adipogenesis. DGAT2
is important as it catalyzes the final step of TG synthesis and therefore is important in
adipogenesis promoting lipid accumulation. Previous analysis using both isolated murine
preadipocytes and 3T3-L1 cells has shown that the temporal pattern of DGAT2 expression
closely mimicked that of genes whose expression is regulated by the C/EBP family, with
notable changes in C/EBP and β expression during adipogenesis. This present study, again, 
highlighted a substantial reduction in CEBP mRNA expression after day 6 that slowly
increased over subsequent days (Dicker et al., 2007; Payne et al., 2007).
In addition to examining mRNA expression during differentiation, secretion of
adipokines was also examined. These studies utilised conditioned media to assess the
secretion of leptin and adiponectin by ELISA. Previous studies examining leptin secretion as
adipogenesis progresses noted its substantial increase at the later stages of differentiation.
Recent studies have also begun to capture the gene expression data as assessed by microarray
and real-time PCR, to use bioinformatics algorithms to predict the secretome of
differentiating preadipocytes, with the most significant adipokines confirmed at the protein
level using western blots or ELISA assays. This study, as well as highlighting a novel
candidate, matrix gla protein (MGP), which was upregulated (approximately 30-fold) during
adipogenesis, also re-affirmed leptin release (approximately 50-fold increase (Mutch et al.,
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2009). Such changes in leptin secretion in this present chapter align with Mutch’s findings
along with previous reports of leptin level changes during differentiation noted by others
(McTernan, 2003). Furthermore the data in this chapter, examining adiponectin secretion, is
in accordance with previous findings identifying a substantial up regulation of adiponectin
mRNA and protein secretion post day 3 (Kappes and Loffler, 2000; Mutch et al., 2009; Tian
et al., 2010).
To gather as much data across the individual preadipocyte sample several time points
were investigated during differentiation and samples taken for either mRNA, oil red O,
protein expression or glycerol release; where feasible samples were collected from the same
time point in essence to maximise the data from each individual cultured preadipocyte cell
sample (Deng et al., 2006; Dicker et al., 2007; Kappes and Loffler, 2000; Marshak and
Greenwalt, 2007; Payne et al., 2007; Tian et al., 2010). This meant the same preadipocyte
cell samples were grown to assess a variety of measurements over the course of the
differentiation, rather than differentiating preadipocytes cells for one particular assay each
time. It should be stressed though that this system was designed to work on a small scale to
evaluate the effects on cellular mechanisms post differentiation and not to produce a high
rapid throughput system, as has been established by others previously (Marshak and
Greenwalt, 2007).
In summary, this current chapter has examined a variety of differentiation markers
from lipolysis, adipogenesis, mRNA and protein data, as well as pictorial morphological
changes during differentiation to highlight that, under the current culture system, the
preadipocytes undergo differentiation comparable to previous studies. Following
differentiation the cells were subsequently utilised for the studies as outlined in the following
chapters, where post-differentiation cellular mechanisms of ER stress were investigated.
Chapter 4
The Effect of Hyperglycaemia on ER Stress and the Alleviating
Effect of Salicylates on Primary Human Differentiated
Abdominal Subcutaneous Adipocytes
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4.1. Introduction
Obesity-associated inflammation is a key contributory factor in the pathogenesis of type 2
diabetes mellitus (T2DM) and cardiovascular disease (CVD) but the fundamental
mechanisms responsible for activating innate immune inflammatory pathways and insulin
resistance are currently unclear. Cardiovascular disease (CVD) is the main cause of morbidity
and mortality in type 2 diabetes-related costs. In the diabetic population, the relative risk of
coronary heart disease (CHD) is 1.5 to 1.7 in males and 1.7 to 4.0 in females (Charbonnel &
Del Prato, 2003). The relationship between diabetes and cardiovascular events is so stringent
that the American Diabetes Association has identified diabetes as a cardiovascular disease.
Postprandial hyperglycaemia (PPG) is an important contributing factor in the development of
CVD in people with T2DM (Ceriello, 2005). Two recent studies have confirmed that
postprandial hyperglycaemia is an independent risk factor for CVD in type 2 diabetes
(Hanefeld et al, 1996; Cavalot et al, 2006). Intervention studies have also supported the
relevance of PPG in the development of CVD including silent myocardial infarction
(Chiasson et al, 2002; Chiasson et al, 2003; Zeymer et al, 2004).
Therefore whilst clinically relevant, the mechanisms for such occurrences appear to
reach further beyond cellular dysfunction of endothelial cells in response to PPG and may
also impact on adipose tissue (AT). As such a new emerging area has begun to examine the
link between the impact of obesity-induced inflammation, insulin resistance and increased
stress of the endoplasmic reticulum (ER) (Hotamisligil, 2007; Gregor & Hotamisligil,
2007b).
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As discussed fully in chapter 1 the ER represents a highly dynamic organelle with a
central role in lipid and protein biosynthesis (Ozcan et al, 2004). It is extremely sensitive to
alterations in homeostasis, and proteins formed in the ER may fail to attain correct structural
conformation during pathological nutrient excess. Accumulation of misfolded proteins in the
ER causes ER stress and activation of unfolded protein response (UPR) (Harding et al, 2002),
which under normal circumstances alleviates ER stress, restores ER homeostasis and prevents
cell death. One of the factors known to elicit cellular stresses include hyperglycaemia,
however to date the effect of this on ER stress in differentiated primary human adipocytes is
unknown (Cnop et al, 2005; Nakatani et al, 2005).
The UPR is known to signal through three ER transmembrane sensors: PKR-like ER-
regulated kinase (PERK), inositol requiring enzyme1α (IRE1α) and activating transcription 
factor6 (ATF6) (Kim et al, 2008; Malhotra et al, 2008; Scheuner & Kaufman, 2008). These
then activate an adaptive response that results in inhibition of protein translation and increase
in transcription of protein-folding chaperones and ER-associated degradation genes (Ozcan et
al, 2004; van der Kallen et al, 2009). ATF6 induces X-box binding protein 1 (XBP1)
transcription and IRE1α upon activation initiates splicing of XBP1 (XBP1s) mRNA which 
encodes a transcriptional activator that modulates the UPR through regulation of transcription
of ER chaperones (Yoshida et al, 2001). PERK phosphorylates the eukayotic translation
initiation factor 2α (eIF2α) (Harding et al, 1999). Phosphor-eIF2α (p-eIF2α) then attenuates 
protein synthesis and reduces ER protein overload (Harding et al, 2000a; Harding et al,
2000b).
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This also results in increased alternative translation of activation transcription factor 4
(ATF4), which induces expression of many genes, including those involved in apoptosis:
C/EBP homologous protein (CHOP) (Fawcett et al, 1999; Harding et al, 2000a; Szegezdi et
al, 2006; van Huizen et al, 2003). Upon activation during UPR, the cytoplasmic domain of
ATF6 is cleaved and the cleaved N-terminal fragment translocates to the nucleus and activates
the transcription of ER chaperones such as glucose regulated protein (Grp)78/Bip, protein
disulfide isomerase (PDI), Ero1-Lα and calnexin to augment the ER protein folding capacity 
(Gregor & Hotamisligil, 2007a; Gregor & Hotamisligil, 2007b; Hotamisligil, 2007; Scheuner
& Kaufman, 2008; van der Kallen et al, 2009).
Current studies have shown that an enhanced level of the UPR occurs in obese, insulin-
resistant human AT (Boden et al, 2008; Gregor et al, 2009; Sharma et al, 2008). ER stress and
the UPR are linked to major inflammatory and stress-signalling networks, including the
activation of JNK and IKK-NFκB pathways and the production of reactive oxygen species 
(ROS) (Hotamisligil, 2006). Intriguingly, these are also the pathways and mechanisms that
play a central role in obesity-induced inflammation and metabolic abnormalities (Gregor &
Hotamisligil, 2007b). In order to mediate a reduction in increased diabetic risk, previous
rodent and human studies examined whether high doses of salicylates can offer any benefits,
these studies suggest that salicylates can reduce hyperglycaemia (Baron, 1982). In
addition,(Yuan et al, 2001) indirectly investigated the potential mechanisms of
hyperglycaemic effects. In their study, severely obese rodents treated with salicylates
demonstrated reduced signalling through the IKKβ pathway and this was accompanied by 
improved insulin sensitivity in vivo.
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By inhibiting IKKβ activity, salicylates inhibit the activation of nuclear factor-B (NF-B)
via inhibition of phosphorylation and degradation of IBα (Kopp & Ghosh, 1994; Pierce et al,
1996). This inhibition of NF-B may explain some of the clinically documented anti-
inflammatory and insulin sensitising effects of salicylates.
Although ER stress, increased AT inflammation and metabolic dysfunction is associated with
obesity in rodent models, the importance of ER stress and the potential inducers of ER stress
in human adipocytes is not known. Therefore, the objective of the present study was to firstly
show the existence of ER stress in human AT and examine changes with and without obesity;
secondly, to identify the potential effect of hyperglycaemic like conditions on in vitro treated
human AbSc adipocytes and finally ascertain the role of the anti-inflammatory agent, sodium
salicylate (Sal) on ER stress in cultured primary human adipocytes in the presence and
absence of high glucose conditions.
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4.2 Research Design and Methods
4.2.1 Subjects
Human AbSc AT was collected from patients (age: 40.8 (mean ± SD) ±5yrs; Lean BMI:
22.04±2.6kg/m
2
and obese BMI 30±3.5kg/m
2
) undergoing elective or liposuction surgery
with informed consent obtained in accordance with LREC guidelines and with ethics
committee approval. All tissue samples were flash frozen and/or utilised for isolation of
stromal fraction, subsequently used for culturing primary human adipocytes as detailed
(McTernan et al, 2002). In total, 20 human non-diabetic AT samples were analysed, which
were sub-divided into: Lean AbSc (n=10) and Obese AbSc (n=10) based on BMI.
4.2.1.1 Cell Culture
In brief, AbSc AT was digested with collagenase (Worthington Biochemical,
Reading, USA) as previously described to isolate mature adipocytes and pre-adipocytes
(Harte et al, 2003). Firstly, stromal fractions of Human AbSc AT (BMI 25.04±0.6kg/m
2
; n =
3-6) were cultured into tissue culture flasks until confluent and then trypsinised to obtain
cells to carry out the study. The preadipocytes from the same passage were grown in 6-well
plates to confluence in DMEM/Ham’s F-12 phenol-free medium (Invitrogen, Paisley, UK)
containing 10% FCS, penicillin (100 U/ml), streptomycin (100 µg/ml), and transferrin (5
µg/ml).
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At confluence, preadipocytes were differentiated in preadipocyte differentiation
media (Promocell, Germany) containing biotin (8 μg/ml), insulin (500 ng/ml), 
Dexamethasone (400 ng/ml Promocell, Germany), IBMX (44 μg/ml Promocell, Germany),
L-Thyroxin (9ng/ml Promocell, Germany) and Ciglitazone (3μg/ml Promocell, Germany) for
72 hrs. After this period, the differentiating cells were grown in nutrition media containing
DMEM/Ham’s F-12, 3% FCS, d-biotin (8 μg/ml), insulin (500 ng/ml) and Dexamethasone 
(400 ng/ml) until fully differentiated (14-18 days). The viability of adipocytes was assessed
using the trypan blue dye exclusion method (Sigma-Aldrich Corp., Poole, UK) (Matthews et
al, 1985).
4.2.1.2 Treatments
Fully differentiated adipocytes (day 15) were grown in normal DMEM/Ham’s F-12 phenol-
free medium containing only 2% serum (detoxification media) for 24 hrs to remove effects of
growth factors and other components in nutrition media. The treatments were then placed in
the fresh detoxification media for 24 hrs. The cells were treated with tunicamycin
(tunicamycin, Tun: 750ng/ml); tunicamycin is a well known ER stress inducer and therefore
was used as a positive control, glucose (25mM) (Nelson et al, 2000; Zhang et al, 2009; Zu et
al, 2008), referred hereafter as high glucose (HG) (Sigma-aldrich, Poole UK) and sodium
salicylate (Sal: 20mM; Sigma-aldrich, Poole UK for 24 hrs.
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4.2.1.3 Immunoblotting
Cells were washed in PBS and harvested in 250 μl of lysis buffer (20 mM Tris-HCl, pH 7.5; 
137 mM NaCl; 1mM EDTA, pH 8; 1% Triton X-100; 10% glycerol; 1.5mM MgCl2p; Sigma-
aldrich, Poole UK) containing protease and phosphatase inhibitors (10 mM NaF; 1 mM
PMSF; 1 mM sodium metavanadate; 5 μg/ml aprotinin; 10 μg/ml leupeptin; Sigma-aldrich,
Poole UK) and stored at -80˚C until required. Homogenised human AT was extracted using 
RIPA buffer method (Harte et al, 2003). Total protein was determined by Bradford assay
(BioRad, UK). Protein (10-20 μg) from cell lysates were resolved by SDS-PAGE and 
transferred to an Immobilon-P membrane (Millipore, Hertfordshire, UK) by electroblotting.
The membranes were blocked with 0.2% I-BlockTM (Applied Biosystems, Warrington, UK)
dissolved in 0.1% Tween20 in PBS and probed with primary and secondary antibodies.
Primary antibodies were: phospho and total Akt, phospho and total eIF2α, Bip/GRP78, 
Calnexin, Protein disulfide isomerase (PDI), Ero1-Lα, phospho-PERK (p-PERK), IRE1α and 
β-actin (Cell Signalling Technologies, Massachusettes, USA). Antigen-antibody complexes 
were visualized using ECL reagents (Amersham, UK). Scanned autoradiographs were semi-
quantified using 2D densitometry, GeneTools software (Syngene, Cambridge, UK). The
bands were first normalised as a function of the loading control (protein of interest/β-actin) or 
total expression of the proteins (for phospho-proteins), then converted to fold change
compared with controls.
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4.2.1.4 Extraction of RNA and Quantitative RT-PCR
To characterise gene expression, RNA was extracted from adipocytes, according to
manufacturers’ instructions (RNeasy Lipid Tissue Mini Kit, Qiagen, UK). Following DNase
treatment and reverse transcription, mRNA expression levels were determined using an ABI
7500 Real-time PCR Sequence Detection system (Anderson et al, 2001). Pre-optimized
quantitative primer and probe sequences for genes were utilised (Applera, Cheshire, UK).
All reactions were multiplexed with the housekeeping gene 18S, provided as a pre-optimised
control probe (Applera, Cheshire, UK), enabling data to be expressed in relation to an
internal reference to allow for differences in relative threshold efficiency. Data were obtained
as cycle threshold (Ct) values (the cycle number at which logarithmic PCR plots cross a
calculated threshold line) and used to determine ΔCt values (ΔCt=Ct of 18S housekeeping 
gene subtracted from Ct of gene of interest). Measurements were carried out on at least three
occasions for each sample. To exclude potential bias due to averaging, all statistics were
performed at this stage prior to the data being transformed through the power equation 2-ΔΔCt,
4.2.1.5 Statistical Analysis
Data in the text and figures are presented as mean ± standard error of the mean (SEM)
for at least three independent experiments performed in triplicates to ensure reproducibility.
Students t test was used to compare values between two groups unless stated otherwise. P
values <0.05 were considered to represent statistically significant differences.
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4.3 Results
4.3.1 ER Stress Markers are Up-regulated in Obese Human AbSc AT Compared with
Lean
Protein expression of the ER stress markers was measured in 4 obese and 4 lean human AbSc
AT samples. The p-PERK and IRE1α proteins, which are regulators of two important ER 
stress pathways, were increased in obese subjects – although this was only significant for
IRE-1α expression compared with lean (Figure 4.3.1.1). ATF6, which regulates the third ER
stress pathway, was investigated by examining mRNA expression via real-time PCR, as this
proved a more reliable method, with previous studies by (Namba et al, 2007) demonstrating
that up-regulation of ATF6 mRNA expression is involved in enhancing the ER stress
response and is a good marker for the ATF6 ER stress pathway. ATF6 mRNA expression in
AbSc AT of 10 lean and 10 obese subjects was significantly higher (8 fold) in obese subjects
(ΔCt=07.36±1.47) compared with lean (ΔCt=10.57±1.13) (p<0.001) (Figure 4.3.1.2).
Furthermore, the protein expression of down-stream targets of the three ER stress pathways,
i.e. the chaperone proteins Grp78/Bip1, Calnexin, PDI and Ero1-Lα, were all significantly 
increased in AbSc AT of obese subjects (Figure 4.3.1.1). Protein expression was measured
by normalising against the endogenous control, β-actin. The data demonstrate consistent up-
regulation of ER stress markers in obese AbSc AT, as previously shown by three different
groups (Boden et al, 2008; Gregor et al, 2009; Sharma et al, 2008).
89
Figure 4.3.1.1 Protein expression levels of ER stress markers: p-PERK, IRE1α, Grp78/Bip, 
Calnexin, PDI, Ero1-Lα and β-actin (loading control) in lean (n=4) vs. Obese (n=4) human AbSc 
AT. The protein expression was determined from whole AT lysate by western blot. *p<0.05,
**p<0.01 and ***p<0.001 by Student’s t-test.
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4.3.2 Sal Down-regulates PERK and ATF6 Pathway Up-regulated by Tun and HG in
Fully Differentiated Primary Human Preadipocytes
Proximal events for the UPR include the activation of ER-resident signaling molecules such
as PERK and ATF6 in order to initiate transcriptional and translational programs that
alleviate ER stress. To determine the origins of ER stress in human adipocytes, stromal
fractions from human AbSc AT were cultured and differentiated into adipocytes (Figure
4.3.2.1) and these primary adipocytes were then treated with most probable factors elevated
in obesity such as HG for 24 hrs.
Figure 4.3.1.2 mRNA expression of ATF6 in human AbSc AT, Lean vs Obese: both n=10. mRNA
was determined by qRT-PCR. In the figure, values are the mean ± SEM expressed as a relative fold
difference to lean AbSc AT, given an arbitrary value of 1. *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
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Tun which is a known inducer of ER stress was used as a positive control. The protein, p-
eIF2α, is the down-stream-target of p-PERK and was significantly induced by Tun and HG - 
both of them significantly induced the p-eIF2α expression compared with cells treated in 
absence of treatment (control) (Figure 4.3.2.1 and 4.3.2.2). We were also interested in
looking at the effect of Sal on this pathway. Sal significantly down-regulated the expression
of p-eIF2α in adipocytes treated with Tun and HG in combination with Sal (Figure 4.3.2.1
and 4.3.2.2). There was no change in the total eIF2α expression levels. This provides the first 
strong evidence that HG activates the PERK pathway, whilst Sal alleviates this activation in
human differentiated adipocytes.
Figure 4.3.2.1 p-eIF2α in Tun treated adipocytes either alone or in combination with Sal. B was 
measured by western blot. In the figure, values are represented as the mean ± SEM (n=3-6).
*p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
92
Figure 4.3.2.2 p-eIF2α in HG treated adipocytes, either alone or in combination with Sal,  
measured by western blot (n=3-6). In the figure, values represent the mean ± SEM expressed as a
relative fold difference to control given an arbitrary values of 1. *p<0.05, **p<0.01 and
***p<0.001 by Student’s t-test.
93
The ATF6 mRNA level was significantly increased in the cells treated with HG and Tun
(Figure 4.3.2.3). ATF6 mRNA levels were significantly down-regulated in adipocytes treated
with HG and Tun in combination with Sal, and Sal alone (Figure 4.3.2.3).
4.3.3 Down-stream Targets of PERK and ATF6 Pathways are Up-regulated by Tun and
HG: Sal Alleviates ER Stress Response
Protein chaperones and down-stream targets of PERK and ATF6 pathways either protein or
mRNA expression levels were measured in the adipocytes treated with Tun and HG alone or
in combination with Sal. ER resident proteins such as Grp78/BiP, calnexin, PDI and Ero1-Lα 
Figure 4.3.2.3 ATF6 mRNA expression in adipocytes treated with Tun and HG, either alone or in
combination with Sal, was determined by qRT-PCR. In the figure, values are shown as mean ±
SEM, expressed as a relative fold difference to control which was given an arbitrary value of 1.
*p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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act as molecular chaperones to promote proper folding and/or prevent aggregation of folding
intermediates. UPR is induced when Grp78/Bip expression is induced and the PERK, ATF6
and IRE1α which are bound to Grp78/Bip, dissociate and are activated (Hotamisligil, 2007). 
Grp78/Bip was significantly increased in Tun treated cells only (Figures: 4.3.3.1, 4.3.3.2).
HG did not have any effect on Grp78/Bip expression. Sal significantly down-regulated the
expression of Grp78/Bip in Tun treated cells (Figures: 4.3.3.1, 4.3.3.2).
Figures: 4.3.3.1 Protein expression levels of Grp78/Bip in Tun treated adipocytes, either alone or in
combination with Sal, measured by western blot (n=3-6). In the figure, values show the mean ± SEM,
expressed as a relative fold difference to control which was given an arbitrary value of 1. *p<0.05,
**p<0.01 and ***p<0.001 by Student’s t-test.
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Another protein chaperone, Calnexin, was significantly up-regulated by Tun and HG but this
effect was significantly down-regulated by Sal (Figures: 4.3.3.3, 4.3.3.4). Sal alone also
significantly suppressed the Calnexin expression compared with control.
Figures: 4.3.3.2 Protein expression levels of Grp78/Bip in HG treated adipocytes, either alone or in
combination with Sal, by western blot (n=3-6). In the figure, values show the mean ± SEM,
expressed as a relative fold difference to control and given an arbitrary value of 1. No significant
differences were noted compared with control.
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Figures: 4.3.3.3 Protein expression levels of Calnexin in Tun treated adipocytes, alone and in
combination with Sal, by western blot (n=3-6). In the figure, values represent the mean ± SEM
expressed as a relative fold difference to control given an arbitrary value of 1. No significant
differences were noted compared with control. P- Values *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
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Figures: 4.3.3.4 Protein expression levels of Calnexin in HG treated adipocytes, alone and in
combination with Sal, by western blot (n=3-6). In the figure, values show the mean ± SEM
expressed as a relative fold difference to control and given an arbitrary value of 1. No significant
differences were noted compared with control. P- Values *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
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The mRNA expression of the protein chaperones, PDI and Ero1-Lα, were significantly 
increased in Tun and HG treated adipocytes (Figures: 4.3.3.5 and 4.3.3.6). Sal, again,
significantly down-regulated the expression of these chaperones in the adipocytes treated in
combination with Sal. Only PDI wasn’t significantly suppressed by Sal in HG treated cells.
However, Sal alone significantly down-regulated PDI mRNA expression levels (Figure
4.3.3.5).
Figures: 4.3.3.5. PDI mRNA expression in adipocytes treated with Tun and HG, either alone or in
combination with Sal was determined by qRT-PCR (n=3-6). In the figure, values represent the
mean ± SEM expressed as a relative fold difference to control which was given an arbitrary value
of 1. No significant differences were noted compared with control. P- Values *p<0.05, **p<0.01
and ***p<0.001 by Student’s t-test.
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Figure 4.3.3.6 Ero1-Lα mRNA expression in adipocytes treated with Tun and HG, either alone or 
in combination with Sal, was determined by qRT-PCR (n=3-6). In the figure, values show the mean
± SEM expressed as a relative fold difference to control and given an arbitrary value of 1. No
significant differences were noted compared with control. P- Values *p<0.05, **p<0.01 and
***p<0.001 by Student’s t-test.
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Signalling through PERK, ATF6 and IRE1α can induce pro-apoptotic signals during extreme 
ER stress by activating down-stream targets such as CHOP. Therefore, we examined the
mRNA expression of ER stress-induced apoptotic transcription factor CHOP in Tun and HG
treated primary adipocytes. Both treatments significantly increased CHOP expression (at
least 2-fold) (Figure 4.3.3.7). Interestingly, Sal significantly down-regulated CHOP
expression induced by Tun and HG (Figure 4.3.3.7).
Figure 4.3.3.7 CHOP mRNA expression in adipocytes treated with Tun and HG, either alone or in
combination with Sal, was determined by qRT-PCR (n=3-6). In the figure, values represent the
mean ± SEM expressed as a relative fold difference to control and given an arbitrary value of 1. No
significant differences were noted compared with control. P- Values *p<0.05, **p<0.01 and
***p<0.001 by Student’s t-test.
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4.4.1 Activation of AktSer473
Hu et al. (Hu et al, 2004) have reported transient activation of Akt in ER-induced apoptosis
and p-Akt (Ser473) is an important member of the insulin signalling pathway, as it induces
glucose transport and overall insulin sensitivity of the cell. Therefore, Akt activation was
examined by measuring p-AktSer473 levels in the adipocytes treated with Tun and HG, and
in combination with Sal. Interestingly, Tun and HG significantly induced p-AktSer473 levels
compared with controls. There was further significant induction by Sal in adipocytes treated
with Tun and HG (Figures: 4.4.1.1 and 4.4.1.2). Sal, alone, significantly increased p-
AktSer473 levels (Figures: 4.4.1.1 and 4.4.1.2).
Figures: 4.4.1.1 Protein expression levels of p-AktSer473 in Tun treated adipocytes, alone and
in combination with Sal. Protein expression was measured by western blot. In the figure, values
show the mean ± SEM (n=3-6). P-Values: *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-
test.
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Figures: 4.4.1.2 Protein expression levels of p-AktSer473 in HG treated adipocytes, alone and in
combination with Sal. Protein expression was measured by western blot. In the figure, values
represent the mean ± SEM (n=3-6). P-Values: *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-
test.
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4.5 DISCUSSION
The AT plays a central role in the regulation of metabolic homeostasis. The AT in obesity is
challenged by many insults, such as surplus energy, inflammation, insulin resistance and
considerable stress to various organelles. ER is one such organelle which shows significant
signs of stress and has been casually linked as one of the contributing factors for increased
inflammation and insulin resistance. The results of the present study demonstrate that firstly,
there is increased ER stress in obese AbSc AT; secondly, that one factor inducing this
response could be hyperglycaemia and thirdly, that this stress response is alleviated by
salicylates and could contribute to increased insulin sensitivity in adipocytes.
Hyperglycaemia has been shown to be present in obese subjects and has been linked to
increased inflammation and insulin resistance (Belfiore et al, 2001) and, therefore, was
investigated as a potential factor for the induction of ER stress in human adipocytes. Tun is a
well known ER stress inducer and therefore was used as a positive control.
ER stress protein markers were significantly up-regulated in obese human AbSc AT
compared to AbSc AT from lean subjects. The IRE1α and ATF6 expression levels were 
significantly increased in obese AbSc AT. The p-PERK was also increased but this was not
significant. This observation confirms the three previous studies carried out on human AT
(Boden et al, 2008; Gregor et al, 2009; Sharma et al, 2008). PERK, ATF6 and IRE1α play a 
central role in UPR signalling. Upon activation, these factors induce the expression of protein
chaperones for the proper folding of the protein and protein complexes (Eizirik et al, 2008;
Gething & Sambrook, 1992).
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The protein chaperones Grp78/Bip, Calnexin, Ero1-Lα and PDI were all significantly up-
regulated in obese human AbSc AT compared with lean AbSc AT. Increased expression of
PDI and Calnexin confirms the earlier observation made by Boden and colleagues (Boden et
al, 2008). To identify the factors responsible for inducing ER stress in human AT, stromal
fractions isolated from human AT were cultured and then differentiated. The differentiated
adipocytes were then treated with Tun and HG with and without salicylate. Our data clearly
demonstrates that Tun and HG activate the PERK pathway. This activation was measured by
looking at the expression levels of p-eIF2α, a down-stream target of PERK, which was 
significantly increased in Tun and HG treated adipocytes. PERK is activated in response to
accumulation of misfolded proteins in the ER, reducing the rate of protein synthesis through
eIF2α phosphorylation at ser51 to assure proper protein folding (Harding et al, 2000a;
Harding et al, 2000b), whilst also inducing the transcription of protein chaperones. P-eIF2α 
activation was totally eliminated when the above treatment was given in combination with
salicylate. The observation in this study appears to contradict previous work in promonocytic
cell line THP-1 where salicylate and aspirin have been shown to induce eIF2α 
phosphorylation and hence protein synthesis attenuation (Silva et al, 2007). One explanation
for the apparent difference could be that, in that study the cells were exposed to salicylates or
aspirin for a very short time, a maximum of 3 hrs for salicylate and 6 hrs for aspirin while our
observations are based on 24 hr exposure. Alternatively, it could be a cell specific response.
The current observation within this study is further supported by the significant increase in
expression of protein chaperones, specifically CHOP by Tun and HG, the induction of which
was significantly down-regulated by Sal.
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Previous findings have demonstrated that to up-regulate CHOP transcription the PERK-
eIF2α-ATF4 branch of the UPR is essential (Szegezdi et al, 2006).
Modification of ATF6 protein is important for the ER stress response. ER stressors stimulate
the cleavage of ATF6 by Site-1 protease (S1P) and Site-2 protease (S2P) into p50-ATF6,
which acts as a transcription factor. Namba and co-workers have shown that all the ER
stressors they tested (such as thapsigargin and Tun) up-regulated ATF6 mRNA expression
with the cells over-expressing ATF6 mRNA showing an enhanced ER stress response
(Namba et al, 2007). Indeed the adipocytes treated with Tun in this study showed highly
significant induction of ATF6 mRNA expression compared with the controls. Therefore, up-
regulation of ATF6 mRNA expression could be used as an indicator of activation of the
ATF6 pathway. HG also induced ATF6 mRNA expression significantly. Salicylate
significantly down-regulated the ATF6 mRNA expression induced by Tun and HG. Induction
of the ATF6 pathway is supported by the increase in expression of protein chaperones up-
regulated by ATF6. The protein expression of the chaperones, Calnexin, PDI, Ero1-Lα and 
CHOP, was up-regulated in adipocytes treated with Tun and HG. Sal again contributed to the
attenuation of the ER stress by down-regulating both the PERK and ATF6 pathways.
The most interesting observation involved Grp78/Bip expression and its effect on
hyperglycaemic condtions. The Grp78/Bip expression was significantly increased only by
Tun, which was in turn down-regulated by Sal. Despite considerable activation of the UPR,
HG did not induce Grp78/Bip expression. Studies by Zhang have made the same
observations in INS-1 pancreatic β-cells treated with HG (30mM). 
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The reason for this is, as yet, undetermined but would be of considerable interest as
Bertolotti and co-workers (Bertolotti et al, 2000) have shown that PERK is found complexed
with Grp78/Bip in cells in conditions where the cell has no apparent ER related stress. In
order to activate eIF2α, it must dissociate from Grp78 /Bip under UPR condition and our 
results clearly demonstrate that the p-eIF2α and its down-stream target CHOP are activated 
by HG. It is quite possible that another mechanism exists for PERK activation under
hyperglycaemic conditions.
The present study also investigated whether these UPR inducing factors would have an effect
on p-AktSer473 levels. Interestingly, p-AktSer473 was significantly induced by Tun and HG.
This is not a unique observation, as Hu et al. (Hu et al, 2004) also reported transient
activation of Akt during ER stress, induced by thapsigargin and Tun in MCF-7 cells. They
have also demonstrated that blocking Akt activity sensitised MCF-7 cells to ER stress-
induced apoptosis, suggesting that Akt activation is a pro-survival pathway, activated during
ER stress. Additionally studies by Ho and co-workers (Ho et al, 2006) have shown that Akt
is activated under hyperglycaemic conditions (33mM Glucose) in human umbilical vein
endothelial cells (HUVECs) within 24 hrs. The adipocytes treated with Sal alone, or in
combination with Tun or HG, induced p-AktSer473 significantly, at least two fold higher
than HG alone. This could be because of the anti-inflammatory and insulin sensitising effect
of salicylates where it inhibits the activation of nuclear factor-B (NF-B) via inhibition of
phosphorylation and subsequent degradation of IBα (Kopp & Ghosh, 1994; Pierce et al,
1996). Salicylate is an interesting molecule and in our study we have demonstrated that it
successfully alleviates ER stress induced by Tun and HG.
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From this study we could also deduce that it has attenuating effects on at least two of the
three ER stress pathways, namely, the PERK and the ATF6 pathways. The current study did
not investigate the IRE1α pathway but it remains the objective of future studies. The
mechanism by which salicylate ameliorates ER stress is unknown. One possible mechanism
could be the one demonstrated by Yuan et al. (Yuan et al, 2001) in liver and skeletal muscle
tissues of rodents. They and others have shown that salicylates can inhibit the activation of
NF-B by preventing the phosphorylation and subsequent degradation of IBα by down-
regulating IB kinase β (IKKβ) (Yin et al, 1998; Yuan et al, 2001). This mechanism might
only be accurate if the ER stress induced by HG was the result of increased inflammation.
In conclusion this chapter has addressed two main issues: 1) what can induce ER stress in
human adipocytes and 2) whether salicylate can alleviate the ER stress induced by these
factors. We have clearly demonstrated that HG induced significant ER stress in primary
human adipocytes, specifically the PERK and ATF6 pathways, and salicylate fully alleviates
this stress. In addition, salicylate also induces insulin sensitivity by activating Akt. Future
studies will examine the impact of hyperlipidaemia to examine whether this may cause
enhanced ER stress beyond that already identified for induced hyperglycaemic conditions on
adipose cells, and the impact again of salicylates on this pathway.
Chapter 5
The Effect of Hyperlipidaemia Mediating ER Stress in Human
Differentiated Abdominal Subcutaneous Predipocytes
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5.1 Introduction
In human studies dietary cholesterol, trans-fatty acids (TFAs) and saturated fatty acids (SFA)
increase the levels of atherogenic lipoproteins. As such, current recommendations stress the
need to decrease their intake to reduce coronary heart disease (CHD) (Kris-Etherton et al.,
2001). However, the best replacement for the calories supplied by dietary SFA is a matter of
controversy and the effects they cause are not clearly defined.
Current epidemiological studies examining diet, CHD and metabolic risk have
examined dietary effects based on circulating lipoproteins (Brown et al., 2007; Hu et al.,
1997; Mozaffarian and Clarke, 2009; Zock et al., 1997). Cross-sectional data suggest that
SFA adversely affects vascular function whereas polyunsaturated fat (PUFA; mainly linoleic
acid and omega-3 fatty acids (18: 2n-6) n-3 PUFA) appear beneficial (Hall, 2009). Dietary
fats, represents an independent risk factor for CVD and previous studies have shown
eicosapentaenoic acid (EPA) and DHA (Docosahexaenoic acid) to reduce blood pressure,
improve arterial compliance in subjects with T2DM and dyslipidaemia, and augment
endothelium-dependent vasodilatation (Jakobsen et al., 2009). Further meta-analysis
comparing habitual TFA consumption with CHD outcomes in prospective cohort studies
identified that each 2% energy replacement of TFAs with SFAs, mono-unsaturated fatty acids
(MUFAs) or PUFAs would lower CHD risk by 17% (SFA; 95% confidence interval (CI)=7-
25%), 21% (MUFAs 95% CI=12-30%) or 24% (PUFAs 95% CI=15-33%), respectively
(Brown et al., 2007; Jakobsen et al., 2009; Mozaffarian and Clarke, 2009). However these
studies merely provide correlation data and not cause-and-effect relationship, nor do such
studies help us distinguish between the diets, as many logistical issues prevent this insight
such questions and answers remain challenging (Merkel et al., 2001). In addition, it would
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seem necessary to address how acute are the post-prandial effects of diet (high SFA, high
PUFA, high CHO, HG or fibre rich meal) on systemic inflammation as well as the
intracellular response to such an insult (Jakobsen et al., 2009; Kelley et al., 2009).
It is already well established that a prominent feature of the MS is
hypertriglyceridaemia, which frequently accompanies a more general dyslipidaemia.
Hypertriglyceridaemia has direct effects on the endothelium, but atherosclerotic plaque
initiation and progression are also highly related to increased concentrations of small dense
LDL, low plasma concentrations of HDL-cholesterol and the increased inflammatory
environment (Esteve et al., 2005). Obesity, coupled to the resistance of AT to the anti-
lipolytic effects of insulin, results in a chronic elevation of circulating non-esterified fatty
acids (Frayn and Coppack, 1992). This has many important effects including (i) increased TG
secretion by the liver, (ii) production of intracellular intermediates (e.g in myocytes,
endothelial cells) that interfere with insulin signalling (ceramide, diglycerides), inhibit nitric
oxide formation, and promote inflammation, (iii) increased basal insulin secretion and
decreased glucose sensitivity of the pancreatic beta-cell and (iv) ectopic accumulation of TG
in non-AT cell types e.g. myocytes, hepatocytes and pancreatic beta-cells. All these changes
lead to increased diabetic risk coupled with atherosclerosis and CVD which are evident
within the pre-diabetic period, i.e. well before the pancreatic beta-cells have lost the ability to
secrete increasing amounts of insulin that compensates for the increased insulin resistance.
The adipokines leptin and adiponectin, the concentrations of which vary reciprocally as
obesity develops, both stimulate fatty acid oxidation in ectopic tissues, thus protecting them
from the effects of excessive delivery of fatty acid moieties (either as un esterified fatty acids
or as TG within TG-rich lipoproteins) (Sharma and Chetty, 2005; Valle et al., 2005). In
addition, leptin promotes intracellular TG lipolysis in these tissues. As such adipokine
secretion, which is increased in insulin resistant conditions, has reciprocal effects on hepatic
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glucose production, and thus poor glycaemic control, which indirectly contributes to
dyslipidaemia (Valsamakis et al., 2004).
The aims of this chapter were to examine the potential effects of
hyperlipidaemic like conditions on in vitro treated human AbSc adipocytes and ascertain the
role of the anti-inflammatory agent, sodium salicylate (Sal) on ER stress in cultured primary
human adipocytes in the presence and absence of hyperlipidaemic conditions; finally to
assess the comparative effects on adipokine release in treatments.
112
5.2 Research Design and Methods
5.2.1 Subjects. Human AbSc AT was collected from patients undergoing elective or
liposuction surgery with informed consent obtained in accordance with LREC guidelines and
with ethics committee approval. All tissue samples were flash frozen and/or utilised for
isolation of stromal fraction, subsequently used for culturing primary human adipocytes as
detailed (McTernan et al., 2002).
5.2.2 Cell Culture
AbdSc AT was digested with collagenase (Worthington Biochemical, Reading, USA) as
previously described to isolate mature adipocytes and pre-adipocytes (Harte et al., 2003).
Firstly, stromal fractions of Human AbSc AT (BMI 25.04±0.6kg/m
2
; n = 3-6) were cultured
into tissue culture flasks until confluent and then trypsinised to obtain cells to carry out the
study. The preadipocytes from the same passage were grown in 6-well plates to confluence
in DMEM/Ham’s F-12 phenol-free medium (Invitrogen, Paisley, UK) containing 10% FCS,
penicillin (100 U/ml), streptomycin (100 µg/ml), and transferrin (5 µg/ml). At confluence,
preadipocytes were differentiated in preadipocyte differentiation media (Promocell,
Germany) containing biotin (8 μg/ml), insulin (500 ng/ml), Dexamethasone (400 ng/ml), 
IBMX (44 μg/ml), L-Thyroxin (9ng/ml) and Ciglitazone (3μg/ml) for 72 hrs. After this 
period, the differentiating cells were grown in nutrition media containing DMEM/Ham’s F-
12, 3% FCS, d-biotin (8 μg/ml), insulin (500 ng/ml) and Dexamethasone (400 ng/ml) until 
fully differentiated (14-18 days). The viability of adipocytes was assessed using the trypan
blue dye exclusion method (Sigma-Aldrich Corp., Poole, UK) (Matthews et al., 1985).
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5.2.3 Treatments
Fully differentiated adipocytes (day 15) were grown in normal DMEM/Ham’s F-12 phenol-
free medium containing only 2% serum (detoxification media) for 24 hrs to remove effects of
growth factors and other components in nutrition media. The treatments were then placed in
the fresh detoxification media for 24 hrs. The cells were treated with Tun (750ng/ml); SFA
(2mM), glucose (25mM, Sigma-aldrich, Poole, UK) and sodium salicylate (Sal: 20mM;
Sigma-aldrich, Poole, UK), 4-Phenyl butyric acid (PBA: 20mM; Sigma-aldrich, Poole, UK)
and Taurine-conjugated ursodeoxycholic acid (TUDCA:500 µg/ml, Sigma-aldrich, Poole
UK) for 24 hrs. SFA was prepared as 40mM stocks by dissolving stearic palmitic acid
mixture (referred to as SFA (Fluka, UK) in absolute ethanol and then lyophilising it. The
lyophilised SFA was re-constituted in 1 ml 3% BSA (Free-fatty acid free) in Geys buffer by
vortexing and sonicating. The dissolving buffer without SFA was used as control whenever
SFA was used as treatment. All the data shown in this study is from 24 hr treatments, only.
5.2.4 Quantitative Measurement of Secreted Adipokines Concentration From
Treated Differentiated Preadipocytes
Conditioned media from control cultured differentiated adipocytes and from treated
differentiated adipocytes, were assayed for leptin, and IL-6 using human ELISA kits (leptin,
IL-6, Millipore, Cheshire, UK). Conditioned media were analysed using a solid phase
enzyme-linked immunosorbant assay, the leptin ELISA had an assay limit of 0.5 ng/ml, intra
assay coefficient of variance (CV) of 2.6-4.6% and inter-assay variability was 1.4-4.9%; IL-6
ELISA had an assay limit of 0.3 pg/ml, intra assay coefficient of variance (CV) of 4.5-6.9%
and inter-assay variability was 6.2-8.0%. Methodology for the full protocol of a standard
ELISA is given in the materials and methods.
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5.2.5 Immunoblotting
As outlined previously, cells were washed in PBS and harvested in 250 μl of lysis buffer (20 
mM Tris-HCl, pH 7.5; 137 mM NaCl; 1mM EGTA, pH 8; 1% Triton X-100; 10% glycerol;
1.5mM MgCl2) containing protease and phosphatase inhibitors (10 mM NaF; 1 mM PMSF; 1
mM sodium metavanadate; 5 μg/ml aprotinin; 10 μg/ml leupeptin) and stored at -80˚C until 
required (Harte et al., 2003). Protein (10-20μg) from cell lysates were resolved by SDS-
PAGE and transferred to an Immobilon-P membrane (Millipore, Cheshire, UK) by
electroblotting. The membranes were blocked with 0.2% I-BlockTM (Applied Biosystems,
Warrington, UK); 0.1% Tween20 in PBS and probed with primary and secondary antibodies.
Primary antibodies were: phospho and total Akt, phospho and total eIF2α, Bip/GRP78, 
Calnexin, Protein disulfide isomerase (PDI), Ero1-Lα, phospho-PERK (p-PERK), IRE1α and 
β-actin (Cell Signalling Technologies, Massachusettes, USA). Antigen-antibody complexes 
were visualised using ECL reagents (Amersham, UK). Scanned autoradiographs were semi-
quantified using 2D densitometry software (GeneTools, Syngene, UK). The bands were first
normalised as a function of the loading control (protein of interest/β-actin) or total expression 
of the proteins (for phosphor proteins), then converted to fold change compared with
controls.
5.2.6 Extraction of RNA and Quantitative RT-PCR
To characterise gene expression, RNA was extracted from differentiated adipocytes,
according to manufacturers’ instructions (RNeasy Lipid Tissue Mini Kit, Qiagen, UK).
Following DNase treatment and reverse transcription, mRNA expression levels were
determined using an ABI 7500 Real-time PCR Sequence Detection system (Anderson et al.,
2001). Pre-optimised quantitative primer and probe sequences for genes were utilised
(Applera, Cheshire, UK). All reactions were multiplexed with the housekeeping gene 18S,
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provided as a pre-optimised control probe (Applera, Cheshire, UK), enabling data to be
expressed in relation to an internal reference to allow for differences in relative threshold
efficiency. Data were obtained as cycle threshold (Ct) values (the cycle number at which
logarithmic PCR plots cross a calculated threshold line) and used to determine ΔCt values 
(ΔCt=Ct of 18S housekeeping gene subtracted from Ct of gene of interest). Measurements 
were carried out on at least three occasions for each sample. To exclude potential bias due to
averaging, data have been transformed through the Power equation 2-ΔΔCt, all statistics were
performed at this stage.
5.2.7 Statistical Analysis
Data in the text and figures are presented as mean ± standard error of the mean (SEM) for at
least three independent experiments performed in triplicates to ensure reproducibility. Students’
t test was used to compare values between two groups unless stated otherwise. P values <0.05
were considered to represent statistically significant differences.
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5.3 RESULTS
5.3.1 PERK and ATF6 Pathways Altered by SFA in Fully Differentiated Primary
Human Preadipocytes
 The protein, p-eIF2α, is the down-stream-target of p-PERK and was significantly induced by 
Tun and SFA - both of which significantly up-regulated the p-eIF2α expression compared 
with cells treated just with the control (Figures. 5.3.1.1 & 5.3.1.2). In addition, the anti-
inflammatory agent Sal led to a significantly down-regulated expression of p-eIF2α in 
adipocytes treated with Tun and SFA in combination with Sal (Figures. 5.3.1.1 & 5.3.1.2),
whilst there was no change in the total eIF2α expression levels. 
Figure: 5.3.1.1 p-eIF2α protein expression in Tun treated adipocytes, either alone or in combination with 
Sal, as measured by Western blot (n=3-6). In the figure, values are presented as the mean ± SEM
expressed as a relative fold difference to control, which was given an arbitrary value of 1.
P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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The ATF6 mRNA level was significantly increased in the cells treated with Tun but was not
significant in SFA treated cells (Figure 5.3.1.3). ATF6 mRNA levels were significantly
down-regulated in adipocytes treated with Tun in combination with Sal and Sal alone (Figure
Figure 5.3.1.2 p-eIF2α protein expression in SFA treated adipocytes, either alone or in 
combination with Sal, as measured by Western blot (n=3-6). In the figure, values are presented as
the mean ± SEM expressed as a relative fold difference to control, which was given an arbitrary
value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test
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5.3.1.3). Sal also down-regulated ATF6 mRNA expression in SFA treated cells, although this
was not significant (Figure 5.3.1.3).
Figure 5.3.1.3 ATF6 mRNA expression in adipocytes treated with Tun and SFA, either alone or in
combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the figure, values are
presented as the mean ± SEM expressed as a relative fold difference to control, which was given
an arbitrary value of 1. No significant differences were noted compared with control. P- Values
*p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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5.3.2 Down-stream targets of PERK and ATF6 Pathway are Up-regulated
by Tun and SFA: Sal Alleviates ER Stress Response
Grp78/Bip was significantly increased in SFA treated cells (Figures. 5.3.2.1). Sal
significantly down-regulated the expression of Grp78/Bip in SFA treated cells (Figures.
5.3.2.1).
Figure 5.3.2.1 Protein expression levels of Grp78/Bip in SFA treated adipocytes either alone or
in combination with Sal as measured by Western blot (n=3-6). In the figure, values are presented
as the mean ± SEM expressed as a relative fold difference to control, which was given an
arbitrary value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test
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Another protein chaperone, Calnexin, was significantly up-regulated by SFA, which was
significantly down-regulated by Sal (Figure. 5.3.2.4). Sal alone also significantly suppressed
the Calnexin expression compared with control.
Figure 5.3.2.2 Protein expression levels of Calnexin in SFA treated adipocytes, either alone or in
combination with Sal, as measured by Western blot. In the figure, values are presented as the
mean ± SEM expressed as a relative fold difference to control, which was given an arbitrary
value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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The mRNA expression of protein chaperones, PDI and Ero1-Lα, were significantly increased 
in Tun and SFA treated adipocytes (Figures. 5.3.2.3 & 5.3.2.4).
Figure 5.3.2.3 PDI mRNA expression in adipocytes treated with Tun and SFA, either alone or
in combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the figure, values
are presented as the mean ± SEM expressed as a relative fold difference to control, which was
given an arbitrary value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test
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Figure 5.3.2.4 Ero1-Lα mRNA expression in adipocytes treated with Tun and SFA, either alone 
or in combination with Sal.The mRNA was determined by qRT-PCR (n=6). In the figure, values
are presented as the mean ± SEM expressed as a relative fold difference to control, which was
given an arbitrary value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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In adipose cells the expression of the chaperones was down regulated in response to
Salicylate treatment in combination with SFA. To examine this pathway further mRNA
expression of the ER stress-induced apoptotic transcription factor, CHOP, in Tun and SFA
treated primary adipocytes. All these treatments significantly increased CHOP expression (at
least 2-fold) (Figure. 5.3.2.5). In adipose cells Sal co-treated with SFA had a more
significant impact on down-regulating CHOP expression than Tun and Sal (Figure. 5.3.2.5).
Figure 5.3.2.5 CHOP mRNA expression in adipocytes treated with Tun and SFA, either alone
or in combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the figure,
values are presented as the mean ± SEM expressed as a relative fold difference to control,
which was given an arbitrary value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
124
5.3.3 Activation of AktSer473 in Response to High SFA
Akt activation was examined by measuring p-AktSer473 levels in the adipocytes treated with
SFA alone and in combination with Sal. SFA showed no effect on the induction of p-
AktSer473. There was significant induction by Sal in adipocytes treated with SFA (Figures:
5.3.3.1). Sal alone also significantly increased p-AktSer473 levels (Figures: 5.3.3.1).
Figure 5.3.3.1 Expression of p-AktSer473. Protein expression levels of p-AktSer473 in SFA treated
adipocytes, either alone or in combination with Sal, as measured by Western blot. In the figure,
values are presented as the mean ± SEM expressed as a relative fold difference to control (C), which
was given an arbitrary value of 1 (n=3-6). P-Values *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
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5.3.4 Secretion of Adipokines in Response to Inducers of Stress
5.3.4.1 IL-6 Secretion in Response to Treatment
Due to the variability in individual human pre-adipocytes compared across treatment
regimens, data were expressed as relative fold standardised to control when the Western blot
data were examined. From these studies the impact of a known positive inducer of ER stress,
Tun, was examined as well as HG (25mM), and high SFA (2mM) alone compared with
untreated differentiated AbSc pre-adipocyte cells. Tun, HG and SFA all significantly induced
IL-6 secretion (Control: 1(SEM) ± 0.0; Tun: 3.12±1.03**; Glucose: 2.88 ± 0.22**; SFA:
74.31 ±10.33***; P-Values: **p<0.01 and ***p<0.001; Figure 5.3.4.1).
Figure 5.3.4.1 Secretion of interleukin 6 IL-6 in response to treatment. Secretion of IL-6 in Tun
(750ng/ml), glucose (25mM) or SFA (2mM) treated differentiated AbSc adipocytes as measured by
ELISA. In the graph, values are presented as the mean ± SEM (n=6). P-Values: **p<0.01 and
***p<0.001 by Student’s t-test.
***
**
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5.3.4.2 Leptin Secretion in Response to Treatment
From these studies the impact of leptin secretion was examined following treatment with
Tun, HG (25mM) or high SFA (2mM) alone compared with untreated differentiated AbSc
pre-adipocyte cells used as a control set and given an arbitrary value of 1. SFA significantly
reduced the leptin secretion (Control: 1(SEM) ± 0.0; Tun: 1.50 ± 0.35; Glucose: 1.36 ± 0.56;
SFA: 0.46 ± 0.23**; P-Values: **p<0.01; Figure 5.3.4.2).
Figure 5.3.4.2 Secretion of leptin in response to treatment. Secretion of leptin in Tun (750ng/ml),
glucose (25mM) or SFA (2mM) treated differentiated AbSc adipocytes, as measured by ELISA. In
the graph, values are presented as the mean ± SEM (n=6). P-Values: **p<0.01 by Student’s t-test.
**
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5.3.4.3 IL-6 Secretion in Response to SFA, Chemical Chaperones: PBA,
TUDCA and Salicylate
For these studies the impact of leptin secretion was examined following treatment with Tun,
TUDCA and PBA in the presence of SFA (2mM) alone and SFA in combination with Sal.
Untreated differentiated AbSc pre-adipocyte cells were used as a control and set an arbitrary
value of 1 for comparison. SFA significantly induced IL-6 secretion. The chemical chaperone
PBA didn’t have any effect while TUDCA and Sal significantly reduced the IL-6 secretion
induced by SFA (Control: 1(SEM) ± 0.0; SFA: 74.31 ± 10.33***; SFA/PBA: 76.05 ±
17.43***; SFA/TUDCA: 42.10 ± 9.15*** SFA/Sal: 10.47 ± 0.54***; P-Value: ***p<0.001;
Figure 5.3.4.3).
Figure 5.3.4.3 Secretion of IL-6 in response to treatment. Secretion of IL-6 in SFA (2mM) alone or in
the presence of 4-Phenyl butyric acid (PBA: 20mM), Taurine-conjugated ursodeoxycholic acid
(TUDCA:500 µg/ml), or sodium salicylate (Sal: 20mM) in cultured differentiated AbSc adipocytes as
measured by ELISA. In the graph, values are presented as the mean ± SEM (n=6). P-Value:
***p<0.001 by Student’s t-test.
***
***
***
***
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5.3.4.4 Leptin Secretion in Response to SFA, Chemical Chaperones: PBA, TUDCA and
salicylate.
For these studies the impact of leptin secretion was examined following treatment with Tun,
TUDCA and PBA in the presence of SFA (2mM) alone and SFA in combination with Sal.
Untreated differentiated Abd Sc pre-adipocyte cells were used as a control and set an
arbitrary value of one for comparison. SFA significantly reduced the leptin secretion which
was further reduced by PBA and Sal while TUDCA had no effect (Control: 1(SEM) ± 0.0;
SFA: 0.45 ± 0.13**; SFA/PBA: 0.13 ± 0.10***; SFA/TUDCA: 0.45 ± 0.01*** SFA/Sal:
0.16 ± 0.12***; P-Value: ***p<0.001; Figure 5.3.4.4).
Figure 5.3.4.4 Secretion of leptin in response to treatment. Secretion of Leptin in SFA (2mM) alone
or in the presence of 4-Phenyl butyric acid (PBA: 20mM), Taurine-conjugated ursodeoxycholic acid
(TUDCA:500 µg/ml), or sodium salicylate (Sal: 20mM) in cultured differentiated AbSc adipocytes as
measured by ELISA. In the graph, values are presented as the mean ± SEM (n=6). P-Value:
***p<0.001 by Student’s t-test.
**
***
***
***
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5.4 DISCUSSION
The results of the present chapter demonstrate that firstly, SFA can induce ER stress related
mechanisms. Further that activation of SFA mediated stress can be alleviated by salicylates
and therefore could contribute to increased insulin sensitivity in human differentiated
adipocytes. Free fatty acids (FFA or SFA) have been shown to be elevated in blood during
obesity and T2DM and an ability to alleviate this stress within AT provides proof of concept
for the importance of ER stress mechanisms and the significance to reduce them (Boden,
2005; Reinehr et al., 2004).
The differentiated adipocytes were treated with SFA with and without PBA, Tun and
TUDCA, as well as SFA with and without Sal. The current data demonstrated that SFA
activates the PERK pathway. This activation was measured by looking at the expression
levels of p-eIF2α, a down-stream target of PERK, which was significantly increased with Tun 
and SFA treated adipocytes and this was downregulated by Sal. PERK is activated in
response to accumulation of misfolded proteins in the ER, reducing the rate of protein
synthesis through eIF2α phosphorylation at ser51 to assure proper protein folding (Harding et
al., 2000a; Harding et al., 2000b). This also induces the transcription of protein chaperones.
P-eIF2α activation was totally eliminated when SFA treatment was given in combination 
with sal in a similar fashion to the effect noted with HG.
These studies also addressed the protein expression of chaperones, Calnexin, PDI,
Ero1-Lα and CHOP, showing them to be induced by Tun and/or SFA, with the induction 
being significantly down-regulated in the presence of Sal. It has been shown that to up-
regulate CHOP transcription the PERK-eIF2α-ATF4 branch of the UPR is essential 
(Szegezdi et al., 2006).
130
Namba and co-authors (Namba et al., 2007) have shown that all the ER stressors they
examined, such as thapsigargin and Tun up-regulate ATF6 mRNA expression with the cells
over-expressing ATF6 mRNA showing an enhanced ER stress response. Within these current
studies, adipocytes treated with Tun induced ATF6 mRNA expression. In addition, treatment
with sal significantly down-regulated the ATF6 mRNA expression induced by Tun or SFA,
whilst there was no marked reduction in ATF6 mRNA expression with SFA and Sal
treatment. The reason for the lack of response may relate to the time points investigated,
whilst SFA may have a potent effect early on regarding mRNA regulation, this may have
been lost post 24 hrs, further data discussed later examining AKT may also support this
notion.
An interesting observation was noted with Grp78/Bip expression. The Grp78/Bip
expression was significantly increased by Tun and SFA which was in turn down-regulated by
Sal. Despite considerable activation of the UPR, HG did not induce Grp78/Bip expression in
contrast to SFA. This is of note as previous work has suggested that PERK is found in a
complex with Grp78/Bip in cells without ER stress conditions or in an inactive state
(Bertolotti et al., 2000; Zhang et al., 2009). However under SFA conditions, both Grp78/Bip
expression and eIF2α are upregulated in the presence of SFA and its down-stream target 
CHOP is also activated by SFA. It therefore seems likely, as noted for hyperglycaemic
conditions, that another mechanism exists for PERK regulation in SFA conditions.
The present study also investigated whether these UPR inducing factors would have
an effect on p-AktSer473 levels. However under these present conditions it seemed p-
AktSer473 was unaffected by SFA treatment, which also mirrored the lack of ATF6 mRNA
expression. These two observations may be a result of the quick response to SFA inducing an
immediate response that is not observed 24 hrs post treatment. Studies by Hu and co-authors
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have also observed transient activation of Akt during ER stress, induced by thapsigargin and
Tun in MCF-7 cells (Hu et al., 2004).
Finally the down-stream effects on adipokine secretion were analysed to examine
whether, in addition to mediating ER stress, mechanisms considered relevant to ER stress,
such as NFB and JNK pathways could be affected by SFA, glucose and mediators known to
induce ER stress. Current literature indicates a relationship between ER stress and the NFB
and JNK pathways but the intracellular mechanistic cross-talk between them is unknown.
However the current data does highlight that SFA, HG and Tun mediate release of IL-6, with
SFA showing a substantial increase in IL-6 compared to the other treatments. In contrast,
analysis of leptin secretion indicated that SFA treatment led to a reduction in leptin release,
whilst glucose and Tun appeared to have no apparent effect on the adipokine release. These
findings appear consistent with previous work examining release of IL-6 and leptin, amongst
other cytokines, although the explanation for this was not conjectured (Ryan et al., 2010;
Wang et al., 2005). However the differences in adipokine release may highlight the subtle
differences in the pro-inflammatory nature of the adipokines. IL-6 is often examined as the
first acute pro-inflammatory cytokine in human AT, as this cytokine appears dramatically
affected by cellular insults. In contrast, leptin may act as a chronic inflammatory cytokine
when such an insult persists - in this case the 24 hr treatment may not have been long enough
to see a pronounced response. Further examination of IL-6 response with SFA alone, and in
combination with ER stress inducers, noted that all treatment regimens increased IL-6 release
significantly and, perhaps, indirectly indicating that known stressors of ER stress as well as
SFA can impact on regulation of IL-6. The chemical chaperones PBA and TUDCA are
known to reduce ER stress in various cell systems and therefore their effect was examined for
IL-6 and leptin release in combination with SFA treatments. The PBA seems to have no
effect on IL-6 secretion while TUDCA significantly downregulated the SFA induced IL-6
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secretion. In the case of leptin release, neither SFA nor any ER stressor caused up-regulation
of leptin - in fact, there appeared to be a specific reduction in leptin secretion. The chemical
chaperones had opposite effect to what was seen for IL-6 secretion. The reason for this in the
literature is unclear but, again, may indicate leptin’s role as more than a pro-inflammatory
mediator as well as a potential chronic role in inflammation not observed in the first 24 hrs
post insult. In the case of leptin it was PBA which further downregulated the leptin secretion
compared to TUDCA. They may be affecting the ER stress pathways by different
mechanisms and need to be investigated further. It would be of interest to explore this
apparent disparity further, but this was considered beyond the scope of these current studies.
In summary, SFA had a clear impact on ER stress, although it highlighted some subtle
differences in the intracellular pathways between the Tun, high glucose and SFA. This
chapter may suggest SFA has perhaps a more acute effect on p-AktSer473 and ATF6 mRNA
expression which measurement at 24 hr was unable to show. Down-stream signals
highlighted a dramatic effect of SFA treatment on IL-6 secretion from adipose cells which
suggested that SFA had a considerable impact on pro-inflammatory status. These studies also
observed the clear impact of sal, which significantly alleviated ER stress induced by Tun and
SFA. Taken together, it appears that SFA may have a more pronounced immediate impact on
ER stress than glucose, although with chronic elevation of both, as noted in conditions of
diabetes, this may not ultimately lead to much differentiation between disease progression in
the long-term.
Chapter 6
The Effect of Lipopolysaccharide Mediating ER Stress in Human
Differentiated Abdominal Subcutaneous Preadipocytes
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6.1 Introduction
Whilst the role of SFA in increasing inflammation and CVD risk seems implicit, intertwined
with this is the potential role of metabolic endotoxinaemia (Al-Attas et al., 2009; Baker et al.,
2009; Brun et al., 2007; Creely et al., 2007; Ghoshal et al., 2009; Hansson, 2005; Kris-
Etherton et al., 2001; Miller et al., 2009; Shoelson and Goldfine, 2009; Winer et al., 2009). In
essence this is when gut derived bacteria releases a toxin, known as lipopolysaccharide (LPS)
or endotoxin, that has a strong affinity for chylomicrons (lipoproteins that transport dietary
long chain SFA through the gut wall), cross the GI mucosa to increase inflammation
exacerbated postprandially (Ghoshal et al., 2009). Recent data have highlighted that absorbed
gut bacteria, LPS, is raised in patients with T2DM and CVD, which can also affect blood
pressure (Al-Attas et al., 2009; Baker et al., 2009; Creely et al., 2007; Fogelstrand et al.,
2004; Wei et al., 2007). Additionally, recent human studies have explored the effect of a high
fat, high carbohydrate meal on circulating LPS levels in healthy individuals and shown
substantially increased circulating LPS, in conjunction with markers of inflammation - as
noted from mononuclear blood cells (Barcia and Harris, 2005; Ghanim et al., 2009). Murine
studies have also identified an association between LPS and insulin resistance, through
infusion of endotoxin, with the same effect also noted by a high fat diet (Cani et al., 2007);
with insulin resistance and weight gain both impacting on gut permeability (Brun et al., 2007;
Cani et al., 2007; Miller et al., 2009). In addition, previous work has shown that LPS has an
immediate impact on human AT, specifically on the innate immune pathway, acting via key
receptors known as the toll like receptors (TLRs) which recognise antigens, such as LPS, to
initiate an acute phase response to infection (Kaisho and Akira, 2002). Stimulation of the
TLRs leads to intracellular activation of NFB, a key transcription factor in the inflammatory
cascade, that regulates the transcription of numerous pro-inflammatory adipokines (including
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IL-6, IL-11, PAI-1, ANG II, resistin and TNF-) in a rapid response mediated directly by AT,
leading to increased metabolic risk factors (Kopp et al., 2009; Lin et al., 2000; Muzio et al.,
2000; Song et al., 2006). Both inflammation and the resulting pro-inflammatory adipokines
may also lead to increased stress of the ER, which leads to changes in conformation of
proteins and dysregulation of normal metabolism, that also contributes to increased metabolic
risk in conditions of inflammation (Doroudgar et al., 2009; Feuerer et al., 2009; Gregor and
Hotamisligil, 2007; Hotamisligil, 2005; Nishimura et al., 2009; Ozcan et al., 2004; Shoelson
and Goldfine, 2009; Wellen and Hotamisligil, 2005; Xu et al., 2009). Supporting evidence for
the role of SFA and LPS has indirectly been provided by previous studies examining the
impact of Orilstat, a lipase inhibitor, used in the treatment of weight reduction, which leads to
both the lowering of circulating LPS and inflammation (Dixon et al., 2008). In effect, both
LPS and dietary SFA may simultaneously act on the innate immune pathway to lead to a
down-stream pro-inflammatory response via NFB, within AT. To support this concept,
previous studies have shown a direct correlation between TG and LPS in T2D subjects from a
cross-sectional study (Al-Attas et al., 2009). Furthermore, previous correlations have been
observed between insulin and endotoxin levels in humans, which may also highlight the
importance of insulin’s potential to affect gut permeability, as indicated by previous rodent
studies (Creely et al., 2007; Kris-Etherton et al., 2001; Miller et al., 2009). Taken together,
these studies highlight how subtle postprandial changes, induced by a high fat Western diet,
could influence LPS levels. Further, due to the long-term low level nature of these
inflammatory processes, abdominal weight gain and, as such, AT could directly contribute to
the continued pathogenesis of T2D and CVD through LPS induced ER stress (Hansson, 2005;
Shoelson et al., 2006). Therefore the aim of this chapter was to establish whether in vitro low
levels of LPS can induce ER stress pathways, and can this be alleviated by Salicylates as
shown for SFA and glucose.
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6.2 Research Design and Methods
6.2.1 Subjects. Human AbSc AT was collected from patients undergoing elective or
liposuction surgery, with informed consent obtained in accordance with LREC guidelines and
with ethics committee approval. All tissue samples were flash frozen and/or utilised for
isolation of stromal fraction, subsequently used for culturing primary human adipocytes as
detailed (McTernan et al., 2002).
6.2.2 Cell Culture
AbSc AT was digested with collagenase (Worthington Biochemical, Reading, USA), as
previously described, to isolate mature adipocytes and pre-adipocytes (Harte et al., 2003).
Firstly, stromal fractions of Human AbSc AT (BMI 25.04±0.6kg/m
2
; n = 3-6) were cultured
in tissue culture flasks until confluent and then trypsinised to obtain cells to carry out the
study. The preadipocytes from the same passage were grown in 6-well plates to confluence
in DMEM/Ham’s F-12 phenol-free medium (Invitrogen, Paisley, UK) containing 10% FCS,
penicillin (100 U/ml), streptomycin (100 µg/ml) and transferrin (5 µg/ml). At confluence,
preadipocytes were differentiated in preadipocyte differentiation media (Promocell,
Germany) containing biotin (8 μg/ml), insulin (500 ng/ml), Dexamethasone (400 ng/ml), 
IBMX (44 μg/ml), L-Thyroxin (9ng/ml) and Ciglitazone (3μg/ml) for 72 hrs. After this 
period, the differentiating cells were grown in nutrition media containing DMEM/Ham’s F-
12, 3% FCS, d-biotin (8 μg/ml), insulin (500 ng/ml) and Dexamethasone (400 ng/ml) until 
fully differentiated (14-18 days). The viability of adipocytes was assessed using the trypan
blue dye exclusion method (Sigma-Aldrich Corp., Poole, UK) (Matthews et al., 1985).
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6.2.3 Treatments
Fully differentiated adipocytes (day 15) were grown in normal DMEM/Ham’s F-12 phenol-
free medium containing only 2% serum (detoxification media) for 24 hours to remove effects
of growth factors and other components in nutrition media. The treatments were then placed
in the fresh detoxification media for 24 hrs. The cells were treated with LPS (100ng/ml),
tunicamycin (Tun: 750ng/ml); and sodium salicylate (Sal) (20mM) for 24 hrs. All the data
shown in this study is based on a 24 hr treatment.
6.2.4 Quantitative Measurement of Secreted Adipokines Concentration From
Treated Differentiated Predipocytes
Conditioned media from untreated, cultured, differentiated adipocytes (control) and from
treated differentiated adipocytes, were assayed for leptin and IL-6 using human ELISA kits
(leptin, IL-6; Hertfordshire, Millipore, UK). Conditioned media were analysed using a solid
phase enzyme-linked immunosorbant assay, the leptin ELISA had an assay limit of 0.5
ng/ml, intra assay coefficient of variance (CV) of 2.6-4.6% and inter-assay variability was
1.4-4.9%; IL-6 ELISA had an assay limit of 0.3 pg/ml, intra assay coefficient of variance
(CV) of 4.5-6.9% and inter-assay variability was 6.2-8.0%. Methodology for the full protocol
of a standard ELISA is given in the materials and methods.
6.2.5 Immunoblotting
As outlined previously, cells were washed in PBS and harvested in 250 μl of lysis buffer (20 
mM Tris-HCl, pH 7.5; 137 mM NaCl; 1mM EGTA, pH 8; 1% Triton X-100; 10% glycerol;
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1.5mM MgCl2) containing protease and phosphatase inhibitors (10 mM NaF; 1 mM PMSF; 1
mM sodium metavanadate; 5 μg/ml aprotinin; 10 μg/ml leupeptin) and stored at -80˚C until 
required (Harte et al., 2003). Proteins (10-20 μg) from cell lysates were resolved by SDS-
PAGE and transferred to an Immobilon-P membrane (Millipore, Hertfordshire, UK) by
electroblotting. The membranes were blocked with 0.2% I-BlockTM (Applied Biosystems,
Warrington, UK); 0.1% Tween20 in PBS and probed with primary and secondary antibodies.
Primary antibodies were: phospho and total Akt, phospho and total eIF2α, Bip/GRP78, 
Calnexin, Protein disulfide isomerase (PDI), Ero1-Lα, phospho-PERK (p-PERK), IRE1α and 
β-actin (Cell Signalling Technologies, Massachusettes, USA). Antigen-antibody complexes 
were visualised using ECL reagents (Amersham, UK). Scanned autoradiographs were semi-
quantified using 2D densitometry software (GeneTools, Syngene, Cambridge, UK). The
bands were first normalised as a function of the loading control (protein of interest/β-actin) or 
total expression of the proteins (for phosphor proteins), then converted to fold change
compared with controls.
6.2.6 Extraction of RNA and Quantitative RT-PCR
To characterise gene expression, RNA was extracted from differentiated adipocytes,
according to manufacturers’ instructions (RNeasy Lipid Tissue Mini Kit, Qiagen, Crawley,
UK). Following DNase treatment and reverse transcription, mRNA expression levels were
determined using an ABI 7500 Real-time PCR Sequence Detection system. Pre-optimiSed
quantitative primer and probe sequences for genes were utilised (Applera, Cheshire, UK). All
reactions were multiplexed with the housekeeping gene 18S, provided as a pre-optimised
control probe (Applera, Cheshire, UK), enabling data to be expressed in relation to an
internal reference to allow for differences in relative threshold efficiency. Data were obtained
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as cycle threshold (Ct) values (the cycle number at which logarithmic PCR plots cross a
calculated threshold line) and used to determine ΔCt values (ΔCt=Ct of 18S housekeeping 
gene subtracted from Ct of gene of interest). Measurements were carried out on at least three
occasions for each sample. To exclude potential bias due to averaging, data have been
transformed through the Power equation 2-ΔΔCt, all statistics were performed at this stage.
6.2.7 Statistical analysis
Data in the text and figures are presented as mean ± standard error of the mean (SEM) for at
least three independent experiments performed in triplicates to ensure reproducibility. Students
t test was used to compare values between two groups unless stated otherwise. P values <0.05
were considered to represent statistically significant differences.
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6.3 RESULTS
6.3.1 PERK and ATF6 Regulation in Response to LPS
The protein, p-eIF2α, is the down-stream-target of p-PERK and was significantly induced by 
LPS and Tun – both of which significantly induced the p-eIF2α expression compared with 
control; Tun treated cells were used as a comparison with LPS treated cells (Figure 6.3.1.1).
In contrast, Sal significantly down-regulated the expression of p-eIF2α in adipocytes treated 
with LPS and Tun (Figure 6.3.1.1). There was no change in the total eIF2α expression levels. 
Figure 6.3.1.1 Protein expression of p-eIF2α and total p-eIF2α in LPS or Tun treated adipocytes 
either alone or in combination with Sal (n=3-6). In the figure, values are presented as the mean ±
SEM expressed as a relative fold difference to control, which was given an arbitrary value of 1. P-
Values: **p<0.01 and ***p<0.001 by Student’s t-test.
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The ATF6 mRNA level was significantly increased in the cells treated with LPS and Tun
(Figure 6.3.1.2). ATF6 mRNA levels were significantly down-regulated in adipocytes treated
with LPS and Tun, in combination with Sal and Sal alone (Figure 6.3.1.2).
Figure 6.3.1.2 ATF6 mRNA expression in adipocytes treated with LPS or Tun, either alone or
in combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the figure, values
are presented as the mean ± SEM expressed as a relative fold difference to control, which was
given an arbitrary value of 1. P-Values: *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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6.3.2 Down-stream targets of PERK and ATF6 pathway are up-regulated by Tun and
LPS: Sal alleviates ER stress response
Grp78/Bip was significantly increased in Tun treated cells only (Figure. 6.3.2.1). There was
an increase in LPS treated cells but this was not significant. Sal significantly down-regulated
the expression of Grp78/Bip in Tun treated cells (Figure. 6.3.2.1).
Figure 6.3.2.1 Protein expression levels of Grp78/Bip in LPS or Tun treated adipocytes, either
alone or in combination with Sal, as shown by Western blot (n=3-6). In the figure, values are
presented as the mean ± SEM expressed as a relative fold difference to control, which wsa given
an arbitrary value of 1. P-Values: **p<0.01 and ***p<0.001 by Student’s t-test.
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Another protein chaperone, Calnexin, was significantly up-regulated by LPS and Tun but this
effect was significantly down-regulated by Sal (Figure. 6.3.2.2). Sal alone also significantly
suppressed Calnexin expression compared with the control.
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Figure 6.3.2.2 Protein expression levels of Calnexin in LPS or Tun treated adipocytes, either
alone or in combination with Sal, as measured by Western blot. In the figure, values are
presented as the mean ± SEM expressed as a relative fold difference to control, which was given
an arbitrary value of 1. P-Values: *p<0.05, **p<0.01 by Student’s t-test
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The mRNA expression of the protein chaperones PDI and Ero1-Lα were significantly 
increased in LPS and Tun treated adipocytes (Figures: 6.3.2.3 & 6.3.2.4). Sal, again,
significantly down-regulated the expression of these chaperones in the adipocytes treated in
combination with Sal, with Sal alone significantly down-regulating PDI mRNA expression
levels (Figure. 6.3.2.3).
Figures: 6.3.2.3 PDI mRNA expression in adipocytes treated with LPS or Tun, either alone or in
combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the figure, values are
presented as the mean ± SEM expressed as a relative fold difference to control, which was given an
arbitrary value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by Student’s t-test.
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Figure 6.3.2.4 Ero1-Lα mRNA expression in adipocytes treated with LPS or Tun, either alone 
or in combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the figure,
values are presented as the mean ± SEM expressed as a relative fold difference to control,
which was given an arbitrary value of 1. P-Values *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
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Signalling through PERK, ATF6 and IRE1α can induce pro-apoptotic signals during extreme 
ER stress, by activating down-stream targets such as CHOP. Therefore, we examined mRNA
expression of the ER stress-induced apoptotic transcription factor CHOP in LPS treated
primary adipocytes using Tun treated cells as a comparison. Both of these treatments
significantly increased CHOP expression (at least 2-fold) (Figure. 6.3.2.5). Interestingly, Sal
significantly down-regulated CHOP expression induced by LPS and Tun (Figure.6.3.2.5).
Figure 6.3.2.5 CHOP mRNA expression in adipocytes treated with LPs and Tun, either
alone or in combination with Sal. The mRNA was determined by qRT-PCR (n=6). In the
figure, values are presented as the mean ± SEM expressed as a relative fold difference to
control, which ws given an arbitrary value of 1. P-Values: **p<0.01 and ***p<0.001 by
Student’s t-test.
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6.3.3 Activation of AktSer473 in Response to LPS
Akt activation was examined by measuring p-AktSer473 levels in the adipocytes treated with
LPS and Tun alone and in combination with Sal. LPS and Tun treated cells significantly
induced p-AktSer473 levels compared to control. In contrast there was a significant induction
by Sal in adipocytes treated with LPS and Tun (Figure. 6.3.3.1). Whilst Sal alone also
significantly increased p-AktSer473 levels
Figure. 6.3.3.1 Protein expression levels of p-AktSer473 in SFA treated adipocytes, either
alone or in combination with Sal, as measured by Western blot. In the figure, values are
presented as the mean ± SEM expressed as a relative fold difference to control (C), which was
given an arbitrary value of 1 (n=3-6). P-Values *p<0.05, **p<0.01 and ***p<0.001 by
Student’s t-test.
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6.3.4 IL-6 Secretion in Response to Treatment
Due to the variability in individual human pre-adipocytes compared across treatment
regimens, data are expressed as relative fold compared with control, as previously shown
with Western blot data analysis. From these LPS studies, a comparison was undertaken with a
known positive inducer of ER stress, Tun, as well as HG (25mM) and high SFA (2mM) alone
compared with untreated differentiated AbSc pre-adipocyte cells (control), set an arbitrary
value of 1 (Control: 1(SEM) ± 0.0; Tun: 3.12±1.03**; Glucose: 2.88 ± 0.22**; LPS: 41.38 ±
7.12*** SFA: 74.31 ±10.33***; P-Values: **p<0.01 and ***p<0.001; Figure 6.3.4.1).
Figure 6.3.4.1 Secretion of IL-6 in Tun (750ng/ml), glucose (25mM), LPS (100ng/ml) or SFA (2mM)
treated differentiated AbSc adipocytes, as measured by ELISA. In the graph, values are presented as
the mean ± SEM (n=6). P-Values: **p<0.01, ***p<0.001 by Student’s t-test.
** **
***
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Further studies investigated the impact of known chemical chaperones shown to reduce ER
stress, TUDCA and PBA, in the presence of LPS, as well as alone, in cultured adipose cells.
Untreated differentiated AbSc pre-adipocyte cells were used as a control and set an arbitrary
value of 1 for comparison (Control: 1(SEM) ± 0.0; LPS: 41.38 ± 7.12**; LPS/PBA: 44.54 ±
10.83*; LPS/TUDCA: 13.460 ± 2.04**; P-Value: ***p<0.001; Figure 6.3.4.2).
Figure 6.3.4.2 Secretion of IL-6 in LPS (100ng/ml) alone or in the presence of 4-Phenyl butyric acid
(PBA: 20mM), Taurine-conjugated ursodeoxycholic acid (TUDCA: 500 µg/ml) in cultured
differentiated AbSc adipocytes, as measured by ELISA. In the graph, values are presented as the
mean ± SEM (n=6). P-Values: *p<0.05, **p<0.01 by Student’s t-test.
**
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6.3.5 Leptin Secretion in Response to Treatment
For these LPS studies a comparison was undertaken with Tun, as well as HG (25mM), and
high SFA (2mM) alone compared with untreated differentiated AbSc pre-adipocyte cells,
used as a control and set an arbitrary value of 1 for comparison (Control: 1(SEM) ± 0.0; Tun:
1.49±0.35; Glucose: 1.36 ± 0.56; LPS: 131.0.39 ± 7.12; SFA: 0.45 ±0.23**; P-Values:
**p<0.01; Figure 6.3.5.1).
Figure 6.3.5.1 Secretion of leptin in Tun (750ng/ml), glucose (25mM) SFA (2mM) and LPS
(100ng/ml) treated differentiated AbSc adipocytes as measured by ELISA. In the graph, values are
presented as the mean ± SEM (n=6). P-Values: **p<0.01 by Student’s t-test.
**
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Further studies investigated the impact of TUDCA and PBA, in the presence of LPS, in
cultured adipose cells in response to leptin secretion. Untreated differentiated AbSc pre-
adipocyte cells were used as a control and set an arbitrary value of 1 for comparison (Control:
1(SEM) ± 0.0; LPS: 1.31 ± 0.19; LPS/PBA: 0.41 ± 0.01**; LPS/TUDCA: 0.78 ± 0.01; P-
Value: ***p<0.001; Figure 6.3.5.2).
Figure 6.3.5.2 Secretion of leptin in LPS (100ng/ml) alone or in the presence of 4-Phenyl butyric acid
(PBA: 20mM), Taurine-conjugated ursodeoxycholic acid (TUDCA: 500 µg/ml) in cultured
differentiated AbSc adipocytes, as measured by ELISA. In the graph, values are presented as the
mean ± SEM (n=6). P-Value: **p<0.01 by Student’s t-test.
**
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6.4 DISCUSSION
This chapter sought to examine the potential role of gut derived endotoxin and its
potential impact on ER stress in cultured differentiated pre-adipocytes. Whilst aware that
other in vitro studies tend to use milligram doses of LPS, these studies examined much lower
doses to ascertain the potential effects low dose could have on intracellular metabolism. The
results of the present chapter demonstrated that, in a similar manner to SFA, LPS could
induce ER stress related mechanisms. Further that activation of LPS mediated stress could be
reduced by sal. The role of LPS as a mediator of inflammation and insulin resistance has only
been recently studied as previous human studies have highlighted that in states of diabetes and
CVD there are raised circulating LPS levels (Al-Attas et al., 2009; Baker et al., 2009; Brun et
al., 2007; Creely et al., 2007; Miller et al., 2009).
The differentiated adipocytes were treated with LPS, with and without Sal, and
compared with the effects noted for Tun, with and without Sal, for the ER stress pathway. The
current data demonstrated that LPS activated the PERK pathway. This activation was
measured by looking at the expression levels of p-eIF2α, a down-stream target of PERK 
which was significantly increased with LPS treated adipocytes. P-eIF2α activation was 
reduced when LPS treatment was given in combination with sal in a similar fashion to the
effect noted with SFA or HG.
These studies also addressed the protein expression of the chaperones. Calnexin, PDI,
Ero1-Lα and CHOP expression were induced by Tun and or/LPS, with the induction being 
significantly down-regulated in the presence of Sal. It has been shown that to up-regulate
CHOP transcription the PERK-eIF2α-ATF4 branch of the UPR is essential (Szegezdi et al.,
2006). Signalling through PERK, ATF6 and IRE1α can also induce pro-apoptotic signals 
during extreme ER stress by activating down-stream targets such as CHOP.
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Modification of ATF6 protein is also important for the ER stress response. As
discussed in earlier chapters, ER stress mediates the cleavage of ATF6 through Site-1
protease (S1P) and Site-2 protease (S2P) to form p50-ATF6, which acts as a transcription
factor. Within these current studies, adipocytes treated with Tun induced ATF6 mRNA
expression whilst treatment with LPS appeared to lead to a small but significant increase in
ATF6 mRNA expression. Furthermore Sal significantly down-regulated ATF6 mRNA
expression induced by LPS. Again, in a similar fashion to that observed for SFA, the modest
response may relate to the time points investigated, whilst LPS may have a potent effect early
on in mRNA expression this may have been lost post 24 hrs treatment.
Grp78/Bip expression appeared unregulated by LPS alone or in combination with any
treatment. Despite considerable activation of the UPR, LPS did not induce Grp78/Bip
expression. This is of note as previous work has suggested that PERK is found in a complex
with Grp78/Bip in cells without either ER stress or in an inactive state (Bertolotti et al., 2000;
Zhang et al., 2009). However, under LPS conditions, whilst Grp78/Bip expression appeared
unregulated down-stream eIF2α and CHOP was upregulated in the presence of LPS. It 
therefore seems likely, as noted for hyperglycaemic conditions, that another mechanism exists
for PERK regulation in LPS conditions. The present study also investigated whether these
UPR inducing factors would have an effect on p-AktSer473 levels under these present
conditions. The findings demonstrated that p-AktSer473 was significantly altered by LPS, in a
similar fashion to glucose.
Finally the down-stream effects on adipokine secretion were analysed. The IL-6
secretion data, in response to LPS, were compared with control as well as SFA, glucose and
Tun. Interestingly, it appeared that LPS mediated a substantial release of IL-6, and appeared
more potent than Tun and glucose, whilst SFA appeared to produce the most potent induction
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of IL-6 secretion. Analysis of leptin secretion indicated that LPS appeared to have no apparent
effect on the production of leptin from the cultured cells, compared with control or other
treatments. These findings appear consistent with previous work examining release of IL-6
and leptin amongst other cytokines (Ryan et al., 2010; Wang et al., 2005). Further
examination of IL-6 response with LPS alone, and in combination with chemical chaperones
PBA and TUDCA, noted that all treatment regimens increased IL-6 release with the most
substantial increase noted with either LPS alone or in combination with PBA. In contrast,
leptin release following treatment with LPS caused no apparent change in leptin secretion,
whilst LPS in combination with PBA appeared to reduce leptin secretion. Again, as discussed
in chapter 5, leptin may serve as a chronic pro-inflammatory agent rather than an acute one, as
observed with IL-6.
In summary, LPS had a clear impact on ER stress. The role of LPS may have clinical
importance as LPS (endotoxin) is known to have a strong affinity for chylomicrons which are
lipoprotein and support LPS to cross the GI muscoa and enter the systemic circulation
(Ghoshal et al., 2009). Therefore the insult possessed by the combined effect of LPS and
lipoprotein could lead to a dramatic increase in the ER stress pathways within human AT. In
addition, as SFA appeared to have a more acute effect on p-AktSer473 and ATF6 mRNA
expression than LPS, then both together may increase the ER stress pathways in an acute and
chronic fashion. This study further highlights the importance of LPS in it’s activation of
inflammatory pathways and the further need to examine the role of metabolic endotoxinaemia
in greater detail.
Chapter 7
Final Discussion
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7.1 Discussion
Several studies to date have examined the importance of endoplasmic reticulum (ER) stress
and its role as a contributor to insulin resistance. Much of this previous analysis has focussed
on rodent models of obesity (Ozcan et al, 2004; Ozcan et al, 2006; Gregor & Hotamisligil,
2007; Hotamisligil, 2008; Sreejayan et al, 2008; Xu et al, 2010; Yoshiuchi et al, 2009;
Aguirre et al, 2000).
However due to the often noted disparity in functionality of cellular systems between rodents
and man, co-current studies have considered the effect of ER stress within human tissues
(Boden & Merali, 2011; Deldicque et al, 2010; Kars et al, 2010). Furthermore studies have
specifically examined the role of adipose tissue as the importance of ER stress in obesity
associated cellular dysfunction becomes more evident (Miranda et al, 2010; Boden et al,
2010; van der Kallen et al, 2009; Gregor et al, 2009). The importance of the ER is clear as it
is central to the synthesis, folding and trafficking of secretory and membrane proteins, as
such the disruption of this mechanism results in an adaptive unfolded protein response
(UPR). The role of UPR is to restore the disrupted ER homeostasis and reduce stress within
the system. ER stress has multiple functional effects on many cellular systems that include
proliferation, apoptosis, differentiation, glucose homeostasis, as well as insulin signalling
(van der Kallen et al, 2009; Sreejayan et al, 2008; Ozcan et al, 2004). With regard to our
knowledge of the effect of ER stress within rodent models of obesity, we understand that
increasing ER stress leads to impaired insulin action in obese mice (Ozcan et al, 2004) ER
stress is also increased in obese, insulin resistant individuals (Boden & Merali, 2011) and
reduced in tissues of obese subjects post weight loss, in conjunction with improved insulin
sensitivity.
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However whilst there have been limited studies examining either ex vivo adipose
tissue or murine adipocyte cells lines, no work has examined mediators of ER stress and the
ER stress pathway in human differentiated adipocytes, in detail. As such the studies within
this thesis sought to examine the impact of glucose and lipids on the ER pathways, due to
their known effects as mediators of IR and the effect of lipopolysaccharide (LPS) - also
referred to as endotoxin. In previous cellular studies, endotoxin has been shown to represent a
potent stimulus of inflammatory cellular response. Furthermore recent studies with endotoxin
have indicated that chronic low levels of circulating endotoxin are increased in subjects with
diabetes. As such, these low levels can activate the innate immune pathway within adipose
tissue to mediate an inflammatory response affecting insulin sensitivity, combined with the
induction of ER stress (Lira et al, 2010; Creely et al, 2007; Al-Attas et al, 2009). In addition
to examining ER stress we were keen to also examine particular agents known to reduce ER
stress, such as the chemical chaperones 4-phenyl butyric acid (PBA), tauroursodeoxycholic
acid (TUDCA) as well as high doses of salicylates (Ozcan et al, 2009; Kars et al, 2010;
Manrique et al, 2008; Goldfine et al, 2008).
The use of salicylates in patients with T2DM, dates back more than 80 years, with its
use gaining a resurgence in recent times (Manrique et al, 2008; Goldfine et al, 2008) due to a
better understanding of some of the original concerns of Salicylate, such as it causing tinnitus
as well as gastric bleeding (Croft et al, 1971; Fernández et al, 1995). As a result,
modifications to negate these side effects may lead to a more useful therapeutic agent, as
salicylate is now known to impact on the inflammatory regulatory molecule, NFκB resulting 
in reduced hyperglycaemia (Baron, 1982) and improved insulin signaling, accompanied by an
improvement in insulin sensitivity (Yuan et al, 2001; Kopp & Ghosh, 1994; Pierce et al,
1996).
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It should be noted that TUDCA is a bile acid derivative that has been used in Europe
to treat cholelithiasis and cholestatic liver disease. Recent studies have shown that TUDCA
can improve liver and muscle insulin sensitivity in contrast to its effect in adipose tissue
(Kars et al, 2010). As such, whilst TUDCA is considered to reduce ER stress, its functions
adipose tissue may in part induce insulin insensitivity, although there is not sufficient data to
evaluate this thoroughly (Kars et al, 2010). Therefore for this thesis it was clearly relevant to
understand the mechanisms by which TUDCA and other chemical chaperones and ER stress
alleviating agents may act within human differentiated adipocytes.
Initial mRNA analysis of ER stress within human adipose tissue highlighted that
weight gain, as noted through a cross-sectional study examining adipose tissue from lean and
obese individuals, increased ER stress. This confirmed and extended previous studies in this
area (Boden et al, 2008; Gregor et al, 2009; Sharma et al, 2008). Once the initial changes in
ER stress in ex vivo human adipose tissue were observed, studies characterised the human
pre-adipopcyte abdominal subcutaneous differentiation model that would be subsequently
used to undertake the in vitro ER stress studies. For these studies it was essential to ensure
that the pre-adipocyte cells used were fully differentiated, therefore studies were undertaken
to characterise the cells using a variety of methods to confirm differentiation had occurred.
The characterisation of the cells included examination of changes in mRNA and protein
levels during differentiation, using previous studies to affirm our findings. Further analysis
was undertaken through assessment of the accumulation of lipid through oil-red O staining as
well as lipolysis and lipogenesis data and photographical evidence, as noted over time (details
are noted in chapter 4).
Once the differentiated adipocytes were fully characterised, the differentiated cells
were treated with LPS, Tun, high glucose (HG) and saturated fatty acids (SFA) with and
without salicylate. As discussed in the individual chapters, there were subtle variations in the
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impact on ER stress across the pathways and this also affected down-stream adipokine
release. However the data demonstrated that LPS, Tun, HG and SFA activated the PERK
pathway. PERK is known to be activated in response to the accumulation of misfolded
proteins in the ER, and down-stream from PERK the rate of  eIF2α phosphorylation inhibits 
overall translation to alleviate stress on ER (Harding et al, 2000a; Harding et al, 2000b).
This subsequently induced protein chaperone transcription; however addition of salicylate
reversed the PERK activation and reduced pro-inflammatory adipokine release.
Studies also examined the ATF6 pathway which also represents an important ER
stress pathway. The studies showed that in adipocytes treated with Tun, ATF6 mRNA
expression was significantly induced. Furthermore that endotoxin and high glucose
conditions also induced ATF6 mRNA expression, whilst SFA did not significantly induce
expression. Salicylate significantly down-regulated the ATF6 mRNA expression induced by
LPS, Tun and HG. Taken together, these studies have highlighted that Salicylate could
alleviate ER stress by down-regulating the PERK as well as ATF6 pathways and down-
stream adipokine signalling.
The present thesis also examined whether UPR inducing factors would have an effect
on p-AktSer473 levels. Interestingly, p-AktSer473 was significantly induced by LPS, Tun
and HG while SFA had no effect. Further studies with salicylate treating the differentiated
cells with either Sal alone or in combination with LPS, Tun or HG highlighted a significant
increase in p-AktSer473 activation at least two fold higher than LPS or HG alone. Such a
dramatic rise may have arisen due to the combined effects of Salicylate, as an anti-
inflammatory, and the insulin sensitising effects of salicylates, where it inhibits the activation
of NFB via inhibition of phosphorylation and subsequent degradation of IkBα. Within this 
thesis it could be deduced that Salicylate has alleviating effects on at least two of the three
ER stress pathways, PERK and the ATF6. As such it indicates that, in conditions of obesity,
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salicylate has the capacity to reduce protein misfolding which could have beneficial effects
on insulin signalling and insulin sensitivity. It should be stressed that, whilst salicylate may
provide a ‘proof of concept’ that it can reduce ER stress, current therapeutic side effects in
conditions such as diabetes reduces its capacity for use. However researchers are currently re-
evaluating salicylate derivates as potential new agents in the role to prevent the progression
and, in part, reverse the effects of type 2 diabetes as well as vascular disorders (Goldfine et
al, 2010; Kim, 2010; McCarty, 2010).
7.2 Future Directions
This thesis highlights the relevance of understanding ER stress and its response to various
insults in human adipose tissue. Further that ER stress represents a complex, but important
metabolic pathway which feeds into the inflammatory response exacerbated in subjects with
obesity and T2DM. The current thesis undertook novel work establishing that human
differentiated adipocytes, without previous pathological history, would react to insults
experienced in the obese and diabetic states. As such future work which would fall beyond
the current remit of these studies could examine human differentiated adipocytes, under the
same treatment regimens, taken from subjects with and without diabetes as well as those with
and without obesity. We already know from ex vivo studies that there are changes with ER
stress pathways but we are unaware of whether hyperlipidaemia, hyperglycaemia or
metabolic endotoxinaemia have chronic effects on adipose tissue from patients with obesity
or T2DM. It would therefore be interesting to ascertain whether intermittent insults, as might
be perceived postprandially, may lead to more ER stress than continual chronic treatment, as
previous studies examining the effects to SFA and glucose in human mature adipocytes in
chronic and intermittent conditions have shown (Harte et al, 2010). This could also examine
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whether postprandial influences may represent an important factor in short term changes in
the ER mechanism. Based on the collated data within this thesis, it is clear that future studies
should look at the role of the IRE1α pathway by the inducers used within this thesis as well 
as the effects of salicylates on this pathway. It would also be interesting to understand the
mechanism involving Grp78/Bip, under hyperglycaemic conditions, as well as the role of
salicylates as a suppressor of ER stress. It is also apparent that the interaction between ER
stress pathways and inflammatory pathways are not clearly understood. As such the use of
inhibitors as well as knockdown studies in particular pathways may be able to examine the
interaction between the ER, NFB and JNK and the resulting down-stream effects with and
without salicylates. This, in turn, may allow us to undertake detailed analysis on the
interaction between ER stress and inflammation and how they may be inextricably linked in
conditions of obesity and diabetes.
7.3. Conclusion
This current thesis has sought to expand our knowledge and understanding of the
actions of several mediators of insulin resistance. The current studies have highlighted the
potential activation of the ER stress pathway through intracellular signalling and insulin
pathways, which may combine to alter adipokine release and lead to further dysregulation.
Furthermore, comprehension of different metabolic states, such as obesity and diabetes, may
require a more complex understanding of the actions and influence of ER stress than has been
previously considered. It seems apparent that the peripheral nature and site of action of ER
stress necessitates much additional research in order to fully characterise the summative
effects of this intriguing organelle disruption upon the human metabolic state.
APPENDICES
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APPENDIX I : Solutions and Buffers
AI.1 WESTERN BLOTTING SOLUTIONS
1.1 Sodium Dodecyl Sulphate (SDS) (4%)
10 ml 20% SDS solution
50 ml dH2O
Solution stored at room temperature (RT)
1.2 Loading buffer
625 µl Tris-HCl (pH 6.8) 125 mM
500 µl SDS 4%
1 ml Glycerol
200 µl Dithiothreitol (DTT)
125 µl Bromophenol Blue
250 µl Distilled H2O
Electrode Buffer for SDS-PAGE Electrophoresis
REAGENT
FINAL CONCENTRATION
(X5)
QUANTITY
(DILUTED IN 1L)
Tris
1.24 x 10-1 M 15 g
Glycine
(Biorad, Hercules,
CA, USA)
9.6 x 10-1 M 72 g
SDS
20% (v/v) 25 ml
1.3 Transfer Buffer
Transfer Buffer for Electrophoretic Transfer
REAGENT FINAL CONCENTRATION(1X)
Quantity
(DILUTED IN 4L)
Tris 25 mM 15.15 g
Glycine 192 mM 72.0 g
Methanol 100% 1 L
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1.4 Phosphate Buffered Saline (PBS) (pH 7.6)
PBS 120 mM
NaCl 2.7 mM
KCL, 10 mM
1.5 PBS-Tween (PBS-T) (1.0%)
1 L PBS (prepared as above)
1 ml Phosphate Buffered Saline (PBS) (‘Tween 20’ (0.1% (v/v), Sigma UK).
Solution stored at RT.
1.6 PBS/PBS-T solution for antibody preparation (0.5%)
X quantity 1.0% PBS-T (prepared as above)
X quantity PBS (prepared as above)
1.7 Tris-buffered Saline-Tween (TBS-T) (10X): 0.5M Tris Base, 9% NaCl, pH 7.6
61 g Trizma base
90 g NaCl
1 L dH2O
Solution mixed to dissolve and pH adjusted using HCl. Solution stored at RT.
1.8 TBS-T (1X)
TBS-T (10X) diluted (1:10) with dH2O
1.9 Blocking Solution for Millipore® filters (20%)
20 g non-fat milk solution (Marvel Milk Powder, UK)
200 ml PBS 0.5% PBS (Tween 20 (0.1% (v/v), Sigma UK)
AI. 2 GENERAL CELL-CULTURE SOLUTIONS
2.1 Lysis buffer
Ammonium Chloride (NH4Cl) 0.154 mol/l
Potassium Bicarbonate (KHCO3) 10 mmol/l
2.2 Collagenase:
50mls of Hank’s Buffer Salt Solution
450mls of dH2O
5mls Pen/Strep
Stored at -20 oC
2.3 Phenol red-free medium
Dulbecco’s minimal essential medium (DMEM/F-12) Phenol red free
1% transferrin (see below)
Penicillin (100 U/ml) and streptomycin (100 mg/ml) added.
Medium was stored at 4oC.
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2.4 Transferrin
Transferrin binding-protein found in serum, is responsible for the transfer of iron to
cells. Transferrin binds Fe2+ and prevents its oxidization to Fe3+, preventing loss of
iron from the medium. The stimulatory activity of transferring is proposed to be
associated with its iron binding properties and, it is further capable of binding other
metal irons in the medium at concentrations which are toxic (Barnes et al. 1980).
AI. 3 BUFFERS & SOLUTIONS USED IN RT-PCR PROCEDURES
3.1 DNase Treatment
DNase I REACTION
BUFFER
STOP
SOLUTION
1 U/µl in
50% Glycerol
10 mM Tris-HCl (pH7.5)
10 mM CaCl2
10 mM MgCl2
200 mM Tris-HCl (pH 8.3)
20 mM MgCl2
50 mM EDTA
3.2 Reverse Transcription Buffer
100 mM Tris-HCl (pH 9.0 at 25oC)
500 mM KCl
1% Triton® X-100
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APPENDIX II: Reverse Transcription (RT) & Ouantitative Real-Time
Polymerase Chain Reaction
AII.1 mRNA.
Deoxyribonucleic acid (DNA) or genetic code within a gene encoding the protein
structure can be divided into a variable number of introns (non-coding regions) and
exons (coding regions), depending on the particular gene. RNA polymerase
transcribes the nuclear DNA, synthesising messenger ribonucleic acid (mRNA), with
any introns removed. It is these coding regions that ultimately act as ‘blueprints’,
determining the configuration and assembly of the specific polypeptide chain that will
be assembled within the ribosomes in the cell cytoplasm. Analysis of mRNA
expression, allows for estimations to be made as to the level of protein expression of a
particular gene of interest
AII.2 RT-PCR.
To carry out a PCR, complimentary cDNA is essential, as it serves as a DNA
template for RNA. This is termed ‘reverse transcription’ and subsequently allows the
synthesis of cDNA. Such a process involves ‘reading’ mRNA sequences to then
assemble a cDNA chain, that comprises the complimentary bases to that on the
mRNA strand (guanine bonds with cytosine and, adenine to thymine) (Figure
AII.2.1).
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Figure A1I.2.1 Diagram illustrating mRNA, which is then transcribed in a reverse
transcription process to yield single strands of cDNA. G, guanine; U, uracil; A,
adenine; C, cytosine; T, thymine.
AII.3 Quantitative Real-Time PCR.
Quantitative Real-time PCR uses fluorescence technology to monitor amplicon
production during each PCR cycle (for instance, in real-time). This allows analysis of
the amount of template rather than the amount of amplified product at the endpoint of
the reaction. In this study, the mRNA levels were analysed using an ABI 7700
Sequence Detection system, which utilises TaqMan chemistry for highly accurate
quantification of specific mRNA levels (Figure AII.3.1). TaqMan probes contain a
fluorescent reporter dye usually on the 5' base and a quenching dye typically on the 3'
base, which suppresses the reporter. Due to the close proximity of the two, the
quencher prevents emission of any fluorescence while the probe is intact. If the gene
of interest is present, the probe anneals between the forward and reverse primer sites
within the PCR product. When the Taq DNA polymerase replicates a template on
which a TaqMan probe is bound, its 5' exonuclease activity cleaves the probe. This
removes the reporter from the proximity of the quencher, resulting in a florescent
signal that accumulates with each cycle. The fluorescent signal yielded can be
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quantitatively measured by a laser and charged coupled device (CCD) camera,
enabling real time detection of cDNA amplification.
Figure AII.3.1 Diagram outlining TaqMan Sequence Detection Chemistry.
The probe, containing both the fluorescent reporter and quencher dyes, attached to the
complimentary target sequence on the DNA. During polymerisation, the reporter dye
is cleaved from the probe, allowing increased fluorescence of the reporter. This
fluorescence increases in intensity following each amplification cycle, thus making it
possible to monitor the reaction in real-time.
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APPENDIX III: Western Blotting
AIII.1 Calculation of Protein Content of Samples for Western Blot Analysis.
Protein samples were analysed using a spectrophotometer at 655 nm. Conversion of
optical densities to protein content (µg) was calculated by the construction of a standard
curve (Figure AIII.1.1) using bovine serum albumin (BSA) diluted in dH2O, each time
samples were assayed. No protein signal (optical density) was detected in a mixture
containing only Reagent S, Reagent A and Solution B, therefore excluding interference
with calculated protein sample concentrations.
Figure AIII.1.1 Graph to show standard curve used as a reference to calculate protein
content in samples of proteins extracted from adipose tissue and isolated adipocytes.
Bovine serum albumin was diluted in dH2O to known concentrations and absorbance
read at 655 nm on a spectrophotometer.
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AIII.2 Rainbow Marker for Protein Size Comparison in Western Blot Analysis.
Figure AIII.2.1 A ladder of proteins used as a marker (Amersham Pharmacia
Biotech, Buckinghamshire, UK), which is resolved on a 8-15% SDS-PAGE gel
(Laemmli 1970). Black bands represent the same gel exposed to photographic film
(Hyperfilm™ -max).
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Appendix IV ELISA Methodology
AIV.1 Principle of the Assay
This assay employs the quantitative sandwich enzyme immunoassay technique
detailed as follows. A monoclonal antibody specific for the protein of choice (eg IL-6
Leptin, Adiponectin) is pre-coated onto a microplate, in this case Leptin for instance.
Standards and samples are pipetted into the wells and any ‘Leptin’ present is bound
by the immobilized antibody. After washing away any unbound substances, an
enzyme-linked monoclonal antibody specific for leptin is added to the wells.
Following a wash to remove any unbound antibody-enzyme reagent, a substrate
solution is added to the wells and color develops in proportion to the amount of bound
leptin . The color development is stopped and the intensity of the color is measured.
IV.1.1 Calculation of ELISA Results.
Absorbance readings were taken of all wells in duplicates then averaged. The average
readings were subtracted from the blank standard optical density.
Then a standard curve graph was constructed by plotting the mean absorbance for
each standard on the y-axis against the concentration on the x-axis and draws a best fit
curve through the points on the graph. The data may be linearized by plotting the log
of the leptin concentrations versus the log of the O.D. and the best fit line can be
determined by regression analysis in a similar way to the protein concentration graph
undertaken for western blot as outlined in section AIII.1 above. If samples have been
diluted, the concentration read from the standard curve must be multiplied by the
dilution factor.
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1 These authors contributed equally to this work.Recent ﬁndings indicate that endoplasmic reticulum (ER) stress is signiﬁcantly increased in adipose tis-
sue of obese human subjects and is critical to the initiation and integration of pathways of inﬂammation
and insulin action. But the factors inducing ER stress in human adipose tissue are unknown. The common
factors increased in obesity and linked to insulin resistance are hyperglycaemia, hyperlipidemia and also
endotoxemia. Therefore, our aims were to investigate: (1) the role of lipopolysaccharide (LPS), high glu-
cose (HG) and saturated fatty acids (SFA) as inducers of ER stress in primary human adipocytes and (2)
whether salicylate, a known anti-inﬂammatory compound, can alleviate this effect. Components of the ER
stress pathways were studied in human abdominal subcutaneous (AbSc) adipose tissue (AT) from obese
and lean. Following the culture and differentiation of primary human preadipocytes, these adipocytes
were treated with LPS, HG, tunicamycin (Tun) and SFA either alone or in combination with sodium salic-
ylate (Sal). Markers of ER stress were signiﬁcantly increased in AbSc AT of obese. Differentiated human
adipocytes treated with LPS, Tun, HG and SFA showed signiﬁcant activation of eukaryotic translation ini-
tiation factor 2a (eIF2a) and activating transcription factor 6 (ATF6) and their down-stream targets. Sal
alleviated this effect and activated AktSer473 phosphorylation. This study presents important evidence
that: (1) there is increased ER stress in adipose tissue of obese individuals, (2) LPS, hyperglycaemia
and saturated fatty acids induce signiﬁcant ER stress in primary human adipocytes and (3) this induction
is alleviated by salicylate.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Obesity-associated inﬂammation is a key contributory factor in
the pathogenesis of type 2 diabetes mellitus (T2D) and cardiovas-
cular disease (CVD) but the fundamental mechanisms responsible
for activating innate immune inﬂammatory pathways and insulin
resistance are currently unclear. Murine studies have revealed that
one key link is increased endoplasmic reticulum (ER) stress [1]. The
ER has a central role in lipid and protein biosynthesis. During path-
ological nutrient excess, proteins formed in the ER may fail to at-
tain correct conformation and accumulation of misfolded
proteins in the ER causes stress and activates the Unfolded Protein
Response (UPR) signal [2].
The UPR signals through three ER transmembrane sensors: PKR-
like ER-regulated kinase (PERK), inositol requiring enzyme1all rights reserved.
thi).(IRE1a) and activating transcription factor 6 (ATF6) [3]. These acti-
vate an adaptive response that results in inhibition of protein
translation and increase in transcription of protein-folding chaper-
ones and ER-associated degradation genes [2,4]. PERK phosphory-
lates the eukaryotic translation initiation factor 2a (p-eIF2a) [5]. p-
eIF2a then attenuates protein synthesis and reduces ER protein
overload and also activates activation transcription factor4
(ATF4), which induces expression of many genes, including those
involved in apoptosis: C/EBP homologous protein (CHOP) [6].
ATF6 activates transcription of ER chaperones: glucose regulated
protein (Grp)78/Bip, protein disulﬁde isomerase (PDI), Ero1-La
and calnexin to augment the protein folding capacity [1].
An enhanced level of the UPR has been demonstrated in obese,
insulin-resistant human adipose tissues [7–9]. ER stress and the
UPR are linked to major inﬂammatory and stress-signalling net-
works, including the activation of JNK and IKK-NFjB pathways
which play a central role in obesity-induced inﬂammation and
metabolic abnormalities [10]. High doses of salicylates have been
shown to lower blood glucose concentrations [11]. Severely obese
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nalling through IKKb pathway and this was accompanied by im-
proved insulin sensitivity in vivo [12,13].
Although ER stress and metabolic dysfunction is associated with
obesity in rodent models, the importance of ER stress and the po-
tential inducers of ER stress in human adipocytes are not known.
Therefore, the objective of the present study was to show the exis-
tence of ER stress in obese human adipose tissue, identify the po-
tential originators of this stress and also demonstrate the role of
anti-inﬂammatory agent, sodium salicylate on ER stress in primary
human adipocytes. The primary human preadipocytes were cul-
tured and fully differentiated adipocytes were treated with most
probable factors: lipopolysaccharides (LPS), high glucose (HG),
tunicamycin (Tun) and saturated fatty acids (SFA) with and without
salicylate (Sal). ER stress pathways and Akt activationwere studied.
2. Materials and methods
2.1. Subjects
Human Abdominal Subcutaneous (AbSc) adipose tissue (AT)
was collected from patients (age: 40.8 (mean ± SD) ± 5yrs; Lean
BMI: 22.04 ± 2.6 kg/m2 and obese BMI 30 ± 3.5 kg/m2) undergoing
liposuction surgery with informed consent obtained in accordance
with LREC guidelines and with ethics committee approval. All tis-
sue samples were ﬂash frozen and/or utilized for isolation of hu-
man preadipocytes as detailed [14].
2.2. Cell culture
Human AbSc AT (BMI 25.04 ± 0.6 kg/m2; n = 3–6) were digested
with collagenase to isolate preadipocytes as described by Zuk et al.
[14]. Preadipocyteswere then cultured into tissue culture ﬂasks until
conﬂuent and then trypsinized to obtain cells to carry out the study.
The preadipocytes from the same passage were grown in 6-well
plates (104 cells/well in 2 ml media) to conﬂuence in DMEM/Ham’s
F-12 phenol-free medium (Invitrogen, UK) containing 10% FCS, pen-
icillin (100 U/ml), streptomycin (100 lg/ml), and transferrin (5 lg/
ml). At conﬂuence, preadipocytes were differentiated in differentia-
tionmedia (Promocell, Germany) containingbiotin (8 lg/ml), insulin
(500 ng/ml), Dexamethasone (400 ng/ml), IBMX (44 lg/ml), L-Thy-
roxin (9 ng/ml) and Ciglitazone (3 lg/ml) for 72 h. After this period,
the differentiating cells were grown in nutrition media containing
(NM) DMEM/Ham’s F-12, 3% FCS, D-biotin (8 lg/ml), insulin
(500 ng/ml) and Dexamethasone (400 ng/ml) until fully differenti-
ated (14–18 days). The viability of adipocytes was assessed using
the trypan blue dye exclusion method (Sigma–Aldrich) [15].
2.3. Treatments
Differentiated adipocytes (day 15) 24 h prior to treatments
were switched to detoxiﬁcation media (DMEM/Ham’s F-12 phe-
nol-free medium containing only 2% serum) to remove effects of
growth factors and other components in NM. The treatments were
then placed in the fresh detoxiﬁcation media. The cells were trea-
ted with lower or already published concentrations of LPS (100 ng/
ml) [16], Tun (750 ng/ml) [2], glucose (HG) (25 mM), SFA (2 mM)
and Sal (20 mM) for a maximum of 24 h. SFA was prepared as
40 mM stocks by dissolving Stearic Palmitic acid Mixture (Fluka,
UK) in absolute ethanol and then lyophilised and was re-consti-
tuted in 1 ml 3% BSA (Free-fatty acid free) in Gey’s balanced salt
solution (Sigma–Aldrich). The dissolving buffers or solvents were
used as controls. All the data shown in this study is from 24 h treat-
ments only, even though for LPS and Tun, lower time points of 6
and 12 h were also studied.2.4. Immunoblotting
Cells were washed with cold PBS and harvested in lysis buffer
(20 mM Tris–HCl, pH 7.5; 137 mM NaCl; 1 mM EGTA, pH 8; 1% Tri-
ton X-100; 10% glycerol; 1.5 mM MgCl2) containing protease and
phosphatase inhibitors (10 mM NaF; 1 mM PMSF; 1 mM sodium
metavanadate; 5 lg/ml aprotinin; 10 lg/ml leupeptin) (Sigma–Al-
drich, UK) and stored at 80 C until required. SDS–PAGE andWes-
tern blot analysis were performed as described [16]. Primary
antibodies were: phospho and total Akt, phospho and total eIF2a,
Bip/GRP78, Calnexin, PDI, Ero1-La, phospho-PERK (p-PERK), IRE1a
and b-actin (Cell Signalling Technologies). Antigen–antibody com-
plexes were visualized using ECL reagents (Amersham, UK). Auto-
radiographs were semi-quantiﬁed using 2D densitometry software
(GeneTools, UK). The bands were ﬁrst normalised as a function of
the loading control (protein of interest/b-actin) or total expression
of the proteins (for phosphor proteins), then converted to fold
change compared with controls.
2.5. Extraction of RNA and quantitative RT-PCR
RNAwas extracted fromadipocytes (RNeasy Lipid TissueMini Kit,
Qiagen), according to manufacturers’ instructions. Following DNase
treatment and reverse transcription, mRNA expression levels were
determined using an ABI 7500 Real-time PCR Sequence Detection
system [17]. Pre-optimized quantitative primer and probe sequences
for genesATF6, Ero1-La, CHOPandPDIwereutilized (Applera, Chesh-
ire, UK). All reactions were multiplexed with the housekeeping gene
r18S (Applera). Datawere obtained as cycle threshold (Ct) values and
used to determine DCt values (DCt = Ct of gene of interest Ct of
r18s). Measurements were carried out on at least three occasions
for each sample. To exclude potential bias due to averaging, data
was transformed through the Power equation 2DDCt.
2.6. Statistical analysis
Data is presented as mean ± standard error of the mean (SEM)
for at least three independent experiments to ensure reproducibil-
ity. Students t test was used to compare values between two
groups unless stated otherwise. p Values <0.05 were considered
to represent statistically signiﬁcant differences.
3. Results
3.1. ER stress markers are up-regulated in obese human AbSc AT
Protein expression of the ER stress markers was measured in
four obese and four lean human AbSc AT. The p-PERK and IRE1a
proteins were increased in obese subjects – although this was only
signiﬁcant for IRE1a expression comparedwith lean (Fig. 1A). ATF6,
which regulates the third ER stress pathway, was investigated by
examining mRNA expression via real-time PCR, as this proved a
more reliable method [18]. ATF6 mRNA expression from AbSc AT
of 10 lean and 10 obese subjects showed to be signiﬁcantly higher
(8-fold) in obese subjects (DCt = 07.36 ± 1.47) compared with lean
(DCt = 10.57 ± 1.13) (p < 0.001) (Fig. 1B). Furthermore, the protein
expression of down-stream targets of the ER stress pathways,
Grp78/Bip1, Calnexin, PDI and Ero1-La, were all signiﬁcantly in-
creased in AbSc AT of obese subjects (Fig. 1A).
3.2. LPS, Tun, HG and SFA up-regulate PERK and ATF6 pathways in
primary human adipocytes: Sal down-regulates them
To determine the origins of ER stress fully differentiated human
adipocytes were treated with most probable factors elevated in
Fig. 1. Expression of ER stress markers. (A) Protein expression levels of ER stress
markers: p-PERK, IRE1a, Grp78/Bip, Calnexin, PDI, Ero1-La and b-actin(loading
control) in lean (n = 4) vs. obese (n = 4) human AbSc AT. The protein expression was
determined from whole AT lysate by Western blot. (B) mRNA expression of ATF6 in
human AbSc AT, Lean vs Obese: both n = 10. mRNA was determined by qRT-PCR. In
the bar ﬁgure, values are the mean ± SEM (n = 4). *p < 0.05, **p < 0.01 and
***p < 0.001 by Student’s t-test.
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ducer of ER stress was used as a positive control. The protein, p-
eIF2a, down-stream-target of p-PERK, was signiﬁcantly induced
by LPS, Tun, HG and SFA compared with cells treated just with
the solvent of these substrates (controls) (Fig. 2A and B). Sal signif-
icantly down-regulated p-eIF2a in adipocytes treated with LPS,
Tun, HG and SFA in combination with Sal (Fig. 2A and B). There
was no change in the total eIF2a expression levels. This provides
ﬁrst strong evidence that LPS, HG and SFA activate PERK pathway
while Sal alleviates this activation in human adipocytes.
The ATF6 mRNA level was signiﬁcantly increased in the cells
treated with LPS, HG and Tun but was not signiﬁcant in SFA treated
cells (Fig. 2C). ATF6 mRNA levels were signiﬁcantly down-regu-
lated in adipocytes treated with LPS, HG and Tun in combination
with Sal and Sal alone (Fig. 2C). Sal also down-regulated ATF6
mRNA expression in SFA treated cells although not signiﬁcantly
(Fig. 2C). LPS and Tun showed signiﬁcant activation of eIF2a phos-
phorylation and ATF6 expression after 6 and 12 h as well and Sal
down-regulated them (data not shown).
3.3. Down-stream targets of PERK and ATF6 pathway are up-regulated
by LPS, Tun, HG and SFA: Sal alleviates ER stress response
Protein chaperones and down-stream targets of PERK and ATF6
pathways either protein or mRNA expression levels were measured
in the adipocytes treated with LPS, Tun, HG, SFA alone or in combi-
nation with Sal. Grp78/Bip was signiﬁcantly increased in Tun and
SFA treated cells only (Fig. 3A and B). There was an increase in
LPS treated cells but this was not signiﬁcant. HG did not have
any effect on Grp78/Bip expression. Sal signiﬁcantly down-regu-
lated the expression of Grp78/Bip in Tun and SFA treated cells(Fig. 3A and B). Another protein chaperone calnexin was signiﬁ-
cantly up-regulated by LPS, Tun, HG and SFA (Fig. 3C and D) which
was signiﬁcantly down-regulated by Sal (Fig. 3C and D). Sal alone
also signiﬁcantly suppressed the calnexin expression compared
to the controls.mRNA expression of protein chaperones, PDI and
Ero1-La were signiﬁcantly increased in LPS, Tun, HG and SFA trea-
ted adipocytes and Sal signiﬁcantly down-regulated their expres-
sions (Fig. 3E and F). Only PDI wasn’t signiﬁcantly suppressed by
Sal in HG treated cells. However, Sal alone signiﬁcantly down-reg-
ulated PDI mRNA expression levels (Fig. 3E).
Signalling through PERK, ATF6 and IRE1a can induce pro-apop-
totic signals by activating down-stream targets such as CHOP. All
these treatments signiﬁcantly increased the CHOP expression (at
least 2-folds) (Fig. 3G). Interestingly, Sal signiﬁcantly down-regu-
lated the CHOP expression induced by LPS, Tun, HG and SFA
(Fig. 3G).
3.4. Activation of AktSer473
Hu et al. [19] have reported transient activation of Akt in ER-in-
duced apoptosis and p-Akt (Ser473) is also an important member
of insulin signalling pathway as it induces glucose transport and
overall insulin sensitivity of the cell. Therefore, Akt activation
was examined by measuring p-AktSer473. Interestingly, LPS, Tun
and HG signiﬁcantly induced p-AktSer473 levels compared to con-
trols. There was further signiﬁcant induction by Sal in adipocytes
treated with LPS, Tun, HG and SFA (Fig. 4A and B). Sal alone also
signiﬁcantly increased AktSer473 phosphorylation (Fig. 4A and B).4. Discussion
The results of the present study demonstrate that ﬁrstly, there
is increased ER stress in obese human AbSc AT, secondly, the fac-
tors inducing this response could be LPS, hyperglycaemia and
SFA and thirdly, this stress response is alleviated by salicylates
and could contribute to increased insulin sensitivity in adipocytes.
LPS [20], hyperglycaemia [21] and free-fatty acids [22] have all
been shown to be elevated in blood during obesity and have been
linked to increased inﬂammation and insulin resistance and there-
fore, were investigated as possible factors for inducing ER stress in
human adipocytes. Tunicamycin is a well known ER stress inducer
and therefore was used as a positive control.
ER stress protein markers were signiﬁcantly up-regulated in ob-
ese human AbSc AT compared to AbSc AT from lean subjects. The
IRE1a and ATF6 expression levels were signiﬁcantly increased in
obese AbSc AT. The p-PERK was also increased but the increase
was not signiﬁcant. This observation conﬁrms the three previous
studies carried out on human adipose tissue [7–9]. The protein
chaperones Grp78/Bip, Calnexin, Ero1-La and PDI were all signiﬁ-
cantly up-regulated in obese human AbSc AT compared to lean
AbSc AT and this conﬁrms the earlier observation [7].
To identify the factors responsible for inducing ER stress in hu-
man AT, stromal fractions isolated from human AT were cultured
and then differentiated. The differentiated adipocytes were then
treated with LPS, Tun, HG and SFA with and without salicylate.
Our data clearly demonstrates that LPS, Tun, HG and SFA activate
the PERK pathway. This activation was measured by looking at
the expression levels of p-eIF2a, a down-stream target of PERK
which was signiﬁcantly increased in LPS, Tun, HG and SFA treated
adipocytes. P-eIF2a activation was totally eliminated when the
above treatments were given in combination with salicylate. This
observation contradicts another study in promonocytic cell line
THP-1 where salicylate and aspirin have been shown to induce
eIF2a phosphorylation and hence protein synthesis attenuation
[23]. It could be a cell speciﬁc response. Our observation is further
Fig. 2. ER stress pathway expression studies from adipocytes treated with LPS, Tun, HG and SFA either alone or in combination with Sal. (A) p-eIF2a in LPS and Tun treated
adipocytes either alone or in combination with Sal. (B) p-eIF2a in HG and SFA treated adipocytes either alone or in combination with Sal. B and C were measured by Western
blot. (C) mRNA expression ATF6 in adipocytes treated with LPS, Tun, HG and SFA either alone or in combination with Sal. mRNA was determined by qRT-PCR. In the bar ﬁgure,
values are the mean ± SEM (n = 3–6). *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test.
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erones, speciﬁcally CHOP by LPS, Tun, HG and SFA and the induc-
tion of which was signiﬁcantly down-regulated by Sal. It has
been shown that to up-regulate CHOP transcription the PERK-
eIF2a-ATF4 branch of the UPR is essential [24].
Modiﬁcation of ATF6 protein is important for the ER stress re-
sponse. Namba et al. [18] have shown that all the ER stressors they
tested (such as thapsigargin and tunicamycin) up-regulated ATF6
mRNA expression with the cells over-expressing ATF6 mRNA
showing enhanced ER stress response. Indeed the adipocytes trea-
ted with tunicamycin, in this study showed highly signiﬁcant
induction of ATF6 mRNA expression and also the down-stream tar-
gets of ATF6 compared to the controls. Therefore, up-regulation of
ATF6 mRNA expression could be used as an indicator for activation
of the ATF6 pathway. LPS and HG also induced ATF6 mRNA expres-
sion signiﬁcantly while SFA did induce some expression but it was
not signiﬁcant. Salicylate signiﬁcantly down-regulated the ATF6
mRNA expression induced by LPS, Tun and HG. Induction of ATF6
pathway is supported by the increase in expression of protein
chaperones up-regulated by ATF6. The protein chaperones calnex-
in, PDI, Ero1-La and CHOP expression were induced in adipocytes
treated with LPS, Tun, HG and SFA. Sal again helps in alleviating
ER stress by down-regulating both the PERK as well as ATF6
pathways.
The Grp78/Bip expression was signiﬁcantly increased only by
Tun and SFA which was in turn down-regulated by Sal. LPS did
show activation but it was not signiﬁcant. Despite considerable
activation of the UPR, HG did not induce Grp78/Bip expression.
Zhang et al. [25] have made the same observations in INS-1 pancre-
atic b-cells treated with high glucose (30 mM). The reason for thisis not yet known and would be interesting to investigate further
because Bertolotti et al. [26] have shown that PERK is found in a
complex with Grp78/Bip in cells without ER stress conditions and
is inactive. In order to activate eIF2a, it must dissociate from Grp78
/Bip under UPR condition and our results clearly demonstrate that
the p-eIF2a and its down-stream target CHOP are activated by HG.
It is quite possible that another mechanism exists for PERK activa-
tion under hyperglycaemic condition.
The present study also investigated whether these UPR inducing
factors would have effect on p-AktSer473 levels. Interestingly, p-
AktSer473 was signiﬁcantly induced by LPS, Tun and HG while
SFA had no effect. This is not a unique observation, e.g., Hu et al.
[19] have reported transient activation of Akt during ER stress, in-
duced by thapsigargin and tunicamycin in MCF-7 cells. They have
also shown blocking Akt activity, sensitised MCF-7 cells to ER
stress-induced apoptosis, suggesting that Akt activation is a pro-
survival pathway, activated during ER stress. Ho et al. [27] have
also shown Akt activation under hyperglycaemic condition
(33 mM Glucose) in human umbilical vein endothelial cells (HU-
VECs) within 24 h. Similar observation has been made in LPS trea-
ted THP-1 cells [28]. The adipocytes treated with Sal alone or in
combination with LPS, Tun or HG induced p-AktSer473 signiﬁ-
cantly, at least two fold higher than LPS or HG alone. This could
be because of the anti-inﬂammatory and insulin sensitising effect
of salicylates, where it inhibits the activation of nuclear factor-kB
(NF-kB) via inhibition of phosphorylation and subsequent degrada-
tion of IkBa [13,29].
Salicylate is an interesting molecule and in our study we have
demonstrated that it successfully alleviates ER stress induced by
LPS, Tun, HG and SFA. From this study we could also deduce that
Fig. 3. Expression of ER stress chaperones. (A) Protein expression levels of Grp78/Bip in LPS and Tun treated adipocytes either alone or in combination with Sal. (B) Protein
expression levels of Grp78/Bip in HG and SFA treated adipocytes either alone or in combination with Sal. (C) Protein expression levels of Calnexin in LPS and Tun treated
adipocytes either alone or in combination with Sal. (D) Protein expression levels of Calnexin in HG and SFA treated adipocytes either alone or in combination with Sal. (E)
mRNA expression PDI in adipocytes treated with LPS, Tun, HG and SFA either alone or in combination with Sal. (F) mRNA expression Ero1-La in adipocytes treated with LPS,
Tun, HG and SFA either alone or in combination with Sal. (G) mRNA expression CHOP in adipocytes treated with LPS, Tun, HG and SFA either alone or in combination with Sal.
mRNA was determined by qRT-PCR. In the bar ﬁgure, values are the mean ± SEM (n = 3–6). *p < 0.05, **p < 0.01 and ***p < 0.001 by Student’s t-test.
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Fig. 4. Expression of p-AktSer473. (A) Protein expression levels of p-AktSer473 in
LPS and Tun treated adipocytes either alone or in combination with Sal. (B) Protein
expression levels of p-AktSer473 in HG and SFA treated adipocytes either alone or
in combination with Sal. Protein expression was measured by Western blot. In the
bar ﬁgure, values are the mean ± SEM (n = 3–6). *p < 0.05, **p < 0.01 and ***p < 0.001
by Student’s t-test.
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ways, namely, the PERK and the ATF6. The mechanism by which
salicylate ameliorates ER stress is unknown. One of the possible
mechanisms could be the one demonstrated by Yuan et al. [12]
where they and others have shown that salicylates can inhibit
the activation of NF-kB by preventing the phosphorylation and
subsequent degradation of IkBa by down-regulating IkB kinase b
(IKKb) [12,30].
In conclusion this manuscript has addressed two main issues:
(1) what can induce ER stress in human adipocytes and (2) that
salicylate can alleviate the ER stress induced by these factors. We
have clearly demonstrated that endotoxemia (LPS), hyperglyca-
emia (HG) and hyperlipidemia (SFA) could independently induce
signiﬁcant ER stress in primary human adipocytes speciﬁcally
and salicylate alleviated this stress. In addition, salicylate may be
inducing insulin sensitivity by activating Akt. Although all of these
factors can induce ER stress in adipose tissue the mechanism for
inducing ER stress might not be the same and future studies should
concentrate on delineating the mechanisms involved. Role of salic-
ylates as a suppressor of ER stress also needs further investigation.
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